# Patent

## Title
Nucleic acid molecules and other molecules associated with soybean cyst nematode resistance

## Abstract

The present invention is in the field of soybean genetics. More specifically, the invention relates to nucleic acid molecules from regions the soybean genome, which are associated with soybean cyst nematode resistance. The invention also relates to proteins encoded by such nucleic acid molecules as well as antibodies capable of recognizing these proteins. The invention also relates to nucleic acid markers from regions the soybean genome, which are associated with soybean cyst nematode resistance. Moreover, the invention relates to uses of such molecules, including, transforming soybean cyst nematode resistant soybean with constructs containing nucleic acid molecules from regions the soybean genome, which are associated with soybean cyst nematode resistance. Furthermore, the invention relates to the use of such molecules in a plant breeding program.

## Background
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority under 35 U.S.C. §119(e) of U.S. Application No. 60/174,880, filed Jan. 7, 2000, the disclosure of which is herein incorporated by reference in its entirety.


FIELD OF THE INVENTION
The present invention is in the field of soybean genetics. More specifically, the invention relates to nucleic acid molecules from regions of the soybean genome, which are associated with soybean cyst nematode (SCN) resistance. The invention also relates to proteins encoded by such nucleic acid molecules as well as antibodies capable of recognizing these proteins. The invention also relates to nucleic acid markers from regions of the soybean genome, which are associated with SCN resistance. Moreover, the invention relates to uses of such molecules, including, transforming SCN sensitive soybean with constructs containing nucleic acid molecules from regions in the soybean genome, which are associated with SCN resistance. Furthermore, the invention relates to the use of such molecules in a plant breeding program.
BACKGROUND OF THE INVENTION
The soybean, Glycine max (L.) Merril (Glycine max or soybean), is one of the major economic crops grown worldwide as a primary source of vegetable oil and protein (Sinclair and Backman, Compendium of Soybean Diseases, 3rd Ed. APS Press, St. Paul, Minn., p. 106. (1989)). The growing demand for low cholesterol and high fiber diets has also increased soybean's importance as a health food.
Prior to 1940, soybean cultivars were either direct releases of introductions brought from Asia or pure line selections from genetically diverse plant introductions. The soybean plant was primarily used as a hay crop in the early part of the 19th century. Only a few introductions were large-seeded types useful for feed grain and oil production. From the mid 1930's through the 1960's, gains in soybean seed yields were achieved by changing the breeding method from evaluation and selection of introduced germplasm to crossing elite by elite lines. The continuous cycle of cross hybridizing the elite strains selected from the progenies of previous crosses resulted in the modem day cultivars.
Over 10,000 soybean strains have now been introduced into the United States since the early 1900's (Bernard et al., United States National Gennplasm Collections. In: L. D. Hil (ed.), World Soybean Research, pp. 286–289. Interstate Printers and Publ., Danville, Ill. (1976)). A limited number of those introductions form the genetic base of cultivars developed from the hybridization and selection programs (Johnson and Bernard, The Soybean, Norman Ed., Academic Press, N.Y., pp. 1–73 (1963)). For example, in a survey conducted by Specht and Williams, Genetic Contributions, Fehr eds. American Soil Association, Wisconsin, pp. 49–73 (1984), for the 136 cultivars released from 1939 to 1989, only 16 different introductions were the source of cytoplasm for 121 of that 136. Certain soybean strains are sensitive to one or more pathogens. One economically important pathogen is SCN.
SCN accounts for roughly 40% of the total disease in soybean and can result in significant yield losses (up to 90%). SCN is the most destructive pest of soybean to date and accounts for an estimated yield loss of up to $809 million dollars annually. Currently, the most cost effective control measures are crop rotation and the use of host plant resistance. While breeders have successfully developed SCN resistant soybean lines, breeding is both difficult and time consuming due to the complex and polygenic nature of resistance. The resistance is often race specific and does not provide stability over time due to changing SCN populations in the field. In addition, many of the resistant soybean varieties carry a significant yield penalty when grown in the absence of SCN.
SCN, Heterodera glycines Ichinohe, was identified on soybeans in the United States in 1954 at Castle Hayne, N.C. Winstead, et al., Plant Dis. Rep. 39:9–11 (1955). Since its discovery the SCN has been recognized as one of the most destructive pests in soybean. It has been reported in nearly all states in which soybeans are grown, and it causes major production problems in several states, being particularly destructive in the Midwestern states. See generally: Caldwell, et al., Agron. J. 52:635–636 (1960); Rao-Arelli and Anand, Crop. Sci. 28:650–652, (1988); Baltazar and Mansur, Soybean Genet. Newsl. 19:120–122 (1992); Concibido, et al., Crop. Sci., (1993). For example, sensitive soybean cultivars had 5.7–35.8% lower seed yields than did resistant cultivars on SCN race-3 infested sites in Iowa. (Niblack and Norton, Plant Dis. 76:943–948 (1992)).
Shortly after the discovery of SCN in the United States, sources of SCN resistance were identified (Ross and Brim, Plant Dis. Rep. 41:923–924 (1957)). Some lines such as Peking and Plant Introduction (PI) PI88788, were quickly incorporated into breeding programs. Peking became widely used as a source of resistance due to its lack of agronomically undesirable traits, with Pickett as the first SCN resistant cultivar released (Brim and Ross, Crop Sci. 6:305 (1966)). The recognition that certain SCN resistant populations could overcome resistant cultivars lead to an extensive screen for additional sources of SCN resistance. PI88788 emerged as a popular source of race 3 and 4 resistance even though it had a cyst index greater than 10% (but less than 20%) against race 4, and Peking and its derivatives emerged as a popular source for races 1 and 3. PI437654 was subsequently identified as having resistance to all known races and its SCN resistance was backcrossed into Forrest. Currently there are more than 130 PIs known to have SCN resistance.
SCN race 3 is considered to be the prominent race in the Midwestern soybean producing states. Considerable effort has been devoted to the genetics and breeding for resistance to race 3. While both Peking and PI88788 are resistant to SCN race 3, classical genetics studies suggest that they harbor different genes for race 3 resistance (Rao-Arelli and Anand, Crop Sci. 28:650–652 (1988)). Crosses between PI88788(R) and Essex(S) segregate 9(R): 55(S) in the F2 population and 1(R): 26(Seg): 37(S) families in the F3 generation, suggesting that resistance to race 3 in PI88788 is conditioned by one recessive and two dominant genes, where as Peking and PI90763 resistance is conditioned by one dominant and two recessive genes. Based on reciprocal crosses, Peking, Forrest, and PI90763 have genes in common for resistance to SCN race 3 (Rao-Arelli and Anand, Crop Sci., 28:650–652 (1988)). A cross between Peking and PI88788 segregates 13(R):3(S) in the F2 generation, indicating a major difference between the parents for race 3 resistance. Generation mean analysis based on four crosses between resistant and sensitive genotypes; A20 (R), Jack (R), Cordell (R) and A2234 (S), suggests that an additive genetic model is sufficient to explain most of the genetic variation of race 3 SCN resistance in each cross, while the analysis of the pooled data indicates the presence of dominant effects as well (Mansur, Carriquiry and Roa-Arelli, Crop Sci. 33:1249–1253 (1993)). This analysis further indicates that race 3 resistance is probably under the genetic control of three, but not more than four genes.
RFLP analysis of segregating populations between resistant and sensitive lines; PI209332 (R), PI90763 (R), PI88788 (R), Peking (R) and Evan (S), identified a major SCN resistance QTL (rhg1) which maps to linkage group G (Concibido et al., Theor Appl. Genet. 93:234–241 (1996)). In this study, rhg1 explains 51.4% of the phenotypic variation in PI209322, 52.7% of the variation in PI90763, 40.0% of the variation in PI88788 and 28.1% of the variation in Peking. This major resistance QTL was assumed be one and the same in all of the mapping populations employed. However, as pointed out by the authors, it is possible that the genomic interval contains distinct but tightly linked QTLs. In a related study using PI209332 as the source of resistance, Concibido et al., Crop Sci. 36:1643–1650 (1996), show that a QTh on linkage group G (rhg1) is effective against the three SCN races tested, explaining 35% of the phenotypic variation to race 1, 50% of the variation to race 3, and 54% of the variation to race 6. In addition to the major QTL on linkage group G, 4 other QTLs mapping to linkage groups D, J, L and K were identified, with some of the resistance loci behaving in a race specific manner.
Concibido et al. (Crop Sci. 37:258–264 (1997)) found significant association of marker C006V to a major QTL on linkage group G (rhg1) and resistance to race 1, race 3 and race 6, in Peking and PI90763 (Evan X Peking, Evan X PI90763) and races 3 and 6 in PI88788 (Evan X PI88788), in agreement with the previous study based on the P209332 source of resistance (Concibido et al., Crop Sci. 36:1643–1650 (1996)). The resistance locus near C006V was effective against all races tested in all of the resistance sources. While statistically significant against all races, this locus accounts for different proportions of the total phenotypic variation with the races tested. For example, in PI90763 the resistance locus near C006V explains more than three times the phenotypic variation against race 1 than against race 3. The variability can be attributed to differences in the genetic backgrounds, variability among the SCN populations or may be a reflection of the limited size of the plant populations which were employed. This study further identified three additional independent SCN resistance QTLs; one near the RFLP marker A378H mapping to the opposite end of linkage group G from C006V (rhg1), one near the marker B032V-1 on linkage group J and a third linked to A280Hae-1 on linkage group N. Comparisons between the different SCN races indicated that some of the putative SCN QTLs behave in a race specific manner.
PI437654 was identified as having resistance to all known races. Based on analysis of 328 recombinant inbreed lines (RIL) derived from a cross between PI437654 and BSR101, Webb reported six QTLs associated with SCN resistance on linkage groups A2, C1, G, M, L25 and L26 (U.S. Pat. No. 5,491,081). An allele on linkage group G, presumed to be rhg1, is involved with certain SCN races tested (races 1, 2, 3, 5 and 14), and has the largest reported phenotypic effect on resistance to every race. In contrast, the QTLs on linkage groups A2, C1, M, L25 and L26 act in a race specific manner. The QTL on linkage group L25 was reportedly involved with four of the five races, while the QTLs on linkage groups, A2, C1 and L26 were each involved in resistance to two of the five races (U.S. Pat. No. 5,491,081). Webb further reports data that the resistance to any of the five races is likely to result from the combined effects of the QTL involved in each race (U.S. Pat. No. 5,491,081).
Qui et al. (Theor Appl Genet 98:356–364 (1999)) screened 200 F2:3 families derived from a cross between Peking and Essex and identified RFLP markers which are associated with SCN resistance QTLs on linkage groups B, E, I and H. The three QTLs on linkage groups B, E and H jointly account for 57.7% of the phenotypic variation to race 1, the QTLs on linkage groups H and B account for 21.4% of the variation to race 3, while the QTLs on linkage groups I and E are associated with resistance to race 5 accounting for 14.0% of the phenotypic variation. In contrast to previous mapping studies which use Peking as the source of resistance, no significant association was detected to the rhg1 locus on linkage group G. The authors point out that the marker Bng122, which has been shown to have significant linkage to rhg1, is not polymorphic in the population employed (Concibido et al., Crop Sci. 36:1643–1650 (1996)).
It has been reported that the rhg1 locus on linkage group G is necessary for the development of resistance to any of the SCN races. There have been efforts to develop molecular markers to identify breeding lines harboring the rhg1 SCN resistant allele. One of the most commonly used markers for marker assisted selection (MAS) of rhg1 is an SSR locus that co-segregates and maps roughly 0.4 cM from rhg1. This SRR marker, BARC-Satt—309 is able to distinguish most, if not all, of the SCN sensitive genotypes from those harboring rhg1 from important sources of resistance such as Peking and PI437654. Two simple sequence repeat markers have been reported that can be used to select for SCN resistance at the rhg1 locus (Concibido et al., Theor Appl Genet 99: 811–818 (1999)). Satt—309 was also effective in distinguishing SCN resistant sources PI88788 and PI209332 in many, but not all, sensitive genotypes. In particular, Satt—309 can not be used for MAS in populations developed from “typical” southern US cultivars (e.g., Lee, Bragg and Essex) crossed with resistance sources PI88788 or PI209332.
Matson and Williams have reported a dominant SCN resistance locus, Rhg4, which is tightly linked to the ‘i’ locus on linkage group A2 (Matson and Williams, Crop Sci. 5:447 (1965)). The QTL reported by Webb on linkage group A2 maps near the ‘i’ locus and is considered to be Rhg4 (U.S. Pat. No. 5,491,081). Webb concludes that only two loci on linkage groups A2 (Rhg4) and G (rhg1) explain the genetic variation to race 3.
SUMMARY OF THE INVENTION
The present invention includes and provides a method for the production of a soybean plant having an rhg1 SCN resistant allele comprising: (A) crossing a first soybean plant having an rhg1 SCN resistant allele with a second soybean plant having an rhg1 SCN sensitive allele to produce a segregating population; (B) screening the segregating population for a member having an rhg1 SCN resistant allele with a first nucleic acid molecule capable of specifically hybridizing to linkage group G, wherein the first nucleic acid molecule specifically hybridizes to a second nucleic acid molecule that is linked to the rhg1 SCN resistant allele; and, (C) selecting the member for further crossing and selection.
The present invention includes and provides a method of investigating an rhg1 haplotype of a soybean plant comprising: (A) isolating nucleic acid molecules from the soybean plant; (B) determining the nucleic acid sequence of an rhg1 allele or part thereof; and, (C) comparing the nucleic acid sequence of the rhg1 allele or part thereof to a reference nucleic acid sequence. The present invention includes and provides a method of introgressing SCN resistance or partial SCN resistance into a soybean plant comprising: performing marker assisted selection of the soybean plant with a nucleic acid marker, wherein the nucleic acid marker specifically hybridizes with a nucleic acid molecule having a first nucleic acid sequence that is physically linked to a second nucleic acid sequence that is located on linkage group G of soybean A3244, wherein the second nucleic acid sequence is within 500 kb of a third nucleic acid sequence which is capable of specifically hybridizing with the nucleic acid sequence of SEQ ID NO: 5, 6, complements thereof, or fragments thereof having at least 15 nucleotides; and, selecting the soybean plant based on the marker assisted selection.
The present invention includes and provides a method for the production of a soybean plant having an Rhg4 SCN resistant allele comprising: (A) crossing a first soybean plant having an Rhg4 SCN resistant allele with a second soybean plant having an Rhg4 SCN sensitive allele to produce a segregating population; (B) screening the segregating population for a member having an Rhg4 SCN resistant allele with a first nucleic acid molecule capable of specifically hybridizing to linkage group A2, wherein the first nucleic acid molecule specifically hybridizes to a second nucleic acid molecule linked to the Rhg4 SCN resistant allele; and, (C) selecting the member for further crossing and selection.
The present invention includes and provides a method of investigating an Rhg4 haplotype of a soybean plant comprising: (A) isolating nucleic acid molecules from the soybean plant; (B) determining the nucleic acid sequence of an Rhg4 allele or part thereof; and (C) comparing the nucleic acid sequence of the Rhg4 allele or part thereof to a reference nucleic acid sequence.
The present invention includes and provides a method of introgressing SCN resistance or partial SCN resistance into a soybean plant comprising: performing marker assisted selection of the soybean plant with a nucleic acid marker, wherein the nucleic acid marker specifically hybridizes with a nucleic acid molecule having a first nucleic acid sequence that is physically linked to a second nucleic acid sequence that is located on linkage group A2 of soybean A3244, wherein the second nucleic acid sequence is within 500 kb of a third nucleic acid sequence which specifically hybridizes with the nucleic acid sequence of SEQ ID NO: 7, complements thereof, or fragments thereof having at least 15 nucleotides; and, selecting the soybean plant based on the marker assisted selection.
The present invention includes and provides a substantially purified nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 5, 6, 8–23, 28–43, complements thereof, and fragments of either.
The present invention includes and provides a substantially purified first nucleic acid molecule with nucleic acid sequence which specifically hybridizes to a second nucleic acid molecule having a nucleic acid sequence selected from the group consisting of a complement of SEQ ID NOs: 5, 6, 8–23, 28–43.
The present invention includes and provides a substantially purified nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 7, 44–47, and 50–53, complements thereof, and fragments of either.
The present invention includes and provides a substantially purified first nucleic acid molecule with nucleic acid sequence which specifically hybridizes to a second nucleic acid molecule having a nucleic acid sequence selected from the group consisting of a complement of SEQ ID NOs: 50–53.
The present invention includes and provides a substantially purified protein or fragment thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1097, 1098, and 1100–1115 and fragments thereof.
The present invention includes and provides a substantially purified protein or fragment thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs 1099, and 1116–1119 and fragments thereof.
The present invention includes and provides a transformed plant having a nucleic acid molecule which comprises: (A) an exogenous promoter region which functions in a plant cell to cause the production of a mRNA molecule; (B) a structural nucleic acid molecule encoding a protein or fragment thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1097, 1100, 1098, 1101, 1102–1115; and (C) a 3′ non-translated sequence that functions in the plant cell to cause termination of transcription and addition of polyadenylated ribonucleotides to a 3′ end of the mRNA molecule.
The present invention includes and provides a transformed plant having a nucleic acid molecule which comprises: (A) an exogenous promoter region which functions in a plant cell to cause the production of a mRNA molecule; (B) a structural nucleic acid molecule encoding a protein or fragment thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1099, 1116–1119; and (C) a 3′ non-translated sequence that functions in the plant cell to cause termination of transcription and addition of polyadenylated ribonucleotides to a 3′ end of the mRNA molecule.
The present invention includes and provides a transgenic seed having a nucleic acid molecule which comprises: (A) an exogenous promoter region which functions to cause the production of a mRNA molecule; (B) a structural nucleic acid molecule encoding a protein or fragment thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1097, 1100, 1098, 1101, 1102–1115; and (C) a 3′ non-translated sequence that functions to cause termination of transcription and addition of polyadenylated ribonucleotides to a 3′ end of the mRNA molecule.
The present invention includes and provides a transgenic seed having a nucleic acid molecule which comprises: (A) an exogenous promoter region which functions to cause the production of a mRNA molecule; (B) a structural nucleic acid molecule encoding a protein or fragment thereof comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 1099, 1116–1119; and (C) a 3′ non-translated sequence that functions to cause termination of transcription and addition of polyadenylated ribonucleotides to a 3′ end of the mRNA molecule.



DESCRIPTION OF THE FIGURES
FIG. 1 is an amino acid sequence alignment of the leucine rich repeat domain of rhg1.
FIG. 2 is an amino acid sequence alignment of the leucine rich repeat domain of Rhg4.



DESCRIPTION OF THE SEQUENCE LISTINGS
The following sequence listings form part of the present specification and are included to further demonstrate certain aspects of the present invention. The invention may be better understood by reference to one or more of these sequences in combination with the detailed description presented herein.
SEQ ID NOs: 1–7 and 1097–1099 all refer to sequences from the line A3244.
SEQ ID NO: 1 is sequence ID 515002_region_G2 from line A3244, and is adjacent to the contig containing rhg1.
SEQ ID NO: 2 is sequence ID 240017_region_G3 from line A3244, and contains the rhg1, v.1 four exon gene at coding coordinates 45163–45314, 45450–45509, 46941–48763, 48975–49573. The amino acid translation for SEQ ID NO: 2 is SEQ ID NO: 1097.
SEQ ID NO: 3 is sequence ID 240017_region_G3 from line A3244, and contains the rhg1, v.2 two exon gene at coding coordinates 46798–48763 and 48975–49573. The amino acid translation for SEQ ID NO: 3 is SEQ ID NO: 1098.
SEQ ID NO: 4 is sequence ID 318013_region_A3 from line A3244, contains the Rhg4 gene at coding coordinates 111805–113968 and 114684–115204, and has an amino acid translation of SEQ ID NO: 1099.
SEQ ID NO: 5 is sequence ID 240017_region_G3—8_mRNA, and comprises the two rhg1, v.2 exons from the coding sequence portion of SEQ ID NO: 3.
SEQ ID NO: 6 is sequence ID 240017_region_G3—8_cds, and comprises the four rhg1, v.1 exons from the coding sequence portion of SEQ ID NO: 2.
SEQ ID NO: 7 is sequence ID 318013_region_A3—17cds, and comprises the Rhg4 coding sequence portion from SEQ ID NO: 4.
SEQ ID NOs: 8–43 and 1100–1115 all refer to rhg1 sequences.
SEQ ID NO: 8 is sequence ID rhg1_A3244_amplicon from line A3244, contains four rhg1, v.1 exons at coding coordinates 113–264, 400–459, 1891–3713, and 3925–4523, and has an amino acid translation of SEQ ID NO: 1100 and 1097.
SEQ ID NO: 9 is sequence ID rhg1_A3244 amplicon, contains two rhg1, v.2 exons at coding coordinates 1748–3713 and 3925–4523 and has an amino acid translation of SEQ ID NO: 1101 and 1098.
SEQ ID NO: 10 is sequence ID rhg1_peking_amplicon from the line peking, contains four rhg1, v.1 exons at coding coordinates 113–264, 400–459, 1888–3710, and 3903–4501, and has an amino acid translation of SEQ ID NO: 1102.
SEQ ID NO: 11 is sequence ID rhg1_peking_amplicon, contains two rhg1, v.2 exons at coding coordinates 1745–3710 and 3903–4501, and has an amino acid translation of SEQ ID NO: 1103.
SEQ ID NO: 12 is sequence ID rhg1_toyosuzu_amplicon from the line toyosuzu, contains four rhg1, v.1 exons at coding coordinates 113–264, 400–459, 1890–3712, and 3924–4522, and has an amino acid translation of SEQ ID NO: 1104.
SEQ ID NO: 13 is sequence ID rhg1_toyosuzu_amplicon, contains two rhg1, v.2 exons at coding coordinates 1747–3712 and 3924–4522, and has an amino acid translation of SEQ ID NO: 1105.
SEQ ID NO: 14 is sequence ID rhg1_will_amplicon from the line will, contains four rhg1, v.1 exons at coding coordinates 113–264, 400–459, 1891–3713, and 3925–4523, and has an amino acid translation of SEQ ID NO: 1106.
SEQ ID NO: 15 is sequence ID rhg1_will_amplicon, contains two rhg1, v.2 exons at coding coordinates 1748–3713 and 3925–4523, and has an amino acid translation of SEQ ID NO: 1107.
SEQ ID NO: 16 is sequence ID rhg1_a2704_amplicon from the line A2704, contains four rhg1, v.1 exons at coding coordinates 113–264, 400–459, 1891–3713, and 3925–4523, and has an amino acid translation of SEQ ID NO: 1108.
SEQ ID NO: 17 is sequence ID rhg1_a2704_amplicon, contains two rhg1, v.2 exons at coding coordinates 1748–3713 and 3925–4523, and has an amino acid translation of SEQ ID NO: 1109.
SEQ ID NO: 18 is sequence ID rhg1_noir_amplicon from the line noir, contains four rhg1, v.1 exons at coding coordinates 113–264, 400–459, 1876–3698, and 3910–4508, and has an amino acid translation of SEQ ID NO: 1110.
SEQ ID NO: 19 is sequence ID rhg1_noir_amplicon, contains two rhg1, v.2 exons at coding coordinates 1733–3698 and 3910–4508, and has an amino acid translation of SEQ ID NO: 1111.
SEQ ID NO: 20 is sequence ID rhg1_lee_amplicon from the line lee, contains four rhg1, v.1 exons at coding coordinates 113–264, 400–459, 1876–3698, and 3910–4508, and has an amino acid translation of SEQ ID NO: 1112.
SEQ ID NO: 21 is sequence ID rhg1_lee_amplicon, contains two rhg1, v.2 exons at coding coordinates 1733–3698 and 3910–4508, and has an amino acid translation of SEQ ID NO: 1113.
SEQ ID NO: 22 is sequence ID rhg1_pi200499_amplicon from the line PI200499, contains four rhg1, v.1 exons at coding coordinates 113–264, 400–459, 1876–3698, and 3910–4508, and has an amino acid translation of SEQ ID NO: 1114.
SEQ ID NO: 23 is sequence ID rhg1_pi200499_amplicon, contains two rhg1, v.2 exons at coding coordinates 1733–3698 and 3910–4508, and has an amino acid translation of SEQ ID NO: 1115.
SEQ ID NO: 24 is sequence ID 240017_region_G3_forward—1, is a primer that hybridizes to coordinates 45051–45077 on contig 240017_region_G3 before the start codon, and can be used with SEQ ID NO: 25.
SEQ ID NO: 25 is sequence ID 240017_region_G3_reverse—1, is a primer that hybridizes to coordinates 47942–47918 on contig 240017 region G3, and can be used with SEQ ID NO: 24.
SEQ ID NO: 26 is sequence ID 240017_region_G3_forward—2, is a primer that hybridizes to coordinates 47808–47831 on contig 240017_region_G3, and can be used with SEQ ID NO: 27.
SEQ ID NO: 27 is sequence ID 240017_region_G3_reverse—2, is a primer that hybridizes to coordinates 49553–49531 of contig 240017_region_G3 prior to the stop codon, and can be used with SEQ ID NO: 26.
Primers given by SEQ ID NOs: 24–27 are used to create the amplicons of SEQ ID NOs: 8–23. The final 22 bases are added to the actual amplicons in order to simulate the rest of the gene to the stop codon, in order to allow complete translation.
SEQ ID NO: 28 is sequence ID rhg1_A3244_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 8.
SEQ ID NO: 29 is sequence ID rhg1_peking_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 10.
SEQ ID NO: 30 is sequence ID rhg1_toyosuzu_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 12.
SEQ ID NO: 31 is sequence ID rhg1_will_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 14.
SEQ ID NO: 32 is sequence ID rhg1_a2704_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 16.
SEQ ID NO: 33 is sequence ID rhg1_noir_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 18.
SEQ ID NO: 34 is sequence ID rhg1_lee_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 20.
SEQ ID NO: 35 is sequence ID rhg1_pi200499_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 22.
SEQ ID NO: 36 is sequence ID rhg1_A3244_amplicon_cds—2, which is the coding sequence portion of SEQ ID NO: 9.
SEQ ID NO: 37 is sequence ID rhg1_peking_amplicon_cds—2, which is the coding sequence portion of SEQ ID NO: 11.
SEQ ID NO: 38 is sequence ID rhg1_toyosuzu_amplicon_cds—2, which is the coding sequence portion of SEQ ID NO: 13.
SEQ ID NO: 39 is sequence ID rhg1_will_amplicon_cds—2, which is the coding sequence portion of SEQ ID NO: 15.
SEQ ID NO: 40 is sequence ID rhg1_a2704_amplicon_cds—2, which is the coding sequence portion of SEQ ID NO: 17.
SEQ ID NO: 41 is sequence ID rhg1_noir_amplicon_cds—2, which is the coding sequence portion of SEQ ID NO: 19.
SEQ ID NO: 42 is sequence ID rhg1_lee_amplicon_cds—2, which is the coding sequence portion of SEQ ID NO: 21.
SEQ ID NO: 43 is sequence ID rhg1_pi200499_amplicon_cds—2, which is the coding sequence portion of SEQ ID NO: 23.
SEQ ID NOs: 44–53 and 1116–1119 all refer to Rhg4 sequences
SEQ ID NO: 44 is sequence ID rhg4_a3244_amplicon from the line A3244, contains Rhg4 at coding coordinates 79–2242 and 2958–3478, is made using SEQ ID NOs: 48 and 49, and has an amino acid translation of SEQ ID NO: 1116 and 1099.
SEQ ID NO: 45 is sequence ID rhg4_Minsoy_amplicon from the line Minsoy, contains Rhg4 at coding coordinates 79–2242 and 2958–3478, is made using SEQ ID NOs: 48 and 49, and has an amino acid translation of SEQ ID NO: 1117.
SEQ ID NO: 46 is sequence ID rhg4_Jack_amplicon from the line Jack, contains Rhg4 at coding coordinates 79–2242 and 2958–3478, is made using SEQ ID NO: 48 and 49, and has an amino acid translation of SEQ ID NO: 1118.
SEQ ID NO: 47 is sequence ID rhg4_peking_amplicon from the line Peking, contains Rhg4 at coding coordinates 79–2242 and 2958–3478, is made using SEQ ID NOs: 48 and 49, and has an amino acid translation of SEQ ID NO: 1119.
SEQ ID NO: 48 is sequence ID 318013_region_A3_forward, hybridizes to coordinates 111727–111756 of contig 318013_region_A3, and is a primer used with SEQ ID NO: 49 to create Rhg4 amplicons.
SEQ ID NO: 49 is sequence ID 318013_region_A3_reverse, hybridizes to coordinates 115206–115177 of contig 318013_region_A3, and is a primer used with SEQ ID NO: 48 to create Rhg4 amplicons.
SEQ ID NO: 50 is sequence ID rhg4_A3244_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 44.
SEQ ID NO: 51 is sequence ID rhg4_Minsoy_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 45.
SEQ ID NO: 52 is sequence ID rhg4_Jack_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 46.
SEQ ID NO: 53 is sequence ID rhg4_peking_amplicon_cds, which is the coding sequence portion of SEQ ID NO: 47.
SEQ ID NO: 1120 is sequence ID consensusLRR, which is a consensus sequence for the LRR repeats shown in FIGS. 1 and 2.
SEQ ID NO: 1121 is sequence ID rhg1LRR, which is the amino acid sequence of the LRR domain shown in FIG. 1.
SEQ ID NO: 1122 is sequence ID Rhg4LRR, which is the amino acid sequence of the LRR domain shown in FIG. 2.
SEQ ID NO: 1123 is sequence ID 240017_region_G3_forward—1_b, which is an alternate primer that hybridizes to coordinates 45046–45072 on contig 240017_region_G3 before the start codon, and which can be used with SEQ ID NO: 25.
Table 1 below provides further information on the sequences described herein.
In table 1, for all rows, “Seq Num” refers to the corresponding SEQ ID NO in the sequence listing.
For rows with SEQ ID NOs: 1–53 and 1120–1123“Seq ID” refers to the name of the SEQ ID NO given in the “Seq Num” column.
For rows with SEQ ID NOs: 2–4,8–23, and 44–47“Coding Sequence” refers to the coordinates of the coding portion of the SEQ ID NO given in the “Seq Num” column, and “AA” refers to the SEQ ID NO that is the amino acid translation of the SEQ ID NO given in the “Seq Num” column.
For rows with SEQ ID NOs: 24–27 and 1123, “Primer location on 240017_region_G3” refers to the coordinates of the 240017_region_G3 contig to which the SEQ ID NO given in the “Seq Num” column hybridizes.
For rows with SEQ ID NOs: 48 and 49, “Primer location on 318013region_A3” refers to the coordinates of the 318013_region_A3 contig to which the SEQ ID NO given in the “Seq Num” column hybridizes.
For rows with SEQ ID NOs: 54–400, “Seq ID” refers to the names of amplicon sequences. Within the Seq ID is the “_” (double length underscore) symbol. The name before this symbol refers to the name of the contig in which the amplicon is found, and the numbers after this symbol refer to the nucleotide location of the SSR on the contig.
For rows with SEQ ID NOs: 401–1096, “Seq ID” refers to the names of primer sequences used in PCR to generate the amplicon sequences in table 1. For these rows, the “Seq ID” name contains the same name as the amplicon that is generated by the pair of primers of which the SEQ ID NO referred to in the first column is a member. The “Seq ID” name also contains either “Forward” or “Reverse,” which indicates the orientation of the primer. For these sequences, “location of primer on contig start” and “location of primer on contig end” refer, respectively, to the first and last base number of the contig on which the primer aligns.








TABLE 1





Seq Num
Seq ID




















Coding Sequence
AA No.


1
515O02_region_G2


2
240O17_region_G3
45163–45314, 45450–45509, 46941–48763, 48975–49573
1097


3
240O17_region_G3
46798–48763, 48975–49573
1098


4
318O13_region_A3
111805–113968, 114684–115204
1099


5
240O17_region_G3_8_mRNA


6
240O17_region_G3_8_cds


7
318O13_region_A3_17_cds


8
rhg1_A3244_amplicon
113–264, 400–459, 1891–3713, 3925–4523
1100


9
rhg1_A3244_amplicon
1748–3713, 3925–4523
1101


10
rhg1_peking_amplicon
113–264, 400–459, 1888–3710, 3903–4501
1102


11
rhg1_peking_amplicon
1745–3710, 3903–4501
1103


12
rhg1_toyosuzu_amplicon
113–264, 400–459, 1890–3712, 3924–4522
1104


13
rhg1_toyosuzu_amplicon
1747–3712, 3924–4522
1105


14
rhg1_will_amplicon
113–264, 400–459, 1891–3713, 3925–4523
1106


15
rhg1_will_amplicon
1748–3713, 3925–4523
1107


16
rhg1_a2704_amplicon
113–264, 400–459, 1891–3713, 3925–4523
1108


17
rhg1_a2704_amplicon
1748–3713, 3925–4523
1109


18
rhg1_noir_amplicon
113–264, 400–459, 1876–3698, 3910–4508
1110


19
rhg1_noir_amplicon
1733–3698, 3910–4508
1111


20
rhg1_lee_amplicon
113–264, 400–459, 1876–3698, 3910–4508
1112


21
rhg1_lee_amplicon
1733–3698, 3910–4508
1113


22
rhg1_pi200499_amplicon
113–264, 400–459, 1876–3698, 3910–4508
1114


23
rhg1_pi200499_amplicon
1733–3698, 3910–4508
1115




Primer location on 240O17_region_G3


24
240O17_region_G3_forward_1
45051–45077


25
240O17_region_G3_reverse_1
47942–47918


26
240O17_region_G3_forward_2
47808–47831


27
240O17_region_G3_reverse_2
49553–49531


28
rhg1_A3244_amplicon_cds


29
rhg1_peking_amplicon_cds


30
rhg1_toyosuzu_amplicon_cds


31
rhg1_will_amplicon_cds


32
rhg1_a2704_amplicon_cds


33
rhg1_noir_amplicon_cds


34
rhg1_lee_amplicon_cds


35
rhg1_pi200499_amplicon_cds


36
rhg1_A3244_amplicon_cds_2


37
rhg1_peking_amplicon_cds_2


38
rhg1_toyosuzu_amplicon_cds_2


39
rhg1_will_amplicon_cds_2


40
rhg1_a2704_amplicon_cds_2


41
rhg1_noir_amplicon_cds_2


42
rhg1_lee_amplicon_cds_2


43
rhg1_pi200499_amplicon_cds_2




Coding Sequence


44
rhg4_a3244_amplicon
79–2242, 2958–3478
1116


45
rhg4_Minsoy_amplicon
79–2242, 2958–3478
1117


46
rhg4_Jack_amplicon
79–2242, 2958–3478
1118


47
rhg4_peking_amplicon
79–2242, 2958–3478
1119




Primer location on 318O13_region_A3


48
318O13_region_A3_forward
111727–111756


49
318O13_region_A3_reverse
115206–115177


50
rhg4_A3244_amplicon_cds


51
rhg4_Minsoy_amplicon_cds


52
rhg4_Jack_amplicon_cds


53
rhg4_peking_amplicon_cds


54
240O17_region_G3_289711_11


55
240O17_region_G3_236585_14


56
240O17_region_G3_168772_13


57
240O17_region_G3_332420_21


58
240O17_region_G3_228126_18


59
240O17_region_G3_139723_11


60
240O17_region_G3_280585_14


61
240O17_region_G3_70509_14


62
240O17_region_G3_50537_17


63
240O17_region_G3_231556_17


64
240O17_region_G3_117057_11


65
240O17_region_G3_23092_13


66
240O17_region_G3_297741_14


67
240O17_region_G3_206502_14


68
240O17_region_G3_221223_13


69
240O17_region_G3_169084_14


70
240O17_region_G3_94891_14


71
240O17_region_G3_281852_61


72
240O17_region_G3_46583_12


73
240O17_region_G3_306835_13


74
240O17_region_G3_85471_12


75
240O17_region_G3_257208_12


76
240O17_region_G3_150390_17


77
240O17_region_G3_34697_75


78
240O17_region_G3_150374_13


79
240O17_region_G3_40513_22


80
240O17_region_G3_268602_14


81
240O17_region_G3_25357_13


82
240O17_region_G3_137548_13


83
240O17_region_G3_139131_13


84
240O17_region_G3_203855_12


85
240O17_region_G3_199049_15


86
240O17_region_G3_320907_12


87
240O17_region_G3_16407_17


88
240O17_region_G3_206516_17


89
240O17_region_G3_264495_13


90
240O17_region_G3_156785_13


91
240O17_region_G3_187129_12


92
240O17_region_G3_214106_13


93
240O17_region_G3_149013_12


94
240O17_region_G3_326352_16


95
240O17_region_G3_278962_12


96
240O17_region_G3_256930_13


97
240O17_region_G3_29646_14


98
240O17_region_G3_29618_13


99
240O17_region_G3_108561_14


100
240O17_region_G3_143975_14


101
240O17_region_G3_108431_20


102
240O17_region_G3_281764_11


103
240O17_region_G3_130058_15


104
240O17_region_G3_310590_52


105
240O17_region_G3_313405_14


106
240O17_region_G3_302190_13


107
240O17_region_G3_225343_17


108
240O17_region_G3_208823_14


109
240O17_region_G3_74285_11


110
240O17_region_G3_109052_16


111
240O17_region_G3_6395_12


112
240O17_region_G3_244905_16


113
240O17_region_G3_244956_13


114
240O17_region_G3_117220_13


115
240O17_region_G3_134707_14


116
240O17_region_G3_35078_13


117
240O17_region_G3_210506_16


118
240O17_region_G3_116961_26


119
240O17_region_G3_51073_13


120
240O17_region_G3_55291_15


121
240O17_region_G3_229651_18


122
240O17_region_G3_303308_19


123
240O17_region_G3_168373_20


124
240O17_region_G3_253333_17


125
240O17_region_G3_5791_13


126
240O17_region_G3_206841_19


127
240O17_region_G3_202827_12


128
240O17_region_G3_322656_13


129
240O17_region_G3_111841_14


130
240O17_region_G3_192719_13


131
240O17_region_G3_195630_17


132
240O17_region_G3_69999_13


133
240O17_region_G3_11176_13


134
240O17_region_G3_228643_13


135
240O17_region_G3_88478_19


136
240O17_region_G3_108950_13


137
240O17_region_G3_121054_14


138
240O17_region_G3_188337_14


139
240O17_region_G3_255944_21


140
240O17_region_G3_219518_14


141
240O17_region_G3_235601_15


142
240O17_region_G3_301529_13


143
240O17_region_G3_94795_14


144
240O17_region_G3_46703_23


145
240O17_region_G3_59616_14


146
240O17_region_G3_296933_15


147
240O17_region_G3_192428_17


148
240O17_region_G3_191490_14


149
240O17_region_G3_201115_11


150
240O17_region_G3_72882_15


151
240O17_region_G3_69514_13


152
240O17_region_G3_37699_47


153
240O17_region_G3_11301_29


154
240O17_region_G3_141875_12


155
240O17_region_G3_98090_18


156
240O17_region_G3_43298_35


157
240O17_region_G3_262094_11


158
240O17_region_G3_262079_15


159
240O17_region_G3_59090_12


160
240O17_region_G3_245723_13


161
240O17_region_G3_194628_54


162
240O17_region_G3_4566_16


163
240O17_region_G3_96209_14


164
240O17_region_G3_248715_17


165
240O17_region_G3_71410_40


166
240O17_region_G3_226519_13


167
240O17_region_G3_11282_19


168
240O17_region_G3_170504_12


169
240O17_region_G3_40864_14


170
240O17_region_G3_13529_14


171
240O17_region_G3_22858_14


172
240O17_region_G3_309211_13


173
240O17_region_G3_55568_26


174
240O17_region_G3_73238_16


175
240O17_region_G3_52488_19


176
318O13_region_A3_471518_14


177
318O13_region_A3_231599_23


178
318O13_region_A3_375912_13


179
318O13_region_A3_180013_12


180
318O13_region_A3_171606_14


181
318O13_region_A3_416256_13


182
318O13_region_A3_231395_15


183
318O13_region_A3_5502_47


184
318O13_region_A3_93061_14


185
318O13_region_A3_111684_19


186
318O13_region_A3_69328_14


187
318O13_region_A3_36529_17


188
318O13_region_A3_139128_12


189
318O13_region_A3_495674_13


190
318O13_region_A3_187577_13


191
318O13_region_A3_453036_14


192
318O13_region_A3_374041_13


193
318O13_region_A3_3412_11


194
318O13_region_A3_276495_28


195
318O13_region_A3_151839_17


196
318O13_region_A3_292912_12


197
318O13_region_A3_104560_12


198
318O13_region_A3_65193_11


199
318O13_region_A3_110573_70


200
318O13_region_A3_65117_12


201
318O13_region_A3_490837_16


202
318O13_region_A3_107448_11


203
318O13_region_A3_331_23


204
318O13_region_A3_193470_13


205
318O13_region_A3_183305_14


206
318O13_region_A3_55050_14


207
318O13_region_A3_224693_21


208
318O13_region_A3_207216_12


209
318O13_region_A3_4654_22


210
318O13_region_A3_408959_13


211
318O13_region_A3_132288_22


212
318O13_region_A3_292822_20


213
318O13_region_A3_311076_12


214
318O13_region_A3_509623_13


215
318O13_region_A3_190404_14


216
318O13_region_A3_164916_15


217
318O13_region_A3_21028_13


218
318O13_region_A3_208012_17


219
318O13_region_A3_484089_14


220
318O13_region_A3_332780_17


221
318O13_region_A3_480137_37


222
318O13_region_A3_441056_14


223
318O13_region_A3_77486_11


224
318O13_region_A3_272468_11


225
318O13_region_A3_425319_17


226
318O13_region_A3_413879_31


227
318O13_region_A3_80477_64


228
318O13_region_A3_277272_50


229
318O13_region_A3_509642_13


230
318O13_region_A3_321771_14


231
318O13_region_A3_26788_12


232
318O13_region_A3_262706_16


233
318O13_region_A3_243928_16


234
318O13_region_A3_23246_14


235
318O13_region_A3_165406_12


236
318O13_region_A3_486294_14


237
318O13_region_A3_46754_12


238
318O13_region_A3_381116_15


239
318O13_region_A3_350369_11


240
318O13_region_A3_138841_13


241
318O13_region_A3_12158_14


242
318O13_region_A3_315368_13


243
318O13_region_A3_307549_13


244
318O13_region_A3_159857_14


245
318O13_region_A3_140551_15


246
318O13_region_A3_279869_11


247
318O13_region_A3_78292_35


248
318O13_region_A3_185019_12


249
318O13_region_A3_409164_13


250
318O13_region_A3_75392_14


251
318O13_region_A3_231320_12


252
318O13_region_A3_381102_14


253
318O13_region_A3_491826_15


254
318O13_region_A3_56365_21


255
318O13_region_A3_372628_15


256
318O13_region_A3_302609_11


257
318O13_region_A3_341804_11


258
318O13_region_A3_217037_11


259
318O13_region_A3_264929_68


260
318O13_region_A3_55499_12


261
318O13_region_A3_295634_14


262
318O13_region_A3_269358_15


263
318O13_region_A3_457009_24


264
318O13_region_A3_176598_14


265
318O13_region_A3_278266_12


266
318O13_region_A3_391810_12


267
318O13_region_A3_269485_15


268
318O13_region_A3_359247_17


269
318O13_region_A3_315094_13


270
318O13_region_A3_307823_13


271
318O13_region_A3_248588_15


272
318O13_region_A3_252426_85


273
318O13_region_A3_513314_16


274
318O13_region_A3_68183_14


275
318O13_region_A3_471191_13


276
318O13_region_A3_163547_18


277
318O13_region_A3_417867_15


278
318O13_region_A3_332465_14


279
318O13_region_A3_207697_14


280
318O13_region_A3_277229_43


281
318O13_region_A3_36366_11


282
318O13_region_A3_91970_12


283
318O13_region_A3_211533_11


284
318O13_region_A3_336301_11


285
318O13_region_A3_441603_14


286
318O13_region_A3_468354_15


287
318O13_region_A3_188983_18


288
318O13_region_A3_115502_17


289
318O13_region_A3_163006_13


290
318O13_region_A3_119283_14


291
318O13_region_A3_491126_11


292
318O13_region_A3_99512_21


293
318O13_region_A3_280291_17


294
318O13_region_A3_138443_19


295
318O13_region_A3_115973_14


296
318O13_region_A3_329977_14


297
318O13_region_A3_205203_14


298
318O13_region_A3_153114_12


299
318O13_region_A3_34581_13


300
318O13_region_A3_292577_19


301
318O13_region_A3_445391_20


302
318O13_region_A3_350540_17


303
318O13_region_A3_453879_15


304
318O13_region_A3_201246_13


305
318O13_region_A3_326020_13


306
318O13_region_A3_503801_14


307
318O13_region_A3_302400_52


308
318O13_region_A3_448857_15


309
318O13_region_A3_48364_14


310
318O13_region_A3_251804_48


311
318O13_region_A3_382583_13


312
318O13_region_A3_124737_14


313
318O13_region_A3_124766_13


314
318O13_region_A3_461351_16


315
318O13_region_A3_64953_19


316
318O13_region_A3_366586_13


317
318O13_region_A3_46190_15


318
318O13_region_A3_81016_11


319
318O13_region_A3_134426_14


320
318O13_region_A3_292724_14


321
318O13_region_A3_187096_17


322
318O13_region_A3_381693_13


323
318O13_region_A3_361286_33


324
318O13_region_A3_482668_14


325
318O13_region_A3_128002_12


326
318O13_region_A3_499270_14


327
318O13_region_A3_231650_12


328
318O13_region_A3_199851_13


329
318O13_region_A3_324629_13


330
318O13_region_A3_374190_19


331
318O13_region_A3_460603_13


332
318O13_region_A3_108681_14


333
318O13_region_A3_459791_47


334
318O13_region_A3_4257_20


335
318O13_region_A3_238810_14


336
318O13_region_A3_245817_14


337
318O13_region_A3_245956_14


338
318O13_region_A3_74148_14


339
318O13_region_A3_74089_15


340
318O13_region_A3_241686_12


341
318O13_region_A3_47476_12


342
318O13_region_A3_164550_12


343
318O13_region_A3_101255_15


344
515O02_region_G2_16189_11


345
515O02_region_G2_71925_13


346
515O02_region_G2_4707_12


347
515O02_region_G2_118904_18


348
515O02_region_G2_13655_17


349
515O02_region_G2_53900_13


350
515O02_region_G2_8079_14


351
515O02_region_G2_9969_28


352
515O02_region_G2_72308_77


353
515O02_region_G2_99475_19


354
515O02_region_G2_118615_18


355
515O02_region_G2_119001_46


356
515O02_region_G2_118958_43


357
515O02_region_G2_17197_13


358
515O02_region_G2_105163_29


359
515O02_region_G2_111335_13


360
515O02_region_G2_106396_13


361
515O02_region_G2_59229_17


362
515O02_region_G2_73795_20


363
515O02_region_G2_85664_20


364
515O02_region_G2_36921_17


365
515O02_region_G2_124150_19


366
515O02_region_G2_5089_14


367
515O02_region_G2_58221_15


368
515O02_region_G2_96139_14


369
515O02_region_G2_70595_13


370
515O02_region_G2_4340_15


371
515O02_region_G2_90417_11


372
515O02_region_G2_49711_17


373
515O02_region_G2_63053_13


374
515O02_region_G2_63076_14


375
515O02_region_G2_44442_12


376
515O02_region_G2_44422_19


377
515O02_region_G2_44158_19


378
515O02_region_G2_44141_17


379
515O02_region_G2_90762_17


380
515O02_region_G2_106241_14


381
515O02_region_G2_109676_12


382
515O02_region_G2_86242_14


383
515O02_region_G2_83109_12


384
515O02_region_G2_10461_15


385
515O02_region_G2_67608_15


386
515O02_region_G2_63275_46


387
515O02_region_G2_62405_14


388
515O02_region_G2_33563_12


389
515O02_region_G2_33146_14


390
515O02_region_G2_102179_29


391
515O02_region_G2_2646_15


392
515O02_region_G2_76652_24


393
515O02_region_G2_66280_14


394
515O02_region_G2_54768_13


395
515O02_region_G2_62580_14


396
515O02_region_G2_34598_55


397
515O02_region_G2_77680_13


398
515O02_region_G2_77693_12


399
515O02_region_G2_97392_14


400
515O02_region_G2_97359_15












location of primer
location of primer




on contig start
on contig end


401
240O17_region_G3_289711_11_Forward_Primer
289637
289661


402
240O17_region_G3_289711_11_Reverse_Primer
289756
289732


403
240O17_region_G3_236585_14_Forward_Primer
236511
236535


404
240O17_region_G3_236585_14_Reverse_Primer
236638
236614


405
240O17_region_G3_168772_13_Forward_Primer
168683
168707


406
240O17_region_G3_168772_13_Reverse_Primer
168811
168786


407
240O17_region_G3_332420_21_Forward_Primer
332375
332399


408
240O17_region_G3_332420_21_Reverse_Primer
332505
332481


409
240O17_region_G3_228126_18_Forward_Primer
228048
228072


410
240O17_region_G3_228126_18_Reverse_Primer
228182
228158


411
240O17_region_G3_139723_11_Forward_Primer
139666
139690


412
240O17_region_G3_139723_11_Reverse_Primer
139802
139778


413
240O17_region_G3_280585_14_Forward_Primer
280524
280550


414
240O17_region_G3_280585_14_Reverse_Primer
280661
280637


415
240O17_region_G3_70509_14_Forward_Primer
70478
70502


416
240O17_region_G3_70509_14_Reverse_Primer
70616
70592


417
240O17_region_G3_50537_17_Forward_Primer
50455
50479


418
240O17_region_G3_50537_17_Reverse_Primer
50593
50569


419
240O17_region_G3_231556_17_Forward_Primer
231468
231492


420
240O17_region_G3_231556_17_Reverse_Primer
231606
231582


421
240O17_region_G3_117057_11_Forward_Primer
117029
117053


422
240O17_region_G3_117057_11_Reverse_Primer
117169
117145


423
240O17_region_G3_23092_13_Forward_Primer
23010
23034


424
240O17_region_G3_23092_13_Reverse_Primer
23151
23127


425
240O17_region_G3_297741_14_Forward_Primer
297680
297704


426
240O17_region_G3_297741_14_Reverse_Primer
297823
297799


427
240O17_region_G3_206502_14_Forward_Primer
206456
206480


428
240O17_region_G3_206502_14_Reverse_Primer
206600
206581


429
240O17_region_G3_221223_13_Forward_Primer
221134
221158


430
240O17_region_G3_221223_13_Reverse_Primer
221278
221254


431
240O17_region_G3_169084_14_Forward_Primer
169051
169075


432
240O17_region_G3_169084_14_Reverse_Primer
169196
169173


433
240O17_region_G3_94891_14_Forward_Primer
94784
94808


434
240O17_region_G3_94891_14_Reverse_Primer
94929
94905


435
240O17_region_G3_7439_12_Forward_Primer
7397
7421


436
240O17_region_G3_7439_12_Reverse_Primer
7542
7518


437
240O17_region_G3_281852_61_Forward_Primer
281797
281821


438
240O17_region_G3_281852_61_Reverse_Primer
281943
281919


439
240O17_region_G3_46583_12_Forward_Primer
46554
46578


440
240O17_region_G3_46583_12_Reverse_Primer
46700
46676


441
240O17_region_G3_306835_13_Forward_Primer
306727
306751


442
240O17_region_G3_306835_13_Reverse_Primer
306874
306849


443
240O17_region_G3_85471_12_Forward_Primer
85359
85383


444
240O17_region_G3_85471_12_Reverse_Primer
85507
85483


445
240O17_region_G3_257208_12_Forward_Primer
257129
257153


446
240O17_region_G3_257208_12_Reverse_Primer
257278
257254


447
240O17_region_G3_150390_17_Forward_Primer
150327
150351


448
240O17_region_G3_150390_17_Reverse_Primer
150476
150452


449
240O17_region_G3_34697_75_Forward_Primer
34662
34685


450
240O17_region_G3_34697_75_Reverse_Primer
34811
34787


451
240O17_region_G3_150374_13_Forward_Primer
150327
150351


452
240O17_region_G3_150374_13_Reverse_Primer
150476
150452


453
240O17_region_G3_40513_22_Forward_Primer
40422
40446


454
240O17_region_G3_40513_22_Reverse_Primer
40572
40548


455
240O17_region_G3_268602_14_Forward_Primer
268555
268579


456
240O17_region_G3_268602_14_Reverse_Primer
268705
268681


457
240O17_region_G3_25357_13_Forward_Primer
25271
25295


458
240O17_region_G3_25357_13_Reverse_Primer
25422
25402


459
240O17_region_G3_137548_13_Forward_Primer
139088
139111


459
240O17_region_G3_137548_13_Forward_Primer
137505
137528


460
240O17_region_G3_137548_13_Reverse_Primer
139239
139215


460
240O17_region_G3_137548_13_Reverse_Primer
137656
137632


461
240O17_region_G3_139131_13_Forward_Primer
139088
139111


462
240O17_region_G3_139131_13_Reverse_Primer
139239
139215


463
240O17_region_G3_203855_12_Forward_Primer
203749
203773


464
240O17_region_G3_203855_12_Reverse_Primer
203901
203877


465
240O17_region_G3_199049_15_Forward_Primer
199008
199033


466
240O17_region_G3_199049_15_Reverse_Primer
199160
199136


467
240O17_region_G3_320907_12_Forward_Primer
320885
320906


468
240O17_region_G3_320907_12_Reverse_Primer
321038
321015


469
240O17_region_G3_16407_17_Forward_Primer
16330
16354


470
240O17_region_G3_16407_17_Reverse_Primer
16483
16459


471
240O17_region_G3_206516_17_Forward_Primer
206482
206506


472
240O17_region_G3_206516_17_Reverse_Primer
206635
206616


473
240O17_region_G3_264495_13_Forward_Primer
264423
264447


474
240O17_region_G3_264495_13_Reverse_Primer
264577
264553


475
240O17_region_G3_156785_13_Forward_Primer
156713
156737


476
240O17_region_G3_156785_13_Reverse_Primer
156868
156844


477
240O17_region_G3_187129_12_Forward_Primer
187068
187092


478
240O17_region_G3_187129_12_Reverse_Primer
187223
187199


479
240O17_region_G3_214106_13_Forward_Primer
214042
214067


480
240O17_region_G3_214106_13_Reverse_Primer
214197
214173


481
240O17_region_G3_149013_12_Forward_Primer
148898
148922


482
240O17_region_G3_149013_12_Reverse_Primer
149053
149027


483
240O17_region_G3_326352_16_Forward_Primer
326311
326335


484
240O17_region_G3_326352_16_Reverse_Primer
326467
326443


485
240O17_region_G3_278962_12_Forward_Primer
278933
278957


486
240O17_region_G3_278962_12_Reverse_Primer
279089
279065


487
240O17_region_G3_256930_13_Forward_Primer
256850
256874


488
240O17_region_G3_256930_13_Reverse_Primer
257006
256982


489
240O17_region_G3_29646_14_Forward_Primer
29589
29613


490
240O17_region_G3_29646_14_Reverse_Primer
29746
29721


491
240O17_region_G3_29618_13_Forward_Primer
29589
29613


492
240O17_region_G3_29618_13_Reverse_Primer
29746
29721


493
240O17_region_G3_108561_14_Forward_Primer
108518
108542


494
240O17_region_G3_108561_14_Reverse_Primer
108675
108651


495
240O17_region_G3_143975_14_Forward_Primer
143939
143964


496
240O17_region_G3_143975_14_Reverse_Primer
144096
144072


497
240O17_region_G3_108431_20_Forward_Primer
108362
108386


498
240O17_region_G3_108431_20_Reverse_Primer
108520
108497


499
240O17_region_G3_281764_11_Forward_Primer
281645
281669


500
240O17_region_G3_281764_11_Reverse_Primer
281803
281779


501
240O17_region_G3_130058_15_Forward_Primer
129994
130018


502
240O17_region_G3_130058_15_Reverse_Primer
130153
130129


503
240O17_region_G3_310590_52_Forward_Primer
310533
310557


504
240O17_region_G3_310590_52_Reverse_Primer
310692
310668


505
240O17_region_G3_313405_14_Forward_Primer
313345
313369


506
240O17_region_G3_313405_14_Reverse_Primer
313505
313481


507
240O17_region_G3_302190_13_Forward_Primer
302093
302119


508
240O17_region_G3_302190_13_Reverse_Primer
302253
302229


509
240O17_region_G3_225343_17_Forward_Primer
225315
225338


510
240O17_region_G3_225343_17_Reverse_Primer
225475
225451


511
240O17_region_G3_208823_14_Forward_Primer
208760
208784


512
240O17_region_G3_208823_14_Reverse_Primer
208921
208897


513
240O17_region_G3_74285_11_Forward_Primer
74220
74244


514
240O17_region_G3_74285_11_Reverse_Primer
74382
74358


515
240O17_region_G3_109052_16_Forward_Primer
108999
109023


516
240O17_region_G3_109052_16_Reverse_Primer
109161
109137


517
240O17_region_G3_6395_12_Forward_Primer
6285
6309


518
240O17_region_G3_6395_12_Reverse_Primer
6447
6423


519
240O17_region_G3_244905_16_Forward_Primer
244865
244890


520
240O17_region_G3_244905_16_Reverse_Primer
245028
245004


521
240O17_region_G3_244956_13_Forward_Primer
244865
244890


522
240O17_region_G3_244956_13_Reverse_Primer
245028
245004


523
240O17_region_G3_117220_13_Forward_Primer
117175
117199


524
240O17_region_G3_117220_13_Reverse_Primer
117339
117315


525
240O17_region_G3_134707_14_Forward_Primer
134584
134608


526
240O17_region_G3_134707_14_Reverse_Primer
134749
134725


527
240O17_region_G3_35078_13_Forward_Primer
34990
35013


528
240O17_region_G3_35078_13_Reverse_Primer
35157
35133


529
240O17_region_G3_210506_16_Forward_Primer
210477
210501


530
240O17_region_G3_210506_16_Reverse_Primer
210644
210620


531
240O17_region_G3_116961_26_Forward_Primer
116885
116909


532
240O17_region_G3_116961_26_Reverse_Primer
117053
117029


533
240O17_region_G3_51073_13_Forward_Primer
50979
51003


534
240O17_region_G3_51073_13_Reverse_Primer
51147
51123


535
240O17_region_G3_55291_15_Forward_Primer
55164
55188


536
240O17_region_G3_55291_15_Reverse_Primer
55333
55309


537
240O17_region_G3_229651_18_Forward_Primer
229615
229639


538
240O17_region_G3_229651_18_Reverse_Primer
229784
229760


539
240O17_region_G3_303308_19_Forward_Primer
303284
303307


540
240O17_region_G3_303308_19_Reverse_Primer
303454
303429


541
240O17_region_G3_168373_20_Forward_Primer
168262
168286


542
240O17_region_G3_168373_20_Reverse_Primer
168432
168408


543
240O17_region_G3_253333_17_Forward_Primer
253257
253281


544
240O17_region_G3_253333_17_Reverse_Primer
253428
253404


545
240O17_region_G3_5791_13_Forward_Primer
5766
5790


546
240O17_region_G3_5791_13_Reverse_Primer
5937
5912


547
240O17_region_G3_206841_19_Forward_Primer
206821
206840


548
240O17_region_G3_206841_19_Reverse_Primer
206993
206969


549
240O17_region_G3_202827_12_Forward_Primer
202782
202806


550
240O17_region_G3_202827_12_Reverse_Primer
202956
202932


551
240O17_region_G3_322656_13_Forward_Primer
322572
322598


552
240O17_region_G3_322656_13_Reverse_Primer
322748
322724


553
240O17_region_G3_111841_14_Forward_Primer
111709
111733


554
240O17_region_G3_111841_14_Reverse_Primer
111886
111861


555
240O17_region_G3_192719_13_Forward_Primer
192589
192613


556
240O17_region_G3_192719_13_Reverse_Primer
192767
192743


557
240O17_region_G3_195630_17_Forward_Primer
195490
195514


558
240O17_region_G3_195630_17_Reverse_Primer
195672
195648


559
240O17_region_G3_69999_13_Forward_Primer
69858
69881


560
240O17_region_G3_69999_13_Reverse_Primer
70040
70016


561
240O17_region_G3_11176_13_Forward_Primer
11060
11084


562
240O17_region_G3_11176_13_Reverse_Primer
11243
11219


563
240O17_region_G3_228643_13_Forward_Primer
228529
228553


564
240O17_region_G3_228643_13_Reverse_Primer
228713
228689


565
240O17_region_G3_88478_19_Forward_Primer
88378
88402


566
240O17_region_G3_88478_19_Reverse_Primer
88562
88538


567
240O17_region_G3_108950_13_Forward_Primer
108838
108858


568
240O17_region_G3_108950_13_Reverse_Primer
109023
108998


569
240O17_region_G3_121054_14_Forward_Primer
120911
120935


570
240O17_region_G3_121054_14_Reverse_Primer
121096
121072


571
240O17_region_G3_188337_14_Forward_Primer
188204
188228


572
240O17_region_G3_188337_14_Reverse_Primer
191544
191520


572
240O17_region_G3_188337_14_Reverse_Primer
188391
188367


573
240O17_region_G3_255944_21_Forward_Primer
255879
255903


574
240O17_region_G3_255944_21_Reverse_Primer
256068
256044


575
240O17_region_G3_219518_14_Forward_Primer
219420
219444


576
240O17_region_G3_219518_14_Reverse_Primer
219609
219585


577
240O17_region_G3_235601_15_Forward_Primer
235483
235507


578
240O17_region_G3_235601_15_Reverse_Primer
235673
235649


579
240O17_region_G3_301529_13_Forward_Primer
301498
301522


580
240O17_region_G3_301529_13_Reverse_Primer
301689
301665


581
240O17_region_G3_94795_14_Forward_Primer
94735
94756


582
240O17_region_G3_94795_14_Reverse_Primer
94929
94905


583
240O17_region_G3_46703_23_Forward_Primer
46676
46700


584
240O17_region_G3_46703_23_Reverse_Primer
46870
46846


585
240O17_region_G3_59616_14_Forward_Primer
59539
59563


586
240O17_region_G3_59616_14_Reverse_Primer
59738
59714


587
240O17_region_G3_296933_15_Forward_Primer
296908
296932


588
240O17_region_G3_296933_15_Reverse_Primer
297113
297089


589
240O17_region_G3_192428_17_Forward_Primer
192402
192426


590
240O17_region_G3_192428_17_Reverse_Primer
192613
192589


591
240O17_region_G3_191490_14_Forward_Primer
191332
191356


592
240O17_region_G3_191490_14_Reverse_Primer
191544
191520


593
240O17_region_G3_201115_11_Forward_Primer
200994
201018


594
240O17_region_G3_201115_11_Reverse_Primer
201214
201189


595
240O17_region_G3_72882_15_Forward_Primer
72848
72874


596
240O17_region_G3_72882_15_Reverse_Primer
73068
73042


597
240O17_region_G3_69514_13_Forward_Primer
69411
69437


598
240O17_region_G3_69514_13_Reverse_Primer
69632
69608


599
240O17_region_G3_37699_47_Forward_Primer
37601
37625


600
240O17_region_G3_37699_47_Reverse_Primer
37827
37802


601
240O17_region_G3_11301_29_Forward_Primer
11274
11300


602
240O17_region_G3_11301_29_Reverse_Primer
11501
11477


603
240O17_region_G3_141875_12_Forward_Primer
141729
141750


604
240O17_region_G3_141875_12_Reverse_Primer
141964
141939


605
240O17_region_G3_98090_18_Forward_Primer
98037
98062


606
240O17_region_G3_98090_18_Reverse_Primer
98274
98250


607
240O17_region_G3_43298_35_Forward_Primer
43144
43168


608
240O17_region_G3_43298_35_Reverse_Primer
43387
43363


609
240O17_region_G3_262094_11_Forward_Primer
261989
262014


610
240O17_region_G3_262094_11_Reverse_Primer
262236
262211


611
240O17_region_G3_262079_15_Forward_Primer
261989
262014


612
240O17_region_G3_262079_15_Reverse_Primer
262236
262211


613
240O17_region_G3_59090_12_Forward_Primer
58986
59012


614
240O17_region_G3_59090_12_Reverse_Primer
59248
59224


615
240O17_region_G3_245723_13_Forward_Primer
245502
245526


616
240O17_region_G3_245723_13_Reverse_Primer
245766
245742


617
240O17_region_G3_194628_54_Forward_Primer
194581
194607


618
240O17_region_G3_194628_54_Reverse_Primer
194846
194822


619
240O17_region_G3_4566_16_Forward_Primer
4455
4479


620
240O17_region_G3_4566_16_Reverse_Primer
4722
4696


621
240O17_region_G3_96209_14_Forward_Primer
96119
96143


622
240O17_region_G3_96209_14_Reverse_Primer
96392
96368


623
240O17_region_G3_248715_17_Forward_Primer
248633
248657


624
240O17_region_G3_248715_17_Reverse_Primer
248906
248882


625
240O17_region_G3_71410_40_Forward_Primer
71357
71379


626
240O17_region_G3_71410_40_Reverse_Primer
71636
71611


627
240O17_region_G3_226519_13_Forward_Primer
226315
226339


628
240O17_region_G3_226519_13_Reverse_Primer
226598
226574


629
240O17_region_G3_11282_19_Forward_Primer
11217
11242


630
240O17_region_G3_11282_19_Reverse_Primer
11501
11477


631
240O17_region_G3_170504_12_Forward_Primer
170409
170433


632
240O17_region_G3_170504_12_Reverse_Primer
170694
170671


633
240O17_region_G3_40864_14_Forward_Primer
40652
40678


634
240O17_region_G3_40864_14_Reverse_Primer
40938
40912


635
240O17_region_G3_13529_14_Forward_Primer
13332
13356


636
240O17_region_G3_13529_14_Reverse_Primer
13622
13598


637
240O17_region_G3_22858_14_Forward_Primer
22675
22699


638
240O17_region_G3_22858_14_Reverse_Primer
22966
22942


639
240O17_region_G3_309211_13_Forward_Primer
309092
309118


640
240O17_region_G3_309211_13_Reverse_Primer
309383
309358


641
240O17_region_G3_55568_26_Forward_Primer
55375
55399


642
240O17_region_G3_55568_26_Reverse_Primer
55667
55642


643
240O17_region_G3_73238_16_Forward_Primer
73043
73069


644
240O17_region_G3_73238_16_Reverse_Primer
73342
73318


645
240O17_region_G3_52488_19_Forward_Primer
52413
52437


646
240O17_region_G3_52488_19_Reverse_Primer
52712
52688


647
318O13_region_A3_471518_14_Forward_Primer_Seq
471464
471488


648
318O13_region_A3_471518_14_Reverse_Primer_Seq
471567
471541


649
318O13_region_A3_231599_23_Forward_Primer_Seq
231568
231592


650
318O13_region_A3_231599_23_Reverse_Primer_Seq
231672
231651


651
318O13_region_A3_375912_13_Forward_Primer_Seq
375845
375865


652
318O13_region_A3_375912_13_Reverse_Primer_Seq
375954
375932


653
318O13_region_A3_180013_12_Forward_Primer_Seq
179951
179974


654
318O13_region_A3_180013_12_Reverse_Primer_Seq
180060
180038


655
318O13_region_A3_171606_14_Forward_Primer_Seq
171545
171569


656
318O13_region_A3_171606_14_Reverse_Primer_Seq
171657
171633


657
318O13_region_A3_416256_13_Forward_Primer_Seq
416180
416203


658
318O13_region_A3_416256_13_Reverse_Primer_Seq
416293
416269


659
318O13_region_A3_231395_15_Forward_Primer_Seq
231339
231363


660
318O13_region_A3_231395_15_Reverse_Primer_Seq
231461
231438


661
318O13_region_A3_5502_47Forward_Primer_Seq
5461
5485


662
318O13_region_A3_5502_47_Reverse_Primer_Seq
5585
5561


663
318O13_region_A3_93061_14_Forward_Primer_Seq
92988
93012


664
318O13_region_A3_93061_14_Reverse_Primer_Seq
93112
93090


665
318O13_region_A3_111684_19_Forward_Primer_Seq
111646
111670


666
318O13_region_A3_111684_19_Reverse_Primer_Seq
111772
111748


667
318O13_region_A3_69328_14_Forward_Primer_Seq
69246
69269


668
318O13_region_A3_69328_14_Reverse_Primer_Seq
69373
69349


669
318O13_region_A3_36529_17_Forward_Primer_Seq
36488
36512


670
318O13_region_A3_36529_17_Reverse_Primer_Seq
36617
36593


671
318O13_region_A3_139128_12_Forward_Primer_Seq
139043
139067


672
318O13_region_A3_139128_12_Reverse_Primer_Seq
139174
139150


673
318O13_region_A3_495674_13_Forward_Primer_Seq
495592
495616


674
318O13_region_A3_495674_13_Reverse_Primer_Seq
495723
495699


675
318O13_region_A3_187577_13_Forward_Primer_Seq
187482
187506


676
318O13_region_A3_187577_13_Reverse_Primer_Seq
187613
187590


677
318O13_region_A3_453036_14_Forward_Primer_Seq
452999
453023


678
318O13_region_A3_453036_14_Reverse_Primer_Seq
453132
453108


679
318O13_region_A3_374041_13_Forward_Primer_Seq
373964
373988


680
318O13_region_A3_374041_13_Reverse_Primer_Seq
374097
374073


681
318O13_region_A3_3412_11_Forward_Primer_Seq
3319
3341


682
318O13_region_A3_3412_11_Reverse_Primer_Seq
3454
3430


683
318O13_region_A3_276495_28_Forward_Primer_Seq
276462
276485


684
318O13_region_A3_276495_28_Reverse_Primer_Seq
276598
276574


685
318O13_region_A3_151839_17_Forward_Primer_Seq
151744
151768


686
318O13_region_A3_151839_17_Reverse_Primer_Seq
151882
151858


687
318O13_region_A3_292912_12_Forward_Primer_Seq
292875
292899


688
318O13_region_A3_292912_12_Reverse_Primer_Seq
293014
292990


689
318O13_region_A3_104560_12_Forward_Primer_Seq
104464
104488


690
318O13_region_A3_104560_12_Reverse_Primer_Seq
104604
104580


691
318O13_region_A3_65193_11_Forward_Primer_Seq
65155
65179


692
318O13_region_A3_65193_11_Reverse_Primer_Seq
65295
65271


693
318O13_region_A3_110573_70_Forward_Primer_Seq
110533
110559


694
318O13_region_A3_110573_70_Reverse_Primer_Seq
110674
110648


695
318O13_region_A3_65117_12_Forward_Primer_Seq
65034
65058


696
318O13_region_A3_65117_12_Reverse_Primer_Seq
65177
65153


697
318O13_region_A3_490837_16_Forward_Primer_Seq
490762
490786


698
318O13_region_A3_490837_16_Reverse_Primer_Seq
490905
490881


699
318O13_region_A3_107448_11_Forward_Primer_Seq
107385
107411


700
318O13_region_A3_107448_11_Reverse_Primer_Seq
107529
107505


701
318O13_region_A3_331_23_Forward_Primer_Seq
276
301


702
318O13_region_A3_331_23_Reverse_Primer_Seq
421
397


703
318O13_region_A3_193470_13_Forward_Primer_Seq
193444
193468


704
318O13_region_A3_193470_13_Reverse_Primer_Seq
193589
193565


705
318O13_region_A3_183305_14_Forward_Primer_Seq
183239
183263


706
318O13_region_A3_183305_14_Reverse_Primer_Seq
183384
183360


707
318O13_region_A3_55050_14_Forward_Primer_Seq
54998
55022


708
318O13_region_A3_55050_14_Reverse_Primer_Seq
55144
55120


709
318O13_region_A3_224693_21_Forward_Primer_Seq
224656
224682


710
318O13_region_A3_224693_21_Reverse_Primer_Seq
224803
224779


711
318O13_region_A3_207216_12_Forward_Primer_Seq
207152
207176


712
318O13_region_A3_207216_12_Reverse_Primer_Seq
207299
207276


713
318O13_region_A3_4654_22_Forward_Primer_Seq
4612
4636


714
318O13_region_A3_4654_22_Reverse_Primer_Seq
4760
4736


715
318O13_region_A3_408959_13_Forward_Primer_Seq
408918
408942


716
318O13_region_A3_408959_13_Reverse_Primer_Seq
409066
409042


717
318O13_region_A3_132288_22_Forward_Primer_Seq
132192
132216


718
318O13_region_A3_132288_22_Reverse_Primer_Seq
132340
132316


719
318O13_region_A3_292822_20_Forward_Primer_Seq
292747
292771


720
318O13_region_A3_292822_20_Reverse_Primer_Seq
292895
292871


721
318O13_region_A3_311076_12_Forward_Primer_Seq
311027
311051


722
318O13_region_A3_311076_12_Reverse_Primer_Seq
311175
311152


723
318O13_region_A3_509623_13_Forward_Primer_Seq
509584
509608


724
318O13_region_A3_509623_13_Reverse_Primer_Seq
509732
509708


725
318O13_region_A3_190404_14_Forward_Primer_Seq
190358
190382


726
318O13_region_A3_190404_14_Reverse_Primer_Seq
190506
190482


727
318O13_region_A3_164916_15_Forward_Primer_Seq
164808
164832


728
318O13_region_A3_164916_15_Reverse_Primer_Seq
164957
164933


729
318O13_region_A3_21028_13_Forward_Primer_Seq
21001
21026


730
318O13_region_A3_21028_13_Reverse_Primer_Seq
21150
21126


731
318O13_region_A3_208012_17_Forward_Primer_Seq
207955
207979


732
318O13_region_A3_208012_17_Reverse_Primer_Seq
208104
208085


733
318O13_region_A3_484089_14_Forward_Primer_Seq
484036
484060


734
318O13_region_A3_484089_14_Reverse_Primer_Seq
484185
484161


735
318O13_region_A3_332780_17_Forward_Primer_Seq
332723
332747


736
318O13_region_A3_332780_17_Reverse_Primer_Seq
332872
332853


737
318O13_region_A3_480137_37_Forward_Primer_Seq
480059
480084


738
318O13_region_A3_480137_37_Reverse_Primer_Seq
480208
480182


739
318O13_region_A3_441056_14_Forward_Primer_Seq
441011
441035


740
318O13_region_A3_441056_14_Reverse_Primer_Seq
441161
441138


741
318O13_region_A3_77486_11_Forward_Primer_Seq
77447
77471


742
318O13_region_A3_77486_11_Reverse_Primer_Seq
77597
77573


743
318O13_region_A3_272468_11_Forward_Primer_Seq
272423
272447


744
318O13_region_A3_272468_11_Reverse_Primer_Seq
272573
272549


745
318O13_region_A3_425319_17_Forward_Primer_Seq
425233
425257


746
318O13_region_A3_425319_17_Reverse_Primer_Seq
425383
425359


747
318O13_region_A3_413879_31_Forward_Primer_Seq
413835
413859


748
318O13_region_A3_413879_31_Reverse_Primer_Seq
413985
413961


749
318O13_region_A3_80477_64_Forward_Primer_Seq
80440
80464


750
318O13_region_A3_80477_64_Reverse_Prime_Seq
80591
80567


751
318O13_region_A3_277272_50_Forward_Primer_Seq
277213
277237


752
318O13_region_A3_277272_50_Reverse_Primer_Seq
277364
277340


753
318O13_region_A3_509642_13_Forward_Primer_Seq
509604
509628


754
318O13_region_A3_509642_13_Reverse_Primer_Seq
509755
509731


755
318O13_region_A3_321771_14_Forward_Primer_Seq
321663
321687


756
318O13_region_A3_321771_14_Reverse_Primer_Seq
321815
321791


757
318O13_region_A3_26788_12_Forward_Primer_Seq
26734
26758


758
318O13_region_A3_26788_12_Reverse_Primer_Seq
26886
26862


759
318O13_region_A3_262706_16_Forward_Primer_Seq
262649
262673


760
318O13_region_A3_262706_16_Reverse_Primer_Seq
262802
262778


761
318O13_region_A3_243928_16_Forward_Primer_Seq
243891
243915


762
318O13_region_A3_243928_16_Reverse_Primer_Seq
244044
244020


763
318O13_region_A3_23246_148_Forward_Primer_Seq
23215
23239


764
318O13_region_A3_23246_148_Reverse_Primer_Seq
23368
23344


765
318O13_region_A3_165406_12_Forward_Primer_Seq
165367
165391


766
318O13_region_A3_165406_12_Reverse_Primer_Seq
165521
165497


767
318O13_region_A3_486294_14_Forward_Primer_Seq
486208
486232


768
318O13_region_A3_486294_14_Reverse_Primer_Seq
486362
486338


769
318O13_region_A3_46754_12_Forward_Primer_Seq
46661
46685


770
318O13_region_A3_46754_12_Reverse_Primer_Seq
46816
46792


771
318O13_region_A3_381116_15_Forward_Primer_Seq
381080
381104


772
318O13_region_A3_381116_15_Reverse_Primer_Seq
381235
381211


773
318O13_region_A3_350369_11_Forward_Primer_Seq
350295
350319


774
318O13_region_A3_350369_11_Reverse_Primer_Seq
350450
350426


775
318O13_region_A3_138841_13_Forward_Primer_Seq
138795
138819


776
318O13_region_A3_138841_13_Reverse_Primer_Seq
138950
138926


777
318O13_region_A3_12158_142_Forward_Primer_Seq
12117
12141


778
318O13_region_A3_12158_142_Reverse_Primer_Seq
12272
12248


779
318O13_region_A3_315368_13_Forward_Primer_Seq
315310
315334


780
318O13_region_A3_315368_13_Reverse_Primer_Seq
315465
315441


781
318O13_region_A3_307549_13_Forward_Primer_Seq
307464
307488


782
318O13_region_A3_307549_13_Reverse_Primer_Seq
307619
307595


783
318O13_region_A3_159857_14_Forward_Primer_Seq
159772
159796


784
318O13_region_A3_159857_14_Reverse_Primer_Seq
159928
159904


785
318O13_region_A3_140551_15_Forward_Primer_Seq
140454
140478


786
318O13_region_A3_140551_15_Reverse_Primer_Seq
140610
140586


787
318O13_region_A3_279869_11_Forward_Primer_Seq
279797
279821


788
318O13_region_A3_279869_11_Reverse_Primer_Seq
279953
279929


789
318O13_region_A3_78292_35_Forward_Primer_Seq
78265
78291


790
318O13_region_A3_78292_35_Reverse_Primer_Seq
78422
78397


791
318O13_region_A3_185019_12_Forward_Primer_Seq
184953
184977


792
318O13_region_A3_185019_12_Reverse_Primer_Seq
185111
185087


793
318O13_region_A3_409164_13_Forward_Primer_Seq
409082
409106


794
318O13_region_A3_409164_13_Reverse_Primer_Seq
409240
409219


795
318O13_region_A3_75392_14_Forward_Primer_Seq
75287
75311


796
318O13_region_A3_75392_14_Reverse_Primer_Seq
75445
75421


797
318O13_region_A3_231320_12_Forward_Primer_Seq
231269
231293


798
318O13_region_A3_231320_12_Reverse_Primer_Seq
231429
231405


799
318O13_region_A3_381102_14_Forward_Primer_Seq
381041
381064


800
318O13_region_A3_381102_14_Reverse_Primer_Seq
381201
381176


801
318O13_region_A3_491826_15_Forward_Primer_Seq
491753
491777


802
318O13_region_A3_491826_15_Reverse_Primer_Seq
491914
491891


803
318O13_region_A3_56365_21_Forward_Primer_Seq
56336
56360


804
318O13_region_A3_56365_21_Reverse_Primer_Seq
56497
56473


805
318O13_region_A3_372628_15_Forward_Primer_Seq
372554
372578


806
318O13_region_A3_372628_15_Reverse_Primer_Seq
372715
372691


807
318O13_region_A3_217037_11_Forward_Primer_Seq
216919
216943


808
318O13_region_A3_217037_11_Reverse_Primer_Seq
217081
217057


809
318O13_region_A3_302609_11_Forward_Primer_Seq
302575
302599


810
318O13_region_A3_302609_11_Reverse_Primer_Seq
302737
302713


811
318O13_region_A3_341804_11_Forward_Primer_Seq
341686
341710


812
318O13_region_A3_341804_11_Reverse_Primer_Seq
341848
341824


807
318O13_region_A3_217037_11_Forward_Primer_Seq
216919
216943


808
318O13_region_A3_217037_11_Reverse_Primer_Seq
217081
217057


813
318O13_region_A3_264929_68_Forward_Primer_Seq
264862
264886


814
318O13_region_A3_264929_68_Reverse_Primer_Seq
265024
265000


815
318O13_region_A3_55499_12_Forward_Primer_Seq
55400
55424


816
318O13_region_A3_55499_12_Reverse_Primer_Seq
55563
55539


817
318O13_region_A3_295634_14_Forward_Primer_Seq
295538
295562


818
318O13_region_A3_295634_14_Reverse_Primer_Seq
295702
295677


819
318O13_region_A3_269358_15_Forward_Primer_Seq
269242
269266


820
318O13_region_A3_269358_15_Reverse_Primer_Seq
269406
269382


821
318O13_region_A3_457009_24_Forward_Primer_Seq
456924
456948


822
318O13_region_A3_457009_24_Reverse_Primer_Seq
457088
457064


823
318O13_region_A3_176598_14_Forward_Primer_Seq
176554
176578


824
318O13_region_A3_176598_14_Reverse_Primer_Seq
176718
176694


825
318O13_region_A3_278266_12_Forward_Primer_Seq
278210
278234


826
318O13_region_A3_278266_12_Reverse_Primer_Seq
278376
278350


827
318O13_region_A3_391810_12_Forward_Primer_Seq
391683
391707


828
318O13_region_A3_391810_12_Reverse_Primer_Seq
391851
391826


829
318O13_region_A3_269485_15_Forward_Primer_Seq
269383
269407


830
318O13_region_A3_269485_15_Reverse_Primer_Seq
269551
269527


831
318O13_region_A3_359247_17_Forward_Primer_Seq
359218
359243


832
318O13_region_A3_359247_17_Reverse_Primer_Seq
359386
359362


833
318O13_region_A3_315094_13_Forward_Primer_Seq
314976
315002


834
318O13_region_A3_315094_13_Reverse_Primer_Seq
315145
315120


835
318O13_region_A3_307823_13_Forward_Primer_Seq
307784
307809


836
318O13_region_A3_307823_13_Reverse_Primer_Seq
307953
307927


837
318O13_region_A3_248588_15_Forward_Primer_Seq
248540
248564


838
318O13_region_A3_248588_15_Reverse_Primer_Seq
248709
248684


839
318O13_region_A3_252426_85_Forward_Primer_Seq
252398
252423


840
318O13_region_A3_252426_85_Reverse_Primer_Seq
252568
252543


841
318O13_region_A3_513314_16_Forward_Primer_Seq
513209
513233


842
318O13_region_A3_513314_16_Reverse_Primer_Seq
513379
513355


843
318O13_region_A3_68183_14_Forward_Primer_Seq
68108
68132


844
318O13_region_A3_68183_14_Reverse_Primer_Seq
68279
68255


845
318O13_region_A3_471191_13_Forward_Primer_Seq
471059
471083


846
318O13_region_A3_471191_13_Reverse_Primer_Seq
471231
471206


847
318O13_region_A3_163547_18_Forward_Primer_Seq
163459
163483


848
318O13_region_A3_163547_18_Reverse_Primer_Seq
163632
163608


849
318O13_region_A3_417867_15_Forward_Primer_Seq
417839
417863


850
318O13_region_A3_417867_15_Reverse_Primer_Seq
418014
417990


851
318O13_region_A3_332465_14_Forward_Primer_Seq
332346
332370


852
318O13_region_A3_332465_14_Reverse_Primer_Seq
332523
332499


853
318O13_region_A3_207697_14_Forward_Primer_Seq
207578
207602


854
318O13_region_A3_207697_14_Reverse_Primer_Seq
207755
207731


855
318O13_region_A3_277229_43_Forward_Primer_Seq
277186
277210


856
318O13_region_A3_277229_43_Reverse_Primer_Seq
277364
277340


857
318O13_region_A3_36366_11_Forward_Primer_Seq
36323
36345


858
318O13_region_A3_36366_11_Reverse_Primer_Seq
36501
36477


859
318O13_region_A3_91970_12_Forward_Primer_Seq
91938
91962


860
318O13_region_A3_91970_12_Reverse_Primer_Seq
92116
92091


861
318O13_region_A3_211533_11_Forward_Primer_Seq
211406
211430


862
318O13_region_A3_211533_11_Reverse_Primer_Seq
211585
211561


863
318O13_region_A3_336301_11_Forward_Primer_Seq
336174
336198


864
318O13_region_A3_336301_11_Reverse_Primer_Seq
336353
336329


865
318O13_region_A3_441603_14_Forward_Primer_Seq
441539
441563


866
318O13_region_A3_441603_14_Reverse_Primer_Seq
441718
441694


867
318O13_region_A3_468354_15_Forward_Primer_Seq
468263
468287


868
318O13_region_A3_468354_15_Reverse_Primer_Seq
468442
468418


869
318O13_region_A3_188983_18_Forward_Primer_Seq
188855
188879


870
318O13_region_A3_188983_18_Reverse_Primer_Seq
189035
189009


871
318O13_region_A3_115502_17_Forward_Primer_Seq
115469
115493


872
318O13_region_A3_115502_17_Reverse_Primer_Seq
115649
115625


873
318O13_region_A3_163006_13_Forward_Primer_Seq
162972
162996


874
318O13_region_A3_163006_13_Reverse_Primer_Seq
163153
163129


875
318O13_region_A3_119283_14_Forward_Primer_Seq
119199
119224


876
318O13_region_A3_119283_14_Reverse_Primer_Seq
119381
119357


877
318O13_region_A3_491126_11_Forward_Primer_Seq
491062
491086


878
318O13_region_A3_491126_11_Reverse_Primer_Seq
491244
491220


879
318O13_region_A3_99512_21_Forward_Primer_Seq
99398
99422


880
318O13_region_A3_99512_21_Reverse_Primer_Seq
99581
99557


881
318O13_region_A3_280291_17_Forward_Primer_Seq
280201
280226


882
318O13_region_A3_280291_17_Reverse_Primer_Seq
280385
280361


883
318O13_region_A3_138443_19_Forward_Primer_Seq
138304
138329


884
318O13_region_A3_138443_19_Reverse_Primer_Seq
138488
138465


885
318O13_region_A3_115973_14_Forward_Primer_Seq
115832
115856


886
318O13_region_A3_115973_14_Reverse_Primer_Seq
116016
115992


887
318O13_region_A3_329977_14_Forward_Primer_Seq
329864
329889


888
318O13_region_A3_329977_14_Reverse_Primer_Seq
330050
330026


889
318O13_region_A3_205203_14_Forward_Primer_Seq
205090
205115


890
318O13_region_A3_205203_14_Reverse_Primer_Seq
205276
205252


891
318O13_region_A3_153114_12_Forward_Primer_Seq
152969
152993


892
318O13_region_A3_153114_12_Reverse_Primer_Seq
153156
153132


893
318O13_region_A3_34581_13_Forward_Primer_Seq
34523
34547


894
318O13_region_A3_34581_13_Reverse_Primer_Seq
34712
34688


895
318O13_region_A3_292577_19_Forward_Primer_Seq
292549
292573


896
318O13_region_A3_292577_19_Reverse_Primer_Seq
292739
292715


897
318O13_region_A3_445391_20_Forward_Primer_Seq
445356
445382


898
318O13_region_A3_445391_20_Reverse_Primer_Seq
445547
445523


899
318O13_region_A3_350540_17_Forward_Primer_Seq
350421
350445


900
318O13_region_A3_350540_17_Reverse_Primer_Seq
350612
350588


901
318O13_region_A3_453879_15_Forward_Primer_Seq
453725
453750


902
318O13_region_A3_453879_15_Reverse_Primer_Seq
453918
453894


903
318O13_region_A3_201246_13_Forward_Primer_Seq
201128
201153


904
318O13_region_A3_201246_13_Reverse_Primer_Seq
201321
201297


905
318O13_region_A3_326020_13_Forward_Primer_Seq
325902
325927


906
318O13_region_A3_326020_13_Reverse_Primer_Seq
326095
326071


907
318O13_region_A3_503801_14_Forward_Primer_Seq
503656
503680


908
318O13_region_A3_503801_14_Reverse_Primer_Seq
503849
503823


909
318O13_region_A3_302400_52_Forward_Primer_Seq
302283
302307


910
318O13_region_A3_302400_52_Reverse_Primer_Seq
302481
302456


911
318O13_region_A3_448857_15_Forward_Primer_Seq
448748
448772


912
318O13_region_A3_448857_15_Reverse_Primer_Seq
448947
448924


913
318O13_region_A3_48364_14_Forward_Primer_Seq
48232
48256


914
318O13_region_A3_48364_14_Reverse_Primer_Seq
48435
48412


915
318O13_region_A3_251804_48_Forward_Primer_Seq
251738
251762


916
318O13_region_A3_251804_48_Reverse_Primer_Seq
251942
251918


917
318O13_region_A3_382583_13_Forward_Primer_Seq
382549
382574


918
318O13_region_A3_382583_13_Reverse_Primer_Seq
382753
382728


919
318O13_region_A3_124737_14_Forward_Primer_Seq
124641
124665


920
318O13_region_A3_124737_14_Reverse_Primer_Seq
124846
124822


921
318O13_region_A3_124766_13_Forward_Primer_Seq
124641
124665


922
318O13_region_A3_124766_13_Reverse_Primer_Seq
124846
124822


923
318O13_region_A3_461351_16_Forward_Primer_Seq
461218
461242


924
318O13_region_A3_461351_16_Reverse_Primer_Seq
461426
461402


925
318O13_region_A3_64953_19_Forward_Primer_Seq
64798
64823


926
318O13_region_A3_64953_19_Reverse_Primer_Seq
65011
64987


927
318O13_region_A3_366586_13_Forward_Primer_Seq
366508
366532


928
318O13_region_A3_366586_13_Reverse_Primer_Seq
366722
366698


929
318O13_region_A3_46190_15_Forward_Primer_Seq
46012
46037


930
318O13_region_A3_46190_15_Reverse_Primer_Seq
46228
46205


931
318O13_region_A3_81016_11_Forward_Primer_Seq
80927
80952


932
318O13_region_A3_81016_11_Reverse_Primer_Seq
81146
81122


933
318O13_region_A3_134426_14_Forward_Primer_Seq
134253
134277


934
318O13_region_A3_134426_14_Reverse_Primer_Seq
134474
134449


935
318O13_region_A3_292724_14_Forward_Primer_Seq
292549
292573


936
318O13_region_A3_292724_14_Reverse_Primer_Seq
292771
292747


937
318O13_region_A3_187096_17_Forward_Primer_Seq
187058
187082


938
318O13_region_A3_187096_17_Reverse_Primer_Seq
187282
187257


939
318O13_region_A3_381693_13_Forward_Primer_Seq
381658
381683


940
318O13_region_A3_381693_13_Reverse_Primer_Seq
381885
381863


941
318O13_region_A3_361286_33_Forward_Primer_Seq
361173
361197


942
318O13_region_A3_361286_33_Reverse_Primer_Seq
361401
361376


943
318O13_region_A3_482668_14_Forward_Primer_Seq
482592
482616


944
318O13_region_A3_482668_14_Reverse_Primer_Seq
482821
482796


945
318O13_region_A3_128002_12_Forward_Primer_Seq
127882
127906


946
318O13_region_A3_128002_12_Reverse_Primer_Seq
128112
128087


947
318O13_region_A3_499270_14_Forward_Primer_Seq
499184
499208


948
318O13_region_A3_499270_14_Reverse_Primer_Seq
499422
499398


949
318O13_region_A3_231650_12_Forward_Primer_Seq
231568
231592


950
318O13_region_A3_231650_12_Reverse_Primer_Seq
231809
231788


951
318O13_region_A3_199851_13_Forward_Primer_Seq
199762
199786


952
318O13_region_A3_199851_13_Reverse_Primer_Seq
200012
199988


953
318O13_region_A3_324629_13_Forward_Primer_Seq
324540
324564


954
318O13_region_A3_324629_13_Reverse_Primer_Seq
324790
324766


955
318O13_region_A3_374190_19_Forward_Primer_Seq
374129
374152


956
318O13_region_A3_374190_19_Reverse_Primer_Seq
374394
374370


957
318O13_region_A3_460603_13_Forward_Primer_Seq
460450
460474


958
318O13_region_A3_460603_13_Reverse_Primer_Seq
460715
460691


959
318O13_region_A3_108681_14_Forward_Primer_Seq
108524
108548


960
318O13_region_A3_108681_14_Reverse_Primer_Seq
108791
108768


961
318O13_region_A3_459791_47_Forward_Primer_Seq
459639
459663


962
318O13_region_A3_459791_47_Reverse_Primer_Seq
459907
459883


963
318O13_region_A3_4257_20_Forward_Primer_Seq
4172
4196


964
318O13_region_A3_4257_20_Reverse_Primer_Seq
4450
4425


965
318O13_region_A3_238810_14_Forward_Primer_Seq
238563
238589


966
318O13_region_A3_238810_14_Reverse_Primer_Seq
238850
238826


967
318O13_region_A3_245817_14_Forward_Primer_Seq
245713
245738


968
318O13_region_A3_245817_14_Reverse_Primer_Seq
246001
245977


969
318O13_region_A3_245956_14_Forward_Primer_Seq
245713
245738


970
318O13_region_A3_245956_14_Reverse_Primer_Seq
246001
245977


971
318O13_region_A3_74148_14_Forward_Primer_Seq
74050
74075


972
318O13_region_A3_74148_14_Reverse_Primer_Seq
74338
74314


973
318O13_region_A3_74089_15_Forward_Primer_Seq
74050
74075


974
318O13_region_A3_74089_15_Reverse_Primer_Seq
74338
74314


975
318O13_region_A3_241686_12_Forward_Primer_Seq
241470
241494


976
318O13_region_A3_241686_12_Reverse_Primer_Seq
241765
241741


977
318O13_region_A3_47476_12_Forward_Primer_Seq
47280
47304


978
318O13_region_A3_47476_127_Reverse_Primer_Seq
47577
47554


979
318O13_region_A3_164550_12_Forward_Primer_Seq
164323
164347


980
318O13_region_A3_164550_12_Reverse_Primer_Seq
164621
164598


981
318O13_region_A3_101255_15_Forward_Primer_Seq
101119
101144


982
318O13_region_A3_101255_15_Reverse_Primer_Seq
101418
101392


983
515O02_region_G2_16189_11_Forward_Primer
16144
16168


984
515O02_region_G2_16189_11_Reverse_Primer
16244
16220


985
515O02_region_G2_71925_13_Forward_Primer
71880
71905


986
515O02_region_G2_71925_13_Reverse_Primer
71987
71963


987
515O02_region_G2_4707_12_Forward_Primer
4660
4684


988
515O02_region_G2_4707_12Reverse_Primer
4769
4743


989
515O02_region_G2_118904_18_Forward_Primer
118847
118871


990
515O02_region_G2_118904_18_Reverse_Primer
118957
118932


991
515O02_region_G2_13655_17_Forward_Primer
13567
13592


992
515O02_region_G2_13655_17_Reverse_Primer
13698
13673


993
515O02_region_G2_53900_13_Forward_Primer
53843
53867


994
515O02_region_G2_53900_13_Reverse_Primer
53985
53961


995
515O02_region_G2_8079_14_Forward_Primer
8023
8047


996
515O02_region_G2_8079_14_Reverse_Primer
8167
8143


997
515O02_region_G2_9969_28_Forward_Primer
9917
9941


998
515O02_region_G2_9969_28_Reverse_Primer
10062
10038


999
515O02_region_G2_72308_77_Forward_Primer
72272
72298


1000
515O02_region_G2_72308_77_Reverse_Primer
10062
10038


1001
515O02_region_G2_99475_19_Forward_Primer
99408
99433


1002
515O02_region_G2_99475_19_Reverse_Primer
99554
99530


1003
515O02_region_G2_118615_18_Forward_Primer
118512
118535


1004
515O02_region_G2_118615_18_Reverse_Primer
118658
118634


1005
515O02_region_G2_119001_46_Forward_Primer
118931
118956


1006
515O02_region_G2_119001_46_Reverse_Primer
119079
119055


1007
515O02_region_G2_118958_43_Forward_Primer
118931
118956


1008
515O02_region_G2_118958_43_Reverse_Primer
119079
119055


1009
515O02_region_G2_17197_13_Forward_Primer
17128
17152


1010
515O02_region_G2_17197_13_Reverse_Primer
17276
17252


1011
515O02_region_G2_105163_29_Forward_Primer
105068
105092


1012
515O02_region_G2_105163_29_Reverse_Primer
105217
105192


1013
515O02_region_G2_111335_13_Forward_Primer
111308
111332


1014
515O02_region_G2_111335_13_Reverse_Primer
111458
111434


1015
515O02_region_G2_106396_13_Forward_Primer
106318
106342


1016
515O02_region_G2_106396_13_Reverse_Primer
106469
106445


1017
515O02_region_G2_59229_17_Forward_Primer
59203
59227


1018
515O02_region_G2_59229_17_Reverse_Primer
59354
59330


1019
515O02_region_G2_73795_20_Forward_Primer
73769
73793


1020
515O02_region_G2_73795_20_Reverse_Primer
73921
73896


1021
515O02_region_G2_85664_20_Forward_Primer
85586
85611


1022
515O02_region_G2_85664_20_Reverse_Primer
85738
85714


1023
515O02_region_G2_36921_17_Forward_Primer
36830
36854


1024
515O02_region_G2_36921_17_Reverse_Primer
36983
36959


1025
515O02_region_G2_124150_19_Forward_Primer
124073
124096


1026
515O02_region_G2_124150_19_Reverse_Primer
124227
124203


1027
515O02_region_G2_5089_14_Forward_Primer
4999
5024


1028
515O02_region_G2_5089_14_Reverse_Primer
5156
5132


1029
515O02_region_G2_58221_15_Forward_Primer
58197
58220


1030
515O02_region_G2_58221_15_Reverse_Primer
58354
58330


1031
515O02_region_G2_96139_14_Forward_Primer
96022
96046


1032
515O02_region_G2_96139_14_Reverse_Primer
96182
96158


1033
515O02_region_G2_70595_13_Forward_Primer
70472
70496


1034
515O02_region_G2_70595_13_Reverse_Primer
70634
70608


1035
515O02_region_G2_4340_15_Forward_Primer
4312
4337


1036
515O02_region_G2_4340_15_Reverse_Primer
4477
4454


1037
515O02_region_G2_90417_11_Forward_Primer
90335
90359


1038
515O02_region_G2_90417_11_Reverse_Primer
90503
90479


1039
515O02_region_G2_49711_17_Forward_Primer
49652
49676


1040
515O02_region_G2_49711_17_Reverse_Primer
49820
49796


1041
515O02_region_G2_63053_13_Forward_Primer
63005
63029


1042
515O02_region_G2_63053_13_Reverse_Primer
63173
63148


1043
515O02_region_G2_63076_14_Forward_Primer
63005
63029


1044
515O02_region_G2_63076_14_Reverse_Primer
63173
63148


1045
515O02_region_G2_44442_12_Forward_Primer
44335
44359


1046
515O02_region_G2_44442_12_Reverse_Primer
44505
44481


1047
515O02_region_G2_44422_19_Forward_Primer
44335
44359


1048
515O02_region_G2_44422_19_Reverse_Primer
44505
44481


1049
515O02_region_G2_44158_19_Forward_Primer
44075
44100


1050
515O02_region_G2_44158_19_Reverse_Primer
44252
44227


1051
515O02_region_G2_44141_17_Forward_Primer
44075
44100


1052
515O02_region_G2_44141_17_Reverse_Primer
44252
44227


1053
515O02_region_G2_90762_17_Forward_Primer
90637
90663


1054
515O02_region_G2_90762_17_Reverse_Primer
90814
90790


1055
515O02_region_G2_106241_14_Forward_Primer
106160
106184


1056
515O02_region_G2_106241_14_Reverse_Primer
106341
106317


1057
515O02_region_G2_109676_12_Forward_Primer
109609
109634


1058
515O02_region_G3_109676_12_Reverse_Primer
109793
109768


1059
515O02_region_G2_86242_14_Forward_Primer
86134
86158


1060
515O02_region_G2_86242_14_Reverse_Primer
86318
86293


1061
515O02_region_G2_83109_12_Forward_Primer
83017
83041


1062
515O02_region_G2_83109_12_Reverse_Primer
83202
83178


1063
515O02_region_G2_10461_15_Forward_Primer
10418
10442


1064
515O02_region_G2_10461_15_Reverse_Primer
10609
10585


1065
515O02_region_G2_67608_15_Forward_Primer
67552
67577


1066
515O02_region_G2_67608_15_Reverse_Primer
67745
67721


1067
515O02_region_G2_63275_46_Forward_Primer
63148
63173


1068
515O02_region_G2_63275_46_Reverse_Primer
63347
63323


1069
515O02_region_G2_62405_14_Forward_Primer
62374
62399


1070
515O02_region_G2_62405_14_Reverse_Primer
62576
62552


1071
515O02_region_G2_33563_12_Forward_Primer
33460
33484


1072
515O02_region_G2_33563_12_Reverse_Primer
33670
33646


1073
515O02_region_G2_33146_14_Forward_Primer
32949
32973


1074
515O02_region_G2_33146_14_Reverse_Primer
33191
33167


1075
515O02_region_G2_102179_29_Forward_Primer
102102
102126


1076
515O02_region_G2_102179_29_Reverse_Primer
102352
102327


1077
515O02_region_G2_2646_15_Forward_Primer
2553
2577


1078
515O02_region_G2_2646_15_Reverse_Primer
2809
2784


1079
515O02_region_G2_76652_24_Forward_Primer
76567
76591


1080
515O02_region_G2_76652_24_Reverse_Primer
76835
76812


1081
515O02_region_G2_66280_14_Forward_Primer
66052
66077


1082
515O02_region_G2_66280_14_Reverse_Primer
66334
66309


1083
515O02_region_G2_54768_13_Forward_Primer
54640
54666


1084
515O02_region_G2_54768_13_Reverse_Primer
54923
54899


1085
515O02_region_G2_62580_14_Forward_Primer
62552
62576


1086
515O02_region_G2_62580_14_Reverse_Primer
62840
62816


1087
515O02_region_G2_34598_55_Forward_Primer
34473
34497


1088
515O02_region_G2_34598_55_Reverse_Primer
34765
34739


1089
515O02_region_G2_77680_13_Forward_Primer
77444
77470


1090
515O02_region_G2_77680_13_Reverse_Primer
77741
77716


1091
515O02_region_G2_77693_12_Forward_Primer
77444
77470


1092
515O02_region_G2_77693_12_Reverse_Primer
77741
77716


1093
515O02_region_G2_97392_14_Forward_Primer
97255
97280


1094
515O02_region_G2_97392_14_Reverse_Primer
97554
97530


1095
515O02_region_G2_97359_15_Forward_Primer
97255
97280


1096
515O02_region_G2_97359_15_Reverse_Primer
97554
97530


1120
consensusLRR


1121
rhg1LRR


1122
Rhg4LRR











Primer location on 240O17_region_G3


1123
240O17_region_G3_forward_1_b
45046–45072









DETAILED DESCRIPTION OF THE INVENTION
A) rhg1
The present invention provides a method for the production of a soybean plant having an rhg1 SCN resistant allele comprising: (A) crossing a first soybean plant having an rhg1 SCN rersistant allele with a second soybean plant having an rhg1 SCN sensitive allele to produce a segregating population; (B) screening the segregating population for a member having an rhg1 SCN resistant allele with a first nucleic acid molecule capable of specifically hybridizing to linkage group G, wherein the first nucleic acid molecule specifically hybridizes to a second nucleic acid molecule that is linked to the rhg1 SCN resistant allele; and, (C) selecting the member for further crossing and selection.
rhg1 is located on linkage group G (Concibido et al., Crop Sci. 36:1643–1650 (1996)). SCN resistant alleles of rhg1 provide partial resistance to SCN races 1, 2, 3, 5, 6, and 14 (Conciobido et al. (Crop Sci. 37:258–264 (1997)). Also, Webb (U.S. Pat. No. 5,491,081) reports that a QTL on linkage group G (rhg1) provides partial resistance to SCN races 1, 2, 3, 5, and 14. rhg1 and Rhg4 provide complete or nearly complete resistance to SCN race 3 (U.S. Pat. No. 5,491,081). While initially thought to be a recessive gene, rhg1 classification as a recessive gene has been questioned.
Using bioinformatic approaches, the rhg1 coding region is predicted to contain either four exons (rhg1, v.1)(coding coordinates 45163–45314, 45450–45509, 46941–48763, and 48975 49573 of SEQ ID NO: 2) or two exons (rhg1, v.2) (coding coordinates 46798–48763 and 48975 49573 of SEQ ID NO: 3). rhg1, v.1 encodes an 877 amino acid polypeptide. rhg1, v.2 encodes an 854 amino acid length polypeptide. rhg1 codes for a Xa21-like receptor kinase (SEQ ID NOs: 1097, 1098, and 1100–1115) (Song, et al., Science 270, 1804–1806 (1995)). rhg1 has an extracellular leucine rich repeat (LRR) domain (rhg1, v.1, SEQ ID NO: 1097, residues 164–457; rhg1, v.2, SEQ ID NO: 1098, residues 141–434), a transmembrane domain (rhg1, v.1, SEQ ID NO: 1097, residues 508–530; rhg1, v.2, SEQ ID NO: 1098, residues 33–51, and 485–507) and serine/threonine protein kinase (STK) domain (rhg1, v.1, SEQ ID NO: 1097, residues 578–869; rhg1, v.2, SEQ ID NO: 1098, residues 555–846). In a preferred embodiment, the LRR domain has multiple LRR repeats. In a more preferred embodiment, the LRR domain has 12 LRR repeats.
To identify proteins similar to the proteins encoded by rhg1 candidates, database searches are performed using the predicted peptide sequences. The rhg1 candidate shows similarity to CAA18124, which is the Arabidopsis putative receptor kinase (58.4% similarity and 35.8% identity, (CLUSTALW (default parameters), Thompson et al., Nucleic Acids Res. 22:4673–4680 (1994)), GCG package, Genetics Computer Group, Madison, Wis.), and the apple leucine-rich receptor-like protein kinase (g3641252) (53.2% similarity and 31.5% identity, (CLUSTALW (default parameters))), which has both LLR and STK domains, showing conservation in both the LLR and STK domains. The predicted LRR extracellular domain shows similarity to the tomato resistance genes Cf-2.1 (Lycopersicon pimpinellifolium) (66.9% similarity and 45.4% identity (CLUSTALW (default parameters))) and Cf-2.2 (Lycopersicon pimpinellifolium) (66.9% similarity and 45.4% identity (CLUSTALW (default parameters))).
FIG. 1 is an alignment of the LRR domain of the rhg1 gene. A consensus sequence for the LRR is shown as the top row of the alignment. Each row of amino acids represents an LRR domain. The boxed region indicates the putative β-turn/β-sheet structural motif postulated to be involved in ligand binding (Jones and Jones, Adv. Bot. Res. Incorp. Adv. Plant Path. 24;89–167 (1997)). The hydrophobic leucine residues are thought to project into the core of the protein while the flanking amino acids are thought to be solvent exposed where they may interact with the ligand (Kobe and Deisenhofer, Nature 374; 183–186 (1995)). Non-conservative changes in this region are thought to affect folding. An “x” represents an arbitrary amino acid while an “a” represents a hydrophobic residue (leucine, isoleucine, methionine, valine, or phenylalanine). Amino acid substitutions between resistant and sensitive phenotypes are bordered by a double line. The amino acid substitution within the 302–325 region is a histidine/asparagine substitution, and the amino acid substitution within the 422–445 region is a phenylalanine/serine substitution.
As used herein, a naturally occurring rhg1 allele is any allele that encodes for a protein having an extracellular LRR, a transmembrane domain, and STK domain where the naturally occurring allele is present on linkage group G and where certain rhg1 alleles, but not all rhg1 alleles, are capable of providing or contributing to resistance or partial resistance to a race of SCN. It is understood that such an allele can, using for example methods disclosed herein, be manipulated so that the nucleic acid molecule encoding the protein is no longer present on linkage group G. It is also understood that such an allele can, using for example methods disclosed herein, be manipulated so that the nucleic acid molecule sequence is altered.
As used herein, an rhg1 SCN resistant allele is any rhg1 allele where that allele alone or in combination with other SCN resistant alleles present in the plant, such as an Rhg4 SCN resistant allele, provides resistance to a race of SCN, and that resistance is due, at least in part, to the genetic contribution of the rhg1 allele.
SCN resistance or partial resistance is determined by a comparison of the plant in question with a known SCN sensitive host, Lee 74, according to the method set forth in Schmitt, J. Nematol. 20:392–395 (1988). As used herein, resistance to a particular race of SCN is defined as having less than 10% of cyst development relative to the SCN sensitive host Lee 74. Moreover, as used herein, partial resistance to a particular race of SCN is defined as having more than 10% but less than 75% of cyst development relative to the SCN sensitive host Lee 74.
Any soybean plant having an rhg1 SCN resistant allele can be used in conjunction with the present invention. Soybeans with known rhg1 SCN resistant alleles can be used. Such soybeans include but are not limited to PI548402 (Peking), PI200499, A2869, Jack, A2069, PI209332 (No:4), PI404166 (Krasnoaarmejkaja), PI404198 (Sun huan do), PI437654 (Er-hej-jan), PI438489 (Chiquita), PI507354 (Tokei 421), PI548655 (Forrest), PI548988 (Pickett), PI84751, PI437654, PI40792, Pyramid, Nathan, AG2201, A3469, AG3901, A3904, AG4301, AG4401, AG4501, AG4601, PION9492, PI88788, Dyer, Custer, Manokin, and Doles. In a preferred aspect, the soybean plant having an rhg1 SCN resistant allele is an rhg1 haplotype 2 allele. Examples of soybeans with an rhg1 haplotype 2 allele are PI548402 (Peking), PI404166 (Krasnoaarmejkaja), PI404198 (Sun huan do), PI437654 (Er-hej-jan), PI438489 (Chiquita), PI507354 (Tokei 421), PI548655 (Forrest), PI548988 (Pickett), PI84751, PI437654, and PI40792. In addition, using the methods or agents of the present invention, soybeans and wild relative of soybean such as Glycine soja can be screened for the presence of rhg1 SCN resistant alleles.
Any soybean plant having an rhg1 SCN sensitive allele can be used in conjunction with the present invention. Such soybeans include A3244, A2833, AG3001, Williams, Will, A2704, Noir, DK23-51, Lee 74, Essex, Minsoy, A1923, and Hutcheson. In a preferred aspect, the soybean plant having an rhg1 SCN sensitive allele is an rhg1 A3244 allele. In addition, using the methods or agents of the present invention, soybeans and wild relatives of soybean such as Glycine soja can be screened for the presence of rhg1 SCN sensitive alleles.
Table 2, below, is a table showing single nucleotide polymorphisms (SNPs) and insertions/deletions (INDEL) sites for eight haplotype sequences of rhg1.








TABLE 2







Identification
Base number of contig 240O17_region_G3 of reference line A3244




















Hap
PI#
Line
Ph
45173
45309
45400
45416
45439
45611
45916
45958
46049
46113





1
—
A3244
S
G
G
A
T
A
A
A
A
C
A


2
PI548402
Peking
R
G
A
C
C
T
A
G
A
T
G


3
PI423871
Toyosuzu
—
G
A
A
T
A
A
G
A
T
G


4
PI518672
Will
S
G
G
A
T
A
A
A
A
C
A


5
—
A2704
S
G
G
A
T
A
A
A
A
C
A


6
PI290136
Noir
S
A
A
A
C
T
G
A
T
T
A


7
PI548658
Lee 74
S
A
A
A
C
T
G
A
T
T
A


8
PI200499
—
R
G
A
A
C
A
A
A
A
T
A


N/A
PI548667
Essex
S
A
A
A
C
T
G
A
T
T
A


N/A
PI548389
Minsoy
S
G
G
A
T
A
A
A
A
C
A


N/A
PI360843
Oshima.
—
—
—
—
—
—
—
—
—
—
—


N/A
—
A2869
R
—
—
—
—
—
—
—
—
—
—


N/A
PI540556
Jack
R
—
—
—
—
—
—
—
—
—
—


N/A
—
A2069
R
—
—
—
—
—
—
—
—
—
—


N/A
PI209332
No.4
R
—
—
—
—
—
—
—
—
—
—





Hap
PI#
Line
Ph
46227
46703
47057
47140
47208
47571
47617
47796
47856
47937





1
—
A3244
S
d1
0
T
C
C
G
C
A
T
T


2
PI548402
Peking
R
0
d2
C
C
C
G
C
C
C
C


3
PI423871
Toyosuzu
—
0
0
T
C
C
G
C
C
C
C


4
PI518672
Will
S
d1
0
T
A
T
G
C
A
T
T


5
—
A2704
S
d1
0
T
A
T
G
C
A
T
T


6
PI290136
Noir
S
0
d14
T
C
C
A
A
C
C
C


7
PI548658
Lee 74
S
0
d14
T
C
C
G
A
C
C
C


8
PI200499
—
R
0
d14
T
C
C
G
A
C
C
C


N/A
PI548667
Essex
S
0
d14
T
C
C
G
A
C
C
C


N/A
PI548389
Minsoy
S
d1
0
T
A
T
G
C
A
T
T


N/A
PI360843
Oshima.
—
—
0
T
A
T
G
C
A
T/C
T/C


N/A
—
A2869
R
0
d14
T
C
C
G
A
C
C
C


N/A
PI540556
Jack
R
—
—
—
—
—
—
—
C
C
C


N/A
—
A2069
R
—
—
—
—
—
—
—
C
T/C
T/C


N/A
PI209332
No.4
R
—
—
—
—
—
—
—
C
C
C





Hap
PI#
Line
Ph
48012
48060
48073
48135
48279
48413
48681
48881
49012
49316





1
—
A3244
S
T
C
C
A
C
G
A
0
A
T


2
PI548402
Peking
R
T
C
C
G
C
G
G
d19
G
T


3
PI423871
Toyosuzu
—
T
C
C
G
C
G
A
0
A
T


4
PI518672
Will
S
T
C
C
A
C
G
A
0
A
T


5
—
A2704
S
C
T
T
G
T
C
—
0
G
C


6
PI290136
Noir
S
C
T
T
G
T
C
G
0
G
C


7
PI548658
Lee 74
S
C
T
T
G
T
C
G
0
G
C


8
PI200499
—
R
C
T
T
G
T
C
G
0
G
C


N/A
PI548667
Essex
S
C
T
T
G
T
C
A/G
0
G
C


N/A
PI548389
Minsoy
S
C/T
C/T
C/T
A
C
G
A
0
A
T


N/A
PI360843
Oshimas.
—
T
C
C
A/G
C
G
A
0
A
T


N/A
—
A2869
R
C
T
T
G
T
C
G
0
G
C


N/A
PI540556
Jack
R
C
T
T
G
T
C
G
0
G
C


N/A
—
A2069
R
C
T
T
A
T
C
G
0
G
C


N/A
PI209332
No.4
R
C
T
T
A/G
T
C
G
0
G
C









In Table 2, discrete haplotypes are designated 1 through 8. N/A refers to a haplotype that is not characterized. The Plant Introduction classification number is indicated in the “PI#” column. A dash indicates that no PI number is known or assigned for the line under investigation. The line from which the sequences are derived is indicated in the “line” column, with a dash indicating an unknown or unnamed line. The “Ph.” (phenotype) column of table 2 indicates whether a given line has been reported as resistant (R) to at least one race of SCN or sensitive (S).
The nucleotide bases located at each of 30 positions in each of the haplotype sequences is shown in the columns labeled “Base number of contig 240017_region_G3 of reference line A3244.” The base number at the top of each column corresponds to the base number in contig 240017_region_G3 of reference line A3224 (SEQ ID NOs: 2 and 3). The letters G, A, C, and T correspond to the bases guanine, adenine, cytosine, and thymine. Two bases separated by a slash (A/G, C/T, or T/C) indicate uncertainty at the specified position of the haplotype sequence. A “d” followed by a number indicates a deletion of a the length specified. That is, d1 is a one base deletion, d2 is a two base deletion, d14 is a fourteen base deletion, and d19 is a nineteen base deletion. A zero (0) indicates no deletion. A dash indicates that the identity of the base is undetermined.
Examination of table 2 reveals that the amino acid substitutions in the rhg1 coding region are common to the resistant lines PI467312 (Cha-mo-shi-dou), PI88788 and the southern susceptible lines Essex, Hutchenson, Noir and A1923. As used herein, a “southern” cultivar is any cultivar from maturity groups VI, VII, VIII, IX, or X, and a “northern” cultivar is any cultivar from maturity groups 000, 00, 0, I, II, III, IV, or V. This data is consistent with the mapping experiments of Qui et al. (Theor Appl Genet 98:356–364 (1999)). Based on analysis of 200 F2:3 families derived from a cross between Peking and Essex, the authors failed to detect any significant association with SCN resistance to races 1, 2, and 3, and the rhg1 locus on linkage group G. The authors point out that one of the markers, Bng122, which has been shown to have significant linkage to rhg1 (Concibido et al., Crop Sci. 36:1643–1650 (1996)), is not polymorphic in the population employed. It is also possible that the susceptible southern lines contain rhg1 and the susceptible phenotype reflects the polygenic nature of SCN resistance. In a study to uncover QTLs for sudden death syndrome (SDS) in soybean, two SCN resistant alleles originating from the susceptible parent Essex have been described (Hlnetkovsky et al., Crop Sci. 36:393–400).
Tables 3a, 3b, and 3c, below, show lines that share an rhg1 haplotype.







TABLE 3a







Haplotype 2 Lines











PI#
Line
Ph.







PI548402
Peking
R



PI404166
Krasnoaarmejkaja
R



PI404198
(Sun huan do)
R



PI437654
Er-hej-jan
R



PI438489
(Chiquita)
R



PI507354
Tokei 421
R



PI548655
Forrest
R



PI548988
Pickett
R



PI84751
—
R



PI437654
—
R



PI40792
—
—

















TABLE 3b







Haplotype 4 Lines









PI#
Line
Ph.





—
Will
S


PI467312
Cha-mo-shi-dou
R


PI88788 
—
R
















TABLE 3c







Haplotype 6 Lines









Pl#
Line
Ph.





—
Noir
S


—
A1923
S


—
Hutcheson
S









In Tables 3a, 3b, and 3c, Plant Introduction classification number is indicated in the “PI#” column. A dash indicates that no PI number is known or assigned for the line in question. The line from which the sequences are derived is indicated in the “line” column, with a dash indicating an unknown or unnamed line. The “Ph.” column indicates whether a given line has been reported as resistant (R) to at least one race of SCN or sensitive (S), with a dash indicating that the phenotype is unknown.
In a preferred aspect, the source of either an rhg1 SCN sensitive allele or an rhg1 SCN resistant allele, or more preferably both, is an elite plant. An “elite line” is any line that has resulted from breeding and selection for superior agronomic performance. Examples of elite lines are lines that are commercially available to farmers or soybean breeders such as HARTZTM variety H4994, HARTZTM variety H5218, HARTZTM variety H5350, HARTZTM variety H5545, HARTZTM variety H5050, HARTZTM variety H5454, HARTZTM variety H5233, HARTZTM variety H5488, HARTZTM variety HLA572, HARTZTM variety H6200, HARTZTM variety H6104, HARTZTM variety H6255, HARTZTM variety H6586, HARTZTM variety H6191, HARTZTM variety H7440, HARTZTM variety H4452 Roundup ReadyTM, HARTZTM variety H4994 Roundup ReadyTM, HARTZTM variety H4988 Roundup ReadyTM, HARTZTM variety H5000 Roundup ReadyTM, HARTZTM variety H5147 Roundup ReadyTM, HARTZTM variety H5247 Roundup ReadyTM, HARTZTM variety H5350 Roundup ReadyTM, HARTZTM variety H5545 Roundup ReadyTM, HARTZTM variety H5855 Roundup ReadyTM, HARTZTM variety H5088 Roundup ReadyTM, HARTZTM variety H5164 Roundup ReadyTM, HARTZTM variety H5361 Roundup ReadyTM, HARTZTM variety H5566 Roundup ReadyTM, HARTZTM variety H5181 Roundup ReadyTM, HARTZTM variety H5889 Roundup ReadyTM, HARTZTM variety H5999 Roundup ReadyTM, HARTZTM variety H6013 Roundup ReadyTM, HARTZTM variety H6255 Roundup ReadyTM, HARTZTM variety H6454 Roundup ReadyTM, HARTZTM variety H6686 Roundup ReadyTM, HARTZTM variety H7152 Roundup ReadyTM, HARTZTM variety H7550 Roundup ReadyTM, HARTZTM variety H8001 Roundup ReadyTM (HARTZ SEED, Stuttgart, Ark., U.S.A.); A0868, AG0901, A1553, A1900, AG1901, A1923, A2069, AG2101, AG2201, A2247, AG2301, A2304, A2396, AG2401, AG2501, A2506, A2553, AG2701, AG2702, A2704, A2833, A2869, AG2901, AG2902, AG3001, AG3002, A3204, A3237, A3244, AG3301, AG3302, A3404, A3469, AG3502, A3559, AG3601, AG3701, AG3704, AG3750, A3834, AG3901, A3904, A4045 AG4301, A4341, AG4401, AG4501, AG4601, AG4602, A4604, AG4702, AG4901, A4922, AG5401, A5547, AG5602, A5704, AG5801, AG5901, A5944, A5959, AG6101, QR4459 and QP4544 (Asgrow Seeds, Des Moines, Iowa, U.S.A.); DeKalb variety CX445 (DeKalb, Ill.). An elite plant is any plant from an elite line.
B) Rhg4
The present invention provides a method for the production of a soybean plant having an Rhg4 SCN resistant allele comprising: (A) crossing a first soybean plant having an Rhg4 SCN resistant allele with a second soybean plant having an Rhg4 SCN sensitive allele to produce a segregating population; (B) screening the segregating population for a member having an Rhg4 SCN resistant allele with a first nucleic acid molecule capable of specifically hybridizing to linkage group A2, wherein the first nucleic acid molecule specifically hybridizes to a second nucleic acid molecule linked to the Rhg4 SCN resistant allele; and, (C) selecting the member for further crossing and selection.
Rhg4 is located on linkage group A2 (Matson and Williams, Crop Sci. 5:447 (1965)). SCN resistant alleles of Rhg4 provide partial resistance to SCN races 1 and 3 (U.S. Pat. No. 5,491,081). Together, rhg1 and Rhg4 provide complete or nearly complete resistance to SCN race 3. The dominant gene, Rhg4, was found to be closely linked to the seed coat color locus (i) (Matson and Williams, Crop Sci. 5:447 (1965)). The i locus in Peking was also reported to be linked with a recessive gene for resistance to SCN (Sugiyama and Katsumi, Jpn. J. Breed. 16:83–86 (1966)). It is possible that Rhg4 and the recessive gene linked to the i locus are one and the same, which would call into question the classification of Rhg4 as a dominant gene.
Using bioinformatic approaches the Rhg4 coding region is predicted to contain 2 exons (coding coordinates 111805–113968 and 114684–115204 of SEQ ID NO: 4). Rhg4 encodes an 894 amino acid polypeptide. Rhg4 codes for a Xa21-like receptor kinase (SEQ ID NOs: 1099 and 1116–1119) (Song et al., Science 270, 1804–1806, (1995)). Rhg4 has an extracellular LRR domain (Rhg4, SEQ ID NO: 1099, residues 34–44), a transmembrane domain (Rhg4 SEQ ID NO: 1099, residues 449–471), and STK domain (Rhg4, SEQ ID NO: 1099, residues 531–830). In a preferred embodiment, the LRR domain has multiple LRR repeats. In a more preferred embodiment, the LRR domain has 12 LRR repeats.
To identify proteins similar to the Rhg4 candidate, database searches are performed using the predicted peptide sequences. The Rhg4 candidate shows similarity to TMK (Y07748)(73.0% similarity and 54.8% identity (CLUSTALW (default parameters))) and TMK1 PRECURSOR (70.6% similarity and 55.1% identity (CLUSTALW (default parameters))), which are rice and Arabidopsis receptor kinases, respectively. The predicted LRR extracellular domain reveals similarity to TMK (Y07748)(70.1% similarity and 46.6% identity (CLUSTALW (default parameters))), TMK1 PRECURSOR (g1707642) (65.8% similarity and 48.8% identity (CLUSTALW (default parameters))), and F21J9.1 (g2213607) (65.5% similarity and 45.6% identity (CLUSTALW (default parameters))).
FIG. 2 is an alignment of the LRR domain of the Rhg4 gene. A consensus sequence is shown as the top row. Each row of amino acids represents an LRR domain. The boxed region indicates the putative β-turn/β-sheet structural motif postulated to be involved in ligand binding (Jones and Jones, Adv. Bot. Res. Incorp. Adv. Plant Path. 24;89–167 (1997)). The hydrophobic leucine residues are thought to project into the core of the protein while the flanking amino acids are thought to be solvent exposed where they may interact with the ligand (Kobe and Deisenhofer, Nature 374; 183–186 (1995)). An “x” represents an arbitrary amino acid while an “a” represents a hydrophobic residue (leucine, isoleucine, methionine, valine, or phenylalanine).
Amino acid substitutions between resistant and sensitive phenotypes are bordered by a double line. The amino acid substitution within the 35–57 region is a histidine/glutamine substitution, and the amino acid substitution within the 81–104 region is a leucine/phenylalanine substitution.
As used herein, a naturally-occurring Rhg4 allele is any allele that encodes for a protein having an extracellular LRR domain, a transmembrane domain, and STK domain where the naturally occurring allele is present on linkage group A2 and where certain Rgh4 alleles, but not all Rgh4 alleles, are capable of providing or contributing to resistance or partial resistance to a race of SCN. It is understood that such an allele can, using, for example methods disclosed herein, be manipulated so that the nucleic acid molecule encoding the protein is no longer present on linkage group A2. It is also understood that such an allele can, using, for example methods disclosed herein, be manipulated so that the nucleic acid molecule sequence is altered.
As used herein, an Rhg4 SCN resistant allele is any Rhg4 allele where that allele alone or in combination with other SCN resistant alleles present in the plant, such as an rhg1 SCN resistant allele, provides resistance to a race of SCN, and that resistance is due, at least in part, to the genetic contribution of the Rhg4 allele.
Any soybean plant having an Rhg4 SCN resistant allele can be used in conjunction with the present invention. Soybeans with known Rhg4 SCN resistant alleles can be used. Such soybeans include, but are not limited to, PI548402 (Peking), PI437654 (Er-hej-jan), PI438489 (Chiquita), PI507354 (Tokei 421), PI548655 (Forrest), PI548988 (Pickett), PI88788, PI404198 (Sun Huan Do), PI404166 (Krasnoaarmejkaja), Hartwig, Manokin, Doles, Dyer, and Custer. In a preferred aspect, the soybean plant having an Rhg4 SCN resistant allele is an Rhg4 haplotype 3 allele in a plant having either an rhg1 haplotype 2 or rhg1 haplotype 4 allele. Examples of soybeans with an Rhg4 haplotype 3 allele are PI548402 (Peking), PI88788, PI404198 (Sun huan do), PI438489 (Chiquita), PI437654 (Er-hej-jan), PI404166 (Krasnoaarmejkaja), PI548655 (Forrest), PI548988 (Pickett), and PI507354 (Tokei 421). In addition, using the methods or agents of the present invention, soybeans and wild relatives of soybeans such as Glycine soja can be screened for the presence of Rhg4 SCN resistant alleles.
Table 4 below is a table showing single nucleotide polymorphisms (SNPs) for three haplolotype sequences of Rhg4.










TABLE 4







Identification

Base number of contig 318O13_region_A3
Markers



















Hap
PI number
Line
Ph
Coat
111933
112065
112101
112461
114066
scn279
scnb267
scn273





1
—
A2069
R
yellow
T
A
T
A
T
2
2
2


1
—
A2869
R
yellow
T
A
T
A
T
2
2
2


1
—
A3244
S
yellow
T
A
T
A
T
2
2
2


1
PI87631
Kindaizu
R
yellow
T
A
T
A
T
2
2
2


1
PI548389
Minsoy
S
yellow
T
A
T
A
T
2
2
2


1
PI518664
Hutcheson
S
yellow
T
A
T
A
T
2
2
2


1
PI548658
Lee 74
S
yellow
T
A
T
A
T
—
2
2


2
PI540556
Jack
R
yellow
G
A
T
A
T
2
2
1


2
PI360843
Oshimashirome
R
yellow
G
A
T
A
T
—
—
—


2
PI423871
Toyosuzu
R
yellow
G
A
T
A
T
—
—
—


3
PI548402
Peking
R
black
G
C
C
T
G
1
1
1


3
PI88788
—
R
black
G
C
C
T
G
1
1
1


3
PI404198 B
(Sun huan do)
R
black
G
C
C
T
G
1
1
1


3
PI438489 B
(Chiquita)
R
black
G
C
C
T
G
1
1
1


3
PI437654
Er-hej-jan
R
black
G
C
C
T
G
2
1
1


3
PI404166
Krasnoaarmejkaja
R
black
G
C
C
T
G
1
1
—


3
PI290136
Noir
S
black
G
C
C
T
G
1
1
1


3
PI548655
Forrest
R
yellow
G
C
C
T
G
1
1
1


3
PI548988
Pickett
R
yellow
G
C
C
T
G
1
1
1


3
PI507354
Tokei 421
R
yellow
G
C
C
T
G
1
1
1


N/A
PI467312
Cha-mo-shi-dou
R
GnBr
G
C
C
T
—
1
1
1


N/A
PI209332
No.4
R
black
T
A
T
—
—
2
2
2


N/A
PI518672
Will
S
yellow
T
A
T
—
T
2
2
2


N/A
PI548667
Essex
S
yellow
T
A
T
—
T
2
2
2









In Table 4, discrete haplotypes are designated 1 through 3. N/A refers to a haplotype that is not characterized. In Table 4, the Plant Introduction classification number is indicated in the “PI#” column. A dash indicates that no PI number is known or assigned for the line under investigation. The line from which the sequences are derived is indicated in the “line” column, with a dash indicating an unknown or unnamed line. The “Ph.” column of Table 4 indicates whether a given line has been reported to be resistant (R) to at least one race of SCN, or sensitive (S). The “coat” column shows the phenotypic coat color of a seed as either yellow, black, green/brown (GnBr), or unknown/unassigned (dash). At the I locus, black seeded varieties harbor the i allele for black or imperfect black seed coat. In a preferred embodiment, the seed has a yellow coat.
The nucleotide base located at each of 5 positions in each of the haplotype sequences is shown in the columns labeled “Base number of contig 318013_region_A3.” The base number at the top of each column correspond to the base number in the contig 318013_region_A3 of reference line A3244 (SEQ ID NO: 4). The letters G, A, C, and T correspond to the bases guanine, adenine, cytosine, and thymine. A dash indicates that the identity of the base is unknown.
Three different simple sequence repeat (SSR) or microsatellite markers that occur within the sequences, scn279 (SEQ ID NO: 292), scn267 (SEQ ID NO: 282), and scn273 (SEQ ID NO: 294), are listed under “markers.” The allele of each marker occurring in a haplotype is indicated by a 1 or a 2, with a dash indicating that the information is not determined.
Any soybean plant having an Rhg4 SCN sensitive allele can be used in conjunction with the present invention. Such soybeans include A3244, Will, Noir, Lee 74, Essex, Minsoy, A2704, A2833, AG3001, Williams, DK23-51, and Hutcheson. In a preferred aspect, the soybean plant having an Rhg4 SCN sensitive allele is an Rhg4 A3244 allele. In addition, using the methods or agents of the present invention, soybeans and wild relative of soybean such as Glycine soja can be screened for the presence of Rhg4 SCN sensitive alleles.
In a preferred aspect, the source of either an Rhg4 SCN sensitive allele or an Rhg4 SCN resistant allele, or more preferably both, is an elite plant.
In table 5, below, rhg1 and Rhg4 haplotypes for various cultivars are compared.








TABLE 5







Identification
Haplotype












PI#
Line
Coat
Ph.
rhg4
rhg1





—
A3244
yellow
S
1
1


PI548402
Peking
black
R
3
2


PI404198 B
(Sun huan do)
black
R
3
2


PI438489 B
(Chiquita)
black
R
3
2


PI437654
Er-hej-jan
black
R
3
2


PI404166
Krasnoaarmejkaja
black
R
3
2


PI548655
Forrest
yellow
R
3
2


PI548988
Pickett
yellow
R
3
2


PI507354
Tokei 421
yellow
R
3
2


PI88788
—
black
R
3
4


PI467312
Cha-mo-shi-dou
GnBr
R
N/A
4


—
Noir
black
S
3
6


—
Jack
yellow
R
2
N/A


PI360843
Oshimashirome
yellow
R
2
N/A


PI423871
Toyosuzu
yellow
R
2
3


PI209332
No.4
black
R
N/A
N/A


PI87631
Kindaizu
yellow
R
1
—


—
Minsoy
yellow
S
1
N/A


—
Will
yellow
S
N/A
4


—
Hutcheson
yellow
S
1
6


—
Lee 74
yellow
S
N/A
7


—
Essex
yellow
S
N/A
N/A


—
A2069
yellow
R
1
N/A


—
A2869
yellow
R
1
N/A









In Table 5, haplotypes, as used in Tables 2 through 4, are listed for each line. N/A refers to a haplotype that is not characterized. The Plant Introduction classification number is indicated in the “PI#” column. A dash indicates that no PI number is known or assigned for the line under investigation. The line from which the sequences are derived is indicated in the “line” column, with a dash indicating an unknown or unnamed line. The “Ph.” column of table 5 indicates whether a given line has been reported to be resistant (R) to at least one race of SCN, or sensitive (S). The “coat” column shows the phenotypic coat color of a seed as either yellow, black, green/brown (GnBr), or unknown/unassigned (dash). At the I locus, black seeded varieties harbor the i allele for black or imperfect black seed coat. In a preferred embodiment, the seed has a yellow coat.
Screening for rhg1 and Rhg4 Alleles
Any appropriate method can be used to screen for a plant having an rhg1 SCN resistant allele. Any appropriate method can be used to screen for a plant having an Rhg4 SCN resistant allele. In a preferred aspect of the present invention, a nucleic acid marker of the present invention can be used (see section entitled “Screening for rhg1 and Rhg4 alleles” and subsection (ii) of the section entitled “Agents”).
Additional markers, such as SSRs, AFLP markers, RFLP markers, RAPD markers, phenotypic markers, SNPs, isozyme markers, microarray transcription profiles that are genetically linked to or correlated with alleles of a QTL of the present invention can be utilized (Walton, Seed World 22–29 (July, 1993); Burow and Blake, Molecular Dissection of Complex Traits, 13–29, Eds. Paterson, CRC Press, New York (1988)). Methods to isolate such markers are known in the art. For example, locus-specific SSRs can be obtained by screening a genomic library for SSRs, sequencing of “positive” clones, designing primers which flank the repeats, and amplifying genomic DNA with these primers. The size of the resulting amplification products can vary by integral numbers of the basic repeat unit. To detect a polymorphism, PCR products can be radiolabeled, separated on denaturing polyacrylamide gels, and detected by autoradiography. Fragments with size differences >4 bp can also be resolved on agarose gels, thus avoiding radioactivity.
Other SSR markers may be utilized. Amplification of simple tandem repeats, mainly of the [CA]n type were reported by Litt and Luty, Amer. J. Human Genet. 44:397–401 (1989); Smeets et al., Human Genet. 83:245–251 (1989); Tautz, Nucleic Acids Res. 17:6463–6472 (1989); Weber and May, Am. J. Hum. Genet. 44:388–396 (1989). Weber, Genomics 7:524–530 (1990), reported that the level of polymorphism detected by PCR-amplified [CA]n type SSRs depends on the number of the “perfect” (i.e., uninterrupted), tandemly repeated motifs. Below a certain threshold (i.e., 12 CA-repeats), the SSRs were reported to be primarily monomorphic. Above this threshold, however, the probability of polymorphism increases with SSR length. Consequently, long, perfect arrays of SSRs are preferred for the generation of markers, i.e., for the design and synthesis of flanking primers.
Suitable primers can be deduced from DNA databases (e.g., Akkaya et al., Genetics. 132:1131–1139 (1992)). Alternatively, size-selected genomic libraries (200 to 500 bp) can be constructed by, for example, using the following steps: (1) isolation of genomic DNA; (2) digestion with one or more 4 base-specific restriction enzymes; (3) size-selection of restriction fragments by agarose gel electrophoresis, excision and purification of the desire size fraction; (4) ligation of the DNA into a suitable vector and transformation into a suitable E. coli strain; (5) screening for the presence of SSRs by colony or plaque hybridization with a labeled probe; (6) isolation of positive clones and sequencing of the inserts; and (7) design of suitable primers flanking the SSR.
Establishing libraries with small, size-selected inserts can be advantageous for SSR isolation for two reasons: (1) long SSRs are often unstable in E. coli, and (2) positive clones can be sequenced without subcloning. A number of approaches have been reported for the enrichment of SSRs in genomic libraries. Such enrichment procedures are particularly useful if libraries are screened with comparatively rare tri- and tetranucleotide repeat motifs. One such approach has been described by Ostrander et al., Proc. Natl. Acad. Sci.(U.S.A). 89:3419–3423 (1992), who reported the generation of a small-insert phagemid library in an E. coli strain deficient in UTPase (d8t) and uracil-N-glycosylase (ung) genes. In the absence of UTPase and uracil-N-glycosylase, dUTP can compete with dTTP for the incorporation into DNA. Single-stranded phagemid DNA isolated from such a library can be primed with [CA]n and [TG]n primers for second strand synthesis, and the products used to transform a wild-type E. coli strain. Since under these conditions there will be selection against single-stranded, uracil-containing DNA molecules, the resulting library will consist of primer-extended, double-stranded products and an about 50-fold enrichment in CA-repeats.
Other reported enrichment strategies rely on hybridization selection of simple sequence repeats prior to cloning (Karagyozov et al., Nucleic Acids Res. 21:3911–3912 (1993); Armour et al., Hum. Mol. Gen. 3:599–605 (1994); Kijas et al., Genome 38:349–355 (1994); Kandpal et al., Proc. Natl. Acad. Sci.(U.S.A.) 91:88–92 (1994); Edwards et al., Am. J. Hum. Genet. 49:746–756 (1991)). Hybridization selection, can for example, involve the following steps: (1) genomic DNA is fragmented, either by sonication, or by digestion with a restriction enzyme; (2) genomic DNA fragments are ligated to adapters that allow a “whole genome PCR” at this or a later stage of the procedure; (3) genomic DNA fragments are amplified, denatured and hybridized with single-stranded SSR sequences bound to a nylon membrane; (4) after washing off unbound DNA, hybridizing fragments enriched for SSRs are eluted from the membrane by boiling or alkali treatment, reamplified using adapter-complementary primers, and digested with a restriction enzyme to remove the adapters; and (5) DNA fragments are ligated into a suitable vector and transformed into a suitable E. coli strain. SSRs can be found in up to 50–70% of the clones obtained from these procedures (Armour et al., Hum. Mol. Gen. 3:599–605 (1994); Edwards et al., Am. J. Hum. Genet. 49:746–756 (1991)).
An alternative hybridization selection strategy was reported by Kijas et al., Genome 38:599–605 (1994), which replaced the nylon membrane with biotinylated, SSR-complementary oligonucleotides attached to streptavidin-coated magnetic particles. SSR-containing DNA fragments are selectively bound to the magnetic beads, reamplified, restriction-digested and cloned.
It is further understood that other additional markers on linkage group G or A2 may be utilized (Morgante et al., Genome 37: 763–769 (1994)). As used herein, reference to the linkage group of G or A2 refers to the linkage group that corresponds to linkage groups U5 and U3, respectively from the genetic map of Glycine max (Mansur et al., Crop Sci. 36: 1327–1336 (1996), and linkage groups G and A2 respectively of Glycine max x. Glycine sola (Shoemaker et al., Genetics 144: 329–336 (1996)) that is present in Glycine soja (Soybase, an Agricultural Research Service, United States Department of Agriculture http-129.186.26.940/ and USDA —Agricultural Research Service: http-www.ars.usda.gov/)).
PCR-amplified SSRs can be used, because they are locus-specific, codominant, occur in large numbers and allow the unambiguous identification of alleles. Standard PCR-amplified SSR protocols use radioisotopes and denaturing polyacrylamide gels to detect amplified SSRs. In many situations, however, allele sizes are sufficiently different to be resolved on high percentage agarose gels in combination with ethidium bromide staining (Bell and Ecker, Genomics 19:137–144 (1994); Becker and Heun, Genome 38:991–998 (1995); Huttel, Ph.D. Thesis, University of Frankfurt, Germany (1996)). High resolution without applying radioactivity is also provided by nondenaturing polyacrylamide gels in combination with either ethidium bromide (Scrimshaw, Biotechniques 13:2189 (1992)) or silver straining (Klinkicht and Tautz, Molecular Ecology 1: 133–134 (1992); Neilan et al., Biotechniques 17:708–712 (1994)). An alternative of PCR-amplified SSRs typing involves the use of fluorescent primers in combination with a semi-automated DNA sequencer (Schwengel et al., Genomics 22:46–54 (1994)). Fluorescent PCR products can be detected by real-time laser scanning during gel electrophoresis. An advantage of this technology is that different amplification reactions as well as a size marker (each labeled with a different fluorophore) can be combined into one lane during electrophoresis. Multiplex analysis of up to 24 different SSR loci per lane has been reported (Schwengel et al., Genomics 22:46–54 (1994)).
The detection of polymorphic sites in a sample of DNA may be facilitated through the use of nucleic acid amplification methods. Such methods specifically increase the concentration of polynucleotides that span the polymorphic site, or include that site and sequences located either distal or proximal to it. Such amplified molecules can be readily detected by gel electrophoresis or other means.
The most preferred method of achieving such amplification employs the polymerase chain reaction (“PCR”) (Mullis et al., Cold Spring Harbor Symp. Quant. Biol. 51:263–273 (1986); Erlich et al., European Patent Appln. 50,424; European Patent Appln. 84,796, European Patent Application 258,017, European Patent Appln. 237,362; Mullis, European Patent Appln. 201,184; Mullis et al., U.S. Pat. No. 4,683,202; Erlich, U.S. Pat. No. 4,582,788; and Saiki et al., U.S. Pat. No. 4,683,194), using primer pairs that are capable of hybridizing to the proximal sequences that define a polymorphism in its double-stranded form.
In lieu of PCR, alternative methods, such as the “Ligase Chain Reaction” (“LCR”) may be used (Barany, Proc. Natl. Acad. Sci.(U.S.A.) 88:189–193 (1991)). LCR uses two pairs of oligonucleotide probes to exponentially amplify a specific target. The sequences of each pair of oligonucleotides is selected to permit the pair to hybridize to abutting sequences of the same strand of the target. Such hybridization forms a substrate for a template-dependent ligase. As with PCR, the resulting products thus serve as a template in subsequent cycles and an exponential amplification of the desired sequence is obtained.
LCR can be performed with oligonucleotides having the proximal and distal sequences of the same strand of a polymorphic site. In one embodiment, either oligonucleotide will be designed to include the actual polymorphic site of the polymorphism. In such an embodiment, the reaction conditions are selected such that the oligonucleotides can be ligated together only if the target molecule either contains or lacks the specific nucleotide that is complementary to the polymorphic site present on the oligonucleotide. Alternatively, the oligonucleotides may be selected such that they do not include the polymorphic site (see, Segev, PCT Application WO 90/01069).
The “Oligonucleotide Ligation Assay” (“OLA”) may alternatively be employed (Landegren et al., Science 241:1077–1080 (1988)). The OLA protocol uses two oligonucleotides that are designed to be capable of hybridizing to abutting sequences of a single strand of a target. OLA, like LCR, is particularly suited for the detection of point mutations. Unlike LCR, however, OLA results in “linear” rather than exponential amplification of the target sequence.
Nickerson et al. have described a nucleic acid detection assay that combines attributes of PCR and OLA (Nickerson et al., Proc. Natl. Acad. Sci.(U.S.A.) 87:8923–8927 (1990)). In this method, PCR is used to achieve the exponential amplification of target DNA, which is then detected using OLA. In addition to requiring multiple, and separate, processing steps, one problem associated with such combinations is that they inherit all of the problems associated with PCR and OLA.
Schemes based on ligation of two (or more) oligonucleotides in the presence of a nucleic acid having the sequence of the resulting “di-oligonucleotide,” thereby amplifying the di-oligonucleotide, are also known (Wu et al., Genomics 4:560–569 (1989)), and may be readily adapted to the purposes of the present invention.
Other known nucleic acid amplification procedures, such as allele-specific oligomers, branched DNA technology, transcription-based amplification systems, or isothermal amplification methods may also be used to amplify and analyze such polymorphisms (Malek et al., U.S. Pat. No. 5,130,238; Davey et al., European Patent Application 329,822; Schuster et al., U.S. Pat. No. 5,169,766; Miller et al., PCT Patent Application WO 89/06700; Kwoh, et al., Proc. Natl. Acad. Sci.(U.S.A.) 86:1173–1177 (1989); Gingeras et al., PCT Patent Application WO 88/10315; Walker et al., Proc. Natl. Acad. Sci.(U.S.A.) 89:392–396 (1992)).
Polymorphisms can also be identified by Single Strand Conformation Polymorphism (SSCP) analysis. SSCP is a method capable of identifying most sequence variations in a single strand of DNA, typically between 150 and 250 nucleotides in length (Elles, Methods in Molecular Medicine: Molecular Diagnosis of Genetic Diseases, Humana Press (1996); Orita et al., Genomics 5: 874–879 (1989)). Under denaturing conditions a single strand of DNA will adopt a conformation that is uniquely dependent on its sequence conformation. This conformation usually will be different, even if only a single base is changed. Most conformations have been reported to alter the physical configuration or size sufficiently to be detectable by electrophoresis. A number of protocols have been described for SSCP including, but not limited to, Lee et al., Anal. Biochem. 205: 289–293 (1992); Suzuki et al., Anal. Biochem. 192: 82–84 (1991); Lo et al., Nucleic Acids Research 20: 1005–1009 (1992); Sarkar et al., Genomics 13:441–443 (1992). It is understood that one or more of the nucleic acids of the present invention can be utilized as markers or probes to detect polymorphisms by SSCP analysis.
Polymorphisms may also be found using random amplified polymorphic DNA (RAPD) (Williams et al., Nucl. Acids Res. 18: 6531–6535 (1990)) and cleaveable amplified polymorphic sequences (CAPS) (Lyamichev et al., Science 260: 778–783 (1993)). It is understood that one or more of the nucleic acid molecules of the present invention can be utilized as markers or probes to detect polymorphisms by RAPD or CAPS analysis.
The identification of a polymorphism can be determined in a variety of ways. By correlating the presence or absence of it in a plant with the presence or absence of a phenotype, it is possible to predict the phenotype of that plant. If a polymorphism creates or destroys a restriction endonuclease cleavage site, or if it results in the loss or insertion of DNA (e.g., a variable nucleotide tandem repeat (VNTR) polymorphism), it will alter the size or profile of the DNA fragments that are generated by digestion with that restriction endonuclease. As such, individuals that possess a variant sequence can be distinguished from those having the original sequence by restriction fragment analysis. Polymorphisms that can be identified in this manner are termed “restriction fragment length polymorphisms” (“RFLPs”). RFLPs have been widely used in human and plant genetic analyses (Glassberg, UK Patent Application 2135774; Skolnick et al., Cytogen. Cell Genet. 32:58–67 (1982); Botstein et al., Ann. J. Hum. Genet. 32:314–331 (1980); Fischer et al. (PCT Application WO90/13668); Uhlen, PCT Application WO90/11369)).
A central attribute of “single nucleotide polymorphisms,” or “SNPs” is that the site of the polymorphism is at a single nucleotide. SNPs have certain reported advantages over RFLPs and VNTRs. First, SNPs are more stable than other classes of polymorphisms. Their spontaneous mutation rate is approximately 10−9 (Komberg, DNA Replication, W.H. Freeman & Co., San Francisco, 1980), approximately 1,000 times less frequent than VNTRs (U.S. Pat. No. 5,679,524). Second, SNPs occur at greater frequency, and with greater uniformity than RFLPs and VNTRs. As SNPs result from sequence variation, new polymorphisms can be identified by sequencing random genomic or cDNA molecules. SNPs can also result from deletions, point mutations and insertions. Any single base alteration, whatever the cause, can be an SNP. The greater frequency of SNPs means that they can be more readily identified than the other classes of polymorphisms.
SNPs and insertion/deletions can be detected by methods, by any of a variety of methods including those disclosed in U.S. Pat. Nos. 5,210,015; 5,876,930 and 6,030,787 in which an oligonucleotide probe having reporter and quencher molecules is hybridized to a target polynucleotide. The probe is degraded by 5′→3′ exonuclease activity of a nucleic acid polymerase. A useful assay is available from AB Biosystems (850 Lincoln Centre Drive, Foster City, Calif.) as the Taqman® assay.
Specific nucleotide variations such as SNPs and insertion/deletions can also be detected by labeled base extension methods as disclosed in U.S. Pat. Nos. 6,004,744; 6,013,431; 5,595,890; 5,762,876; and 5,945,283. These methods are based on primer extension and incorporation of detectable nucleoside triphosphates. The primer is designed to anneal to the sequence immediately adjacent to the variable nucleotide which can be can be detected after incorporation of as few as one labeled nucleoside triphosphate. U.S. Pat. No. 5,468,613 discloses allele specific oligonucleotide hybridizations where single or multiple nucleotide variations in nucleic acid sequence can be detected in nucleic acids by a process in which the sequence containing the nucleotide variation is amplified, spotted on a membrane and treated with a labeled sequence-specific oligonucleotide probe.
Such methods also include the direct or indirect sequencing of the site, the use of restriction enzymes where the respective alleles of the site create or destroy a restriction site, the use of allele-specific hybridization probes, the use of antibodies that are specific for the proteins encoded by the different alleles of the polymorphism or by other biochemical interpretation. SNPs can be sequenced by a number of methods. Two basic methods may be used for DNA sequencing, the chain termination method of Sanger et al., Proc. Natl. Acad. Sci.(U.S.A.) 74: 5463–5467 (1977), and the chemical degradation method of Maxam and Gilbert, Proc. Nat. Acad. Sci.(U.S.A.) 74: 560–564 (1977). Automation and advances in technology such as the replacement of radioisotopes with fluorescence-based sequencing have reduced the effort required to sequence DNA (Craxton, Methods, 2: 20–26 (1991); Ju et al., Proc. Natl. Acad. Sci. (U.S.A.) 92: 4347–4351 (1995); Tabor and Richardson, Proc. Natl. Acad. Sci.(U.S.A.) 92: 6339–6343 (1995)). Automated sequencers are available from, for example, Pharmacia Biotech, Inc., Piscataway, N.J. (Pharmacia ALF), LI-COR, Inc., Lincoln, Nebr. (LI-COR 4,000) and Millipore, Bedford, Mass. (Millipore BaseStation).
In addition, advances in capillary gel electrophoresis have also reduced the effort required to sequence DNA and such advances provide a rapid high resolution approach for sequencing DNA samples (Swerdlow and Gesteland, Nucleic Acids Res. 18:1415–1419 (1990); Smith, Nature 349:812–813 (1991); Luckey et al., Methods Enzymol. 218:154–172 (1993); Lu et al., J. Chromatog. A. 680:497–501 (1994); Carson et al., Anal. Chem. 65:3219–3226 (1993); Huang et al., Anal. Chem. 64:2149–2154 (1992); Kheterpal et al., Electrophoresis 17:1852–1859 (1996); Quesada and Zhang, Electrophoresis 17:1841–1851 (1996); Baba, Yakugaku Zasshi 117:265–281 (1997), Marino, Appl. Theor. Electrophor. 5:1–5 (1995)).
The genetic linkage of marker molecules can be established by a gene mapping model such as, without limitation, the flanking marker model reported by Lander and Botstein, Genetics, 121:185–199 (1989), and the interval mapping, based on maximum likelihood methods described by Lander and Botstein, Genetics, 121:185–199 (1989), and implemented in the software package MAPMAKER/QTL (Lincoln and Lander, Mapping Genes Controlling Quantitative Traits Using MAPMAKER/QTL, Whitehead Institute for Biomedical Research, Massachusetts, (1990). Additional software includes Qgene, Version 2.23 (1996), Department of Plant Breeding and Biometry, 266 Emerson Hall, Cornell University, Ithaca, N.Y.). Use of Qgene software is a particularly preferred approach.
A maximum likelihood estimate (MLE) for the presence of a marker is calculated, together with an MLE assuming no QTL effect, to avoid false positives. A log10 of an odds ratio (LOD) is then calculated as: LOD=log10 (MLE for the presence of a QTL/MLE given no linked QTL).
The LOD score essentially indicates how much more likely the data are to have arisen assuming the presence of a QTL than in its absence. The LOD threshold value for avoiding a false positive with a given confidence, say 95%, depends on the number of markers and the length of the genome. Graphs indicating LOD thresholds are set forth in Lander and Botstein, Genetics, 121:185–199 (1989), and further described by Arús and Moreno-González, Plant Breeding, Hayward, Bosemark, Romagosa (eds.) Chapman & Hall, London, pp. 314–331 (1993).
Additional models can be used. Many modifications and alternative approaches to interval mapping have been reported, including the use of non-parametric methods (Kruglyak and Lander, Genetics, 139:1421–1428 (1995)). Multiple regression methods or models can be also be used, in which the trait is regressed on a large number of markers (Jansen, Biometrics in Plant Breed, van Oijen, Jansen (eds.) Proceedings of the Ninth Meeting of the Eucarpia Section Biometrics in Plant Breeding, The Netherlands, pp. 116–124 (1994); Weber and Wricke, Advances in Plant Breeding, Blackwell, Berlin, 16 (1994)). Procedures combining interval mapping with regression analysis, whereby the phenotype is regressed onto a single putative QTL at a given marker interval, and at the same time onto a number of markers that serve as ‘cofactors,’ have been reported by Jansen and Stam, Genetics, 136:1447–1455 (1994) and Zeng, Genetics, 136:1457–1468 (1994). Generally, the use of cofactors reduces the bias and sampling error of the estimated QTL positions (Utz and Melchinger, Biometrics in Plant Breeding, van Oijen, Jansen (eds.) Proceedings of the Ninth Meeting of the Eucarpia Section Biometrics in Plant Breeding, The Netherlands, pp.195–204 (1994), thereby improving the precision and efficiency of QTL mapping (Zeng, Genetics, 136:1457–1468 (1994)). These models can be extended to multi-environment experiments to analyze genotype-environment interactions (Jansen et al., Theo. Appl. Genet. 91:33–37 (1995)).
Selection of an appropriate mapping or segregation populations is important to map construction. The choice of appropriate mapping population depends on the type of marker systems employed (Tanksley et al., Molecular mapping plant chromosomes. Chromosome structure and function: Impact of new concepts J. P. Gustafson and R. Appels (eds.), Plenum Press, New York, pp. 157–173 (1988)). Consideration must be given to the source of parents (adapted vs. exotic) used in the mapping population. Chromosome pairing and recombination rates can be severely disturbed (suppressed) in wide crosses (adapted x exotic) and generally yield greatly reduced linkage distances. Wide crosses will usually provide segregating populations with a relatively large array of polymorphisms when compared to progeny in a narrow cross (adapted x adapted).
As used herein, the progeny include not only, without limitation, the products of any cross (be it a backcross or otherwise) between two plants, but all progeny whose pedigree traces back to the original cross. Specifically, without limitation, such progeny include plants that have 12.5% or less genetic material derived from one of the two originally crossed plants. As used herein, a second plant is derived from a first plant if the second plant's pedigree includes the first plant.
An F2 population is the first generation of selfing after the hybrid seed is produced. Usually a single F1 plant is selfed to generate a population segregating for all the genes in Mendelian (1:2:1) fashion. Maximum genetic information is obtained from a completely classified F2 population using a codorninant marker system (Mather, Measurement of Linkage in Heredity: Methuen and Co., (1938)). In the case of dominant markers, progeny tests (e.g., F3, BCF2) are required to identify the heterozygotes, thus making it equivalent to a completely classified F2 population. However, this procedure is often prohibitive because of the cost and time involved in progeny testing. Progeny testing of F2 individuals is often used in map construction where phenotypes do not consistently reflect genotype (e.g., disease resistance) or where trait expression is controlled by a QTL. Segregation data from progeny test populations (e.g., F3 or BCF2) can be used in map construction. Marker-assisted selection can then be applied to cross progeny based on marker-trait map associations (F2, F3), where linkage groups have not been completely disassociated by recombination events (i.e., maximum disequilibrium).
Recombinant inbred lines (RIL) (genetically related lines; usually >F5, developed from continuously selfing F2 lines towards homozygosity) can be used as a mapping population. Information obtained from dominant markers can be maximized by using RIL because all loci are homozygous or nearly so. Under conditions of tight linkage (i.e., about <10% recombination), dominant and co-dominant markers evaluated in RIL populations provide more information per individual than either marker type in backcross populations (Reiter et al., Proc. Natl. Acad. Sci.(U.S.A.) 89:1477–1481 (1992)). However, as the distance between markers becomes larger (i.e., loci become more independent), the information in RIL populations decreases dramatically when compared to codominant markers.
Backcross populations (e.g., generated from a cross between a successful variety (recurrent parent) and another variety (donor parent) carrying a trait not present in the former) can be utilized as a mapping population. A series of backcrosses to the recurrent parent can be made to recover most of its desirable traits. Thus a population is created consisting of individuals nearly like the recurrent parent but each individual carries varying amounts or mosaic of genomic regions from the donor parent. Backcross populations can be useful for mapping dominant markers if all loci in the recurrent parent are homozygous and the donor and recurrent parent have contrasting polymorphic marker alleles (Reiter et al., Proc. Natl. Acad. Sci.(U.S.A.) 89:1477–1481 (1992)). Information obtained from backcross populations using either codominant or dominant markers is less than that obtained from F2 populations because one, rather than two, recombinant gametes are sampled per plant. Backcross populations, however, are more informative (at low marker saturation) when compared to RELs as the distance between linked loci increases in RIL populations (i.e., about 0.15% recombination). Increased recombination can be beneficial for resolution of tight linkages, but may be undesirable in the construction of maps with low marker saturation.
Near-isogenic lines (NIL) created by many backcrosses to produce an array of individuals that are nearly identical in genetic composition except for the trait or genomic region under interrogation can be used as a mapping population. In mapping with NILs, only a portion of the polymorphic loci are expected to map to a selected region.
Bulk segregant analysis (BSA) is a method developed for the rapid identification of linkage between markers and traits of interest (Michelmore, et al., Proc. Natl. Acad. Sci.(U.S.A.) 88:9828–9832 (1991)). In BSA, two bulked DNA samples are drawn from a segregating population originating from a single cross. These bulks contain individuals that are identical for a particular trait (resistant or sensitive to particular disease) or genomic region but arbitrary at unlinked regions (i.e., heterozygous). Regions unlinked to the target region will not differ between the bulked samples of many individuals in BSA.
Plants generated using a method of the present invention can be part of or generated from a breeding program. The choice of breeding method depends on the mode of plant reproduction, the heritability of the trait(s) being improved, and the type of cultivar used commercially (e.g., F1 hybrid cultivar, pureline cultivar, etc). Selected, non-limiting approaches, for breeding the plants of the present invention are set forth below. A breeding program can be enhanced using marker assisted selection of the progeny of any cross. It is further understood that any commercial and non-commercial cultivars can be utilized in a breeding program. Factors such as, for example, emergence vigor, vegetative vigor, stress tolerance, disease resistance, branching, flowering, seed set, seed size, seed density, standability, and threshability etc. will generally dictate the choice.
For highly heritable traits, a choice of superior individual plants evaluated at a single location will be effective, whereas for traits with low heritability, selection should be based on mean values obtained from replicated evaluations of families of related plants. Popular selection methods commonly include pedigree selection, modified pedigree selection, mass selection, and recurrent selection. In a preferred embodiment a backcross or recurrent breeding program is undertaken.
The complexity of inheritance influences choice of the breeding method. Backcross breeding can be used to transfer one or a few favorable genes for a highly heritable trait into a desirable cultivar. This approach has been used extensively for breeding disease-resistant cultivars. Various recurrent selection techniques are used to improve quantitatively inherited traits controlled by numerous genes. The use of recurrent selection in self-pollinating crops depends on the ease of pollination, the frequency of successful hybrids from each pollination, and the number of hybrid offspring from each successful cross.
Breeding lines can be tested and compared to appropriate standards in environments representative of the commercial target area(s) for two or more generations. The best lines are candidates for new commercial cultivars; those still deficient in traits may be used as parents to produce new populations for further selection.
One method of identifying a superior plant is to observe its performance relative to other experimental plants and to a widely grown standard cultivar. If a single observation is inconclusive, replicated observations can provide a better estimate of its genetic worth. A breeder can select and cross two or more parental lines, followed by repeated selfing and selection, producing many new genetic combinations.
The development of new soybean cultivars requires the development and selection of soybean varieties, the crossing of these varieties and selection of superior hybrid crosses. The hybrid seed can be produced by manual crosses between selected male-fertile parents or by using male sterility systems. Hybrids are selected for certain single gene traits such as pod color, flower color, seed yield, pubescence color or herbicide resistance which indicate that the seed is truly a hybrid. Additional data on parental lines, as well as the phenotype of the hybrid, influence the breeder's decision whether to continue with the specific hybrid cross.
Pedigree breeding and recurrent selection breeding methods can be used to develop cultivars from breeding populations. Breeding programs combine desirable traits from two or more cultivars or various broad-based sources into breeding pools from which cultivars are developed by selfing and selection of desired phenotypes. New cultivars can be evaluated to determine which have commercial potential.
Pedigree breeding is used commonly for the improvement of self-pollinating crops. Two parents who possess favorable, complementary traits are crossed to produce an F1. An F2 population is produced by selfing one or several F1's. Selection of the best individuals in the best families is performed. Replicated testing of families can begin in the F4 generation to improve the effectiveness of selection for traits with low heritability. At an advanced stage of inbreeding (i.e., F6 and F7), the best lines or mixtures of phenotypically similar lines are tested for potential release as new cultivars.
Backcross breeding has been used to transfer genes for a simply inherited, highly heritable trait into a desirable homozygous cultivar or inbred line, which is the recurrent parent. The source of the trait to be transferred is called the donor parent. The resulting plant is expected to have the attributes of the recurrent parent (e.g., cultivar) and the desirable trait transferred from the donor parent. After the initial cross, individuals possessing the phenotype of the donor parent are selected and repeatedly crossed (backcrossed) to the recurrent parent. The resulting parent is expected to have the attributes of the recurrent parent (e.g., cultivar) and the desirable trait transferred from the donor parent.
The single-seed descent procedure in the strict sense refers to planting a segregating population, harvesting a sample of one seed per plant, and using the one-seed sample to plant the next generation. When the population has been advanced from the F2 to the desired level of inbreeding, the plants from which lines are derived will each trace to different F2 individuals. The number of plants in a population declines each generation due to failure of some seeds to germinate or some plants to produce at least one seed. As a result, not all of the F2 plants originally sampled in the population will be represented by a progeny when generation advance is completed.
In a multiple-seed procedure, soybean breeders commonly harvest one or more pods from each plant in a population and thresh them together to form a bulk. Part of the bulk is used to plant the next generation and part is put in reserve. The procedure has been referred to as modified single-seed descent or the pod-bulk technique.
The multiple-seed procedure has been used to save labor at harvest. It is considerably faster to thresh pods with a machine than to remove one seed from each by hand for the single-seed procedure. The multiple-seed procedure also makes it possible to plant the same number of seeds of a population each generation of inbreeding.
Descriptions of other breeding methods that are commonly used for different traits and crops can be found in one of several reference books (e.g., Fehr, Principles of Cultivar Development Vol. 1, pp. 2–3 (1987)).
In a preferred aspect of the present invention the source of the rhg1 SCN resistant allele for use in a breeding program is derived from a plant selected from the group consisting of PI548402 (Peking), PI200499, A2869, Jack, A2069, PI209332 (No:4), PI404166 (Krasnoaarmejkaja), PI404198 (Sun huan do), PI437654 (Er-hej-jan), PI438489 (Chiquita), PI507354 (Tokei 421), PI548655 (Forrest), PI548988 (Pickett), PI84751, PI437654, PI40792, Pyramid, Nathan, AG2201, A3469, AG3901, A3904, AG4301, AG4401, AG4501, AG4601, PION9492, PI88788, Dyer, Custer, Manokin, Doles, and SCN resistant progeny thereof (USDA, Soybean Germplasm Collection, University of Illinois, Illinois). In a more preferred aspect, the source of the rhg1 SCN resistant allele for use in a breeding program is derived from a plant selected from the group consisting of PI548402 (Peking), PI404166 (Krasnoaarmejkaja), PI404198 (Sun huan do), PI437654 (Er-hej-jan), PI438489 (Chiquita), PI507354 (Tokei 421), PI548655 (Forrest), PI548988 (Pickett), PI84751, PI437654, PI40792, and SCN resistant progeny thereof.
In a preferred aspect of the present invention the source of the rhg1 SCN sensitive allele for use in a breeding program is derived from a plant selected from the group consisting of A3244, A2833, AG3001, Williams, Will, A2704, Noir, DK23-5 1, Lee 74, Essex, Minsoy, A1923, Hutcheson, and SCN sensitive progeny thereof. In a more preferred aspect, the source of the rhg1 SCN sensitive allele for use in a breeding program is derived from an A3244 plant, and SCN sensitive progeny thereof.
In a preferred aspect of the present invention the source of the Rhg4 SCN resistant allele for use in a breeding program is derived from a plant selected from the group consisting of PI548402 (Peking), PI437654 (Er-hej-jan), PI438489 (Chiquita), PI507354 (Tokei 421), PI548655 (Forrest), PI548988 (Pickett), PI88788, PI404198 (Sun Huan Do), PI404166 (Krasnoaarmejkaja), Hartwig, Manokin, Doles, Dyer, Custer, and SCN resistant progeny thereof. In a more preferred aspect, the source of the Rhg4 SCN resistant allele for use in a breeding program is derived from a plant selected from the group consisting of PI548402 (Peking), PI88788, PI404198 (Sun huan do), PI438489 (Chiquita), PI437654 (Er-hej-jan), PI404166 (Krasnoaarmejkaja), PI548655 (Forrest), PI548988 (Pickett), PI507354 (Tokei 421), and SCN resistant progeny thereof.
In a preferred aspect of the present invention the source of the Rhg4 SCN sensitive allele for use in a breeding program is derived from a plant selected from the group consisting of A3244, Will, Noir, Lee 74, Essex, Minsoy, A2704, A2833, AG3001, Williams, DK23-51, and Hutcheson, and SCN sensitive progeny thereof. In a more preferred aspect, the source of the Rhg4 SCN sensitive allele for use in a breeding program is derived from an A3244 plant, and SCN sensitive progeny thereof.
As used herein linkage of a nucleic acid sequence with another nucleic acid sequence may be genetic or physical. In a preferred embodiment, a nucleic acid marker is genetically linked to either rhg1 or Rhg4, where the marker nucleic acid molecule exhibits a LOD score of greater than 2.0, as judged by interval mapping, for SCN resistance or partial resistance, preferably where the marker nucleic acid molecule exhibits a LOD score of greater than 3.0, as judged by interval mapping, for SCN resistance or partial resistance, more preferably where the marker nucleic acid molecule exhibits a LOD score of greater than 3.5, as judged by interval mapping, for SCN resistance or partial resistance and even more preferably where the marker nucleic acid molecule exhibits a LOD score of about 4.0, as judged by interval mapping, for SCN resistance or partial resistance based on maximum likelihood methods described by Lander and Botstein, Genetics, 121:185–199 (1989), and implemented in the software package MAPMAKER/QTL (default parameters)(Lincoln and Lander, Mapping Genes Controlling Quantitative Traits Using MAPMAKER/QTL, Whitehead Institute for Biomedical Research, Massachusetts, (1990)).
In another embodiment the nucleic acid molecule may be physically linked to either rhg1 or Rhg4. In a preferred embodiment, the nucleic acid marker specifically hybridizes to a nucleic acid molecule having a sequence that is present on linkage group G within 500 kb or 100 kb, more preferably within 50 kb, even more preferably within 25 kb of an rhg1 allele, where the rgh1 allele is preferably a sensitive allele, and more preferably a sensitive allele from A3244. In a preferred embodiment the nucleic acid marker is capable of specifically hybridizing to a nucleic acid molecule having a sequence that is present on linkage group A2 within 500 kb or 100 kb, more preferably within 50 kb, even more preferably within 25 kb of an Rhg4 allele, where the Rgh4 allele is preferably a sensitive allele, and more preferably a sensitive allele from A3244.
The present invention provides a method of investigating an rhg1 haplotype of a soybean plant comprising: (A) isolating nucleic acid molecules from the soybean plant; (B) determining the nucleic acid sequence of an rhg1 allele or part thereof; and, (C) comparing the nucleic acid sequence of the rhg1 allele or part thereof to a reference nucleic acid sequence.
As used herein, the term “investigating” refers to any method capable of detecting a feature, such as a polymorphism or haplotype. Nucleic acid molecules only need to be isolated from a soybean plant to the degree of purity necessary for the task required or to a greater purity if desired. A person of ordinary skill in the art has available techniques to isolate nucleic acid molecules from plants to a sufficient purity, for example without limitation, to sequence the desired region of the nucleic acid molecule or to carry out a marker assay.
The determination of an rhg1 or Rhg4 allele or part thereof may be carried out using any technique. Illustration of such techniques include techniques that provide the nucleic acid sequence for an rhg1 or rhg4 allele or part thereof include amplification of a desired allele or part thereof (see, for example, the Examples and SEQ ID NOs: 8–53). In a preferred embodiment, the nucleic acid sequence determined is that of an exon of an rhg1 allele, more preferably exon 1 or exon 3 of an rhg1 allele, or of an LRR domain. In another preferred embodiment, a single nucleotide is determined. In another preferred embodiment, the nucleic acid sequence determined is that of an LRR domain.
A comparison of a sequence with a reference sequence can be carried out with any appropriate sequence comparison method.
As used herein, a reference sequence is any rhg1 allele sequence or consensus sequence. A reference sequence may be a nucleic acid sequence or an amino acid sequence. In a preferred embodiment, the reference sequence is any SCN resistant rhg1 allele sequence. In a further preferred embodiment, the rhg1 reference sequence is selected from the group consisting of SEQ ID NOs: 2, 3, 5, 6, 8–23, 28–43, 1097, 1098, and 1100–1115.
The present invention provides a method of investigating an Rhg4 haplotype of a soybean plant comprising: (A) isolating nucleic acid molecules from the soybean plant; (B) determining the nucleic acid sequence of an Rhg4 allele or part thereof; and (C) comparing the nucleic acid sequence of the Rhg4 allele or part thereof to a reference nucleic acid sequence.
As used herein, a reference sequence is any Rhg4 allele sequence or consensus sequence. A reference sequence ma be a nucleic acid sequence or an amino acid sequence. In a preferred embodiment, the reference sequence is any SCN resistant Rhg4 allele sequence. In a further preferred embodiment, the Rhg4 reference sequence is selected from the group consisting of SEQ ID NOs: 4, 7, 44–47, 50–53, 1099, and 1116–1119.
The present invention provides a method of introgressing SCN resistance or partial SCN resistance into a soybean plant comprising: performing marker assisted selection of the soybean plant with a nucleic acid marker, wherein the nucleic acid marker specifically hybridizes with a nucleic acid molecule having a first nucleic acid sequence that is physically linked to a second nucleic acid sequence that is located on linkage group G of soybean A3244, wherein the second nucleic acid sequence is within 500 kb of a third nucleic acid sequence which is capable of specifically hybridizing with the nucleic acid sequence of SEQ ID NO: 5, 6, complements thereof, or fragments thereof; and, selecting the soybean plant based on the marker assisted selection.
The present invention provides a method of introgressing SCN resistance or partial SCN resistance into a soybean plant comprising: performing marker assisted selection of the soybean plant with a nucleic acid marker, wherein the nucleic acid marker specifically hybridizes with a nucleic acid molecule having a first nucleic acid sequence that is physically linked to a second nucleic acid sequence that is located on linkage group A2 of soybean A3244, wherein the second nucleic acid sequence is within 500 kb of a third nucleic acid sequence which is capable of specifically hybridizing with the nucleic acid sequence of SEQ ID NO: 7, complements thereor, or fragments thereof; and, selecting the soybean plant based on the marker assisted selection. Marker assisted introgression of traits into plants has been reported. Marker assisted introgression involves the transfer of a chromosome region defined by one or more markers from one germplasm to a second germplasm. In a preferred embodiment the introgression is carried out by backcrossing with an rhg1 or Rhg4 SCN resistant soybean recurrent parent.
In light of the current disclosure, plant introductions and germplasm can be screened with a marker nucleic acid molecule of the present invention to screen for alleles of rhg1 or Rhg4 using one or more of techniques disclosed herein or known in the art.
The present invention also provides for parts of the plants produced by a method of the present invention. Plant parts, without limitation, include seed, endosperm, ovule and pollen. In a particularly preferred embodiment of the present invention, the plant part is a seed.
Plants or parts thereof produced by a method of the present invention may be grown in culture and regenerated. Methods for the regeneration of soybean plants from various tissue types and methods for the tissue culture of soybean are known in the art (See, for example, Widholm et al., In Vitro Selection and Culture-induced Variation in Soybean, In Soybean: Genetics, Molecular Biology and Biotechnology, Eds. Verma and Shoemaker, CAB International, Wallingford, Oxon, England (1996)). Regeneration techniques for plants such as soybean can use as the starting material a variety of tissue or cell types. With soybean in particular, regeneration processes have been developed that begin with certain differentiated tissue types such as meristems, Cartha et al., Can. J. Bot. 59:1671–1679 (1981), hypocotyl sections, Cameya et al., Plant Science Letters 21: 289–294 (1981), and stem node segments, Saka et al., Plant Science Letters, 19: 193–201 (1980); Cheng et al., Plant Science Letters, 19: 91–99 (1980). Regeneration of whole sexually mature soybean plants from somatic embryos generated from explants of immature soybean embryos has been reported (Ranch et al, In Vitro Cellular & Developmental Biology 21: 653–658 (1985). Regeneration of mature soybean plants from tissue culture by organogenesis and embryogenesis has also been reported (Barwale et al., Planta 167: 473–481 (1986); Wright et al., Plant Cell Reports 5: 150–154 (1986)).
Agents
One skilled in the art can refer to general reference texts for detailed descriptions of known techniques discussed herein or equivalent techniques. These texts include Current Protocols in Molecular Biology Ausubel, et al., eds., John Wiley & Sons, N.Y. (1989), and supplements through September (1998), Molecular Cloning, A Laboratory Manual, Sambrook et al, 2nd Ed., Cold Spring Harbor Press, Cold Spring Harbor, N.Y. (1989), Genome Analysis: A Laboratory Manual 1: Analyzing DNA, Birren et al., Cold Spring Harbor Press, Cold Spring Harbor, N.Y. (1997); Genome Analysis: A Laboratory Manual 2: Detecting Genes, Birren et al., Cold Spring Harbor Press, Cold Spring Harbor, N.Y. (1998); Genome Analysis: A Laboratory Manual 3: Cloning Systems, Birren et al., Cold Spring Harbor Press, Cold Spring Harbor, N.Y. (1999); Genome Analysis: A Laboratory Manual 4: Mapping Genomes, Birren et al., Cold Spring Harbor Press, Cold Spring Harbor, N.Y. (1999); Plant Molecular Biology: A Laboratory Manual, Clark, Springer-Verlag, Berlin, (1997), Methods in Plant Molecular Biology, Maliga et al., Cold Spring Harbor Press, Cold Spring Harbor, N.Y. (1995). These texts can, of course, also be referred to in making or using an aspect of the invention. It is understood that any of the agents of the invention can be substantially purified and/or be biologically active and/or recombinant.
(a) Nucleic Acid Molecules
Nucleic acid molecules of the present invention include, without limitation, nucleic acid molecules having a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 1 1096 and complements thereof. A subset of the nucleic acid molecules of the present invention includes nucleic acid molecules that encode a protein or fragment thereof. Another subset of the nucleic acid molecules of the present invention are cDNA molecules. Another subset of the nucleic acid molecules of the present invention includes nucleic acid molecules that are marker molecules. A further subset of the nucleic acid molecules of the present invention are those nucleic acid molecules having promoter sequences.
Fragment nucleic acid molecules may comprise significant portion(s) of, or indeed most of, these nucleic acid molecules. In preferred embodiments, the fragments may comprise smaller polynucleotides, e.g., oligonucleotides having from about 20 to about 250 nucleotide residues and more preferably, about 20 to about 100 nucleotide residues, or about 40 to about 60 nucleotide residues. In another preferred embodiment, fragment molecules may be at least 15 nucleotides, at least 30 nucleotides, at least 50 nucleotides, or at least 100 nucleotides.
The term “substantially purified,” as used herein, refers to a molecule separated from substantially all other molecules normally associated with it in its native state. More preferably a substantially purified molecule is the predominant species present in a preparation. A substantially purified molecule may be greater than 60% free, preferably 75% free, more preferably 90% free, and most preferably 95% free from the other molecules (exclusive of solvent) present in the natural mixture. The term “substantially purified” is not intended to encompass molecules present in their native state.
The agents of the present invention will preferably be “biologically active” with respect to either a structural attribute, such as the capacity of a nucleic acid to hybridize to another nucleic acid molecule, or the ability of a protein to be bound by an antibody (or to compete with another molecule for such binding). Alternatively, such an attribute may be catalytic and thus involve the capacity of the agent to mediate a chemical reaction or response.
The agents of the present invention may also be recombinant. As used herein, the term recombinant describes (a) nucleic acid molecules that are constructed or modified outside of cells and that can replicate or function in a living cell, (b) molecules that result from the transcription, replication or translation of recombinant nucleic acid molecules, or (c) organisms that contain recombinant nucleic acid molecules or are modified using recombinant nucleic acid molecules.
It is understood that the agents of the present invention may be labeled with reagents that facilitate detection of the agent, e.g., fluorescent labels, (Prober et al., Science 238:336–340 (1987); Albarella et al., EP 144914), chemical labels, (Sheldon et al., U.S. Pat. No. 4,582,789; Albarella et al., U.S. Pat. No. 4,563,417), and modified bases, (Miyoshi et al., EP 119448) including nucleotides with radioactive elements, e.g., 32P, 33P, 35S or 125I, such as 32P dCTP.
It is further understood, that the present invention provides recombinant bacterial, animal, fungal and plant cells and viral constructs comprising the agents of the present invention.
Nucleic acid molecules or fragments thereof of the present invention are capable of specifically hybridizing to other nucleic acid molecules under certain circumstances. As used herein, two nucleic acid molecules are said to be capable of specifically hybridizing to one another if the two molecules are capable of forming an anti-parallel, double-stranded nucleic acid structure. A nucleic acid molecule is said to be the “complement” of another nucleic acid molecule if they exhibit “complete complementarity,” i.e., each nucleotide in one sequence is complementary to its base pairing partner nucleotide in another sequence. Two molecules are said to be “minimally complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under at least conventional “low-stringency” conditions. Similarly, the molecules are said to be “complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under conventional “high-stringency” conditions. Nucleic acid molecules which hybridize to other nucleic acid molecules, e.g., at least under low stringency conditions are said to be “hybridizable cognates” of the other nucleic acid molecules. Conventional stringency conditions are described by Sambrook et al., Molecular Cloning, A Laboratory Manual, 2nd Ed., Cold Spring Harbor Press, Cold Spring Harbor, N.Y. (1989) and by Haymes et al., Nucleic Acid Hybridization, A Practical Approach, IRL Press, Washington, D.C. (1985). Departures from complete complementarity are therefore permissible, as long as such departures do not completely preclude the capacity of the molecules to form a double-stranded structure. Thus, in order for a nucleic acid molecule to serve as a primer or probe it need only be sufficiently complementary in sequence to be able to form a stable double-stranded structure under the particular solvent and salt concentrations employed.
Appropriate stringency conditions which promote DNA hybridization, for example, 6.0× sodium chloride/sodium citrate (SSC) at about 45° C., followed by a wash of 2.0×SSC at 50° C., are known to those skilled in the art or can be found in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989), 6.3.1–6.3.6. For example, the salt concentration in the wash step can be selected from a low stringency of about 2.0×SSC at 50° C. to a high stringency of about 0.2×SSC at 50° C. In addition, the temperature in the wash step can be increased from low stringency conditions at room temperature, about 22° C., to high stringency conditions at about 65° C. Both temperature and salt may be varied, or either the temperature or the salt concentration may be held constant while the other variable is changed.
In a preferred embodiment, a nucleic acid of the present invention will specifically hybridize to one or more of the nucleic acid molecules set forth in SEQ ID NO: 1 through SEQ ID NO: 1096 or complements thereof under moderately stringent conditions, for example at about 2.0×SSC and about 65° C.
In a particularly preferred embodiment, a nucleic acid of the present invention will include those nucleic acid molecules that specifically hybridize to one or more of the nucleic acid molecules set forth in SEQ ID NO: 1 through SEQ ID NO: 1096 or complements thereof under high stringency conditions such as 0.2×SSC and about 65° C.
In one aspect of the present invention, the nucleic acid molecules of the present invention comprise one or more of the nucleic acid sequences set forth in SEQ ID NO: 1 through SEQ ID NO: 1096 or complements thereof or fragments of either. In another aspect of the present invention, one or more of the nucleic acid molecules of the present invention share at least 60% sequence identity with one or more of the nucleic acid sequences set forth in SEQ ID NO: 1 through SEQ ID NO: 1096 or complements thereof or fragments of either. In a further aspect of the present invention, one or more of the nucleic acid molecules of the present invention share at least 70% or more, e.g., at least 80%, sequence identity with one or more of the nucleic acid sequences set forth in SEQ ID NO: 1 through SEQ ID NO: 1096 or complements thereof or fragments of either. In a more preferred aspect of the present invention, one or more of the nucleic acid molecules of the present invention share at least 90% or more, e.g., at least 95% and up to 100% sequence identity with one or more of the nucleic acid sequences set forth in SEQ ID NO: 1 through SEQ ID NO: 1096 complements thereof or fragments of either.
As used herein “sequence identity” refers to the extent to which two optimally aligned polynucleotide or peptide sequences are invariant throughout a window of alignment of components, e.g., nucleotides or amino acids. An “identity fraction” for aligned segments of a test sequence and a reference sequence is the number of identical components which are shared by the two aligned sequences divided by the total number of components in reference sequence segment, i.e., the entire reference sequence or a smaller defined part of the reference sequence. “Percent identity” is the identity fraction times 100.
Useful methods for determining sequence identity are disclosed in Guide to Huge Computers, Martin J. Bishop, ed., Academic Press, San Diego, 1994, and Carillo, H., and Lipton, D., SIAM J Applied Math (1988) 48:1073. More particularly, preferred computer programs for determining sequence identity include the Basic Local Alignment Search Tool (BLAST) programs which are publicly available from National Center Biotechnology Information (NCBI) at the National Library of Medicine, National Institute of Health, Bethesda, Md. 20894; see BLAST Manual, Altschul et al., NCBI, NLM, NIH; Altschul et al., J. Mol. Biol. 215:403–410 (1990); version 2.0 or higher of BLAST programs allows the introduction of gaps (deletions and insertions) into alignments; BLASTX can be used to determine sequence identity between a polynucleotide sequence query and a protein sequence database; and, BLASTN can be used to determine sequence identity between between sequences.
For purposes of this invention “percent identity” shall be determined using BLASTX version 2.0.14 (default parameters), BLASTN version 2.0.14, or BLASTP 2.0.14.
A particularly preferred group of nucleic acid sequences are those present in the soybean insert of the clones set forth in table 6 below.









TABLE 6









Names of Clones Containing the Specified Gene










Line
Rhg4
rhg1/frag 1
rhg1/frag 2





Forrest
Forrest 1
Forrest 7
Forrest 13


Peking
Peking 1
Peking 7
Peking 13


Pickett
Pickett 1
Pickett 7
Pickett 13


PI84751
PI 84751.1
PI 84751.7
PI 84751.13


PI87631
PI 87631.1
PI 87631.7
PI 87631.13


PI87631-1
PI 87631-1.1

PI 87631-1.13


PI88788R
PI 88788R.1
PI 88788R.7
PI 88788R.13


PI89772


PI 89772.13


PI90763

PI 90763.7
PI 90763.13


PI200499
PI 200499.1
PI 200499.7
PI 200499.13


PI209332
PI 209332.1

PI 209332.13


PI404166
PI 404166.1
PI 404166.7
PI 404166.13


PI404198A

PI 404198A.7
PI 404198A.13


PI404198B
PI 404198B.1
PI 404198B.7
PI 404198B.13


PI437654
PI 437654.1
PI 437654.7
PI 437654.13


PI438489B
PI 438489.1
PI 438489.7
PI 438489B.13


PI467312
PI 467312.1
PI 467312.7
PI 467312.13


PI507354
PI 507354.1
PI 507354.7
PI 507354.13


PI423871
PI 423871.1
PI 423871.7
PI 423871.13


PI407922

PI 407922.7
PI 407922.13


PI360843
PI 360843.1
PI 360843.7
PI 360843.13


A2869
A2869.1
A2869.7
A2869.13


A2069
A2069.1

A2069.13


Jack
JACK1

JACK13


Will
WILL1
WILL.7
WILL13


Minsoy
Minsoy1
Minsoy.7
MINSOY13


Noir
Noir1
Noir.7
NOIR13


Hutcheson
Hutcheson1
Hutcheson.7
Hutcheson.13


A1923
A1923.1
A1923.7
A1923.13


A2704

A2704.7
A2704.13


Essex
Essex1
Essex.7
ESSEX13


A3244
A3244.1
A3244.7
A3244.13


Lee74
Lee74.1
Lee74.7
Lee74.13


PI437654

R107C17.7
R107C17.13









Table 5 shows clones comprising rhg1 and Rhg4 sequences. The “Lines” column indicates the cultivar from which the sequence in the clone is derived. The Rhg4, rhg1/frag1, and rhg1/frag2 columns show the clones derived from the lines that have the Rhg4, rhg1 fragment 1, or rhg1 fragment 2, respectively. Rhg4 is amplified with SEQ ID NOs: 48 and 49, which produces a 3.5 kb product. rhg1 fragment 1 is amplified with SEQ ID NOs: 24 and 25, which produces a 2.9 kb product, and rhg1 fragment 2 is amplified with SEQ ID NOs: 26 and 27, which produces a 1.75 kb product. All fragments are subcloned into a pCR4-TOPO vector.
(i) Nucleic Acid Molecules Encoding Proteins or Fragments Thereof
A) rhg1
The present invention includes nucleic acid molecules that code for an rhg1 protein or fragment thereof. Examples of such nucleic acid molecules include those that code for the proteins set forth in SEQ ID NOs: 1097, 1100, 1098, 1101, and 1102–1115. Examples of illustrative fragment molecules include, without limitation, an extracellular LRR domain (rhg1, v.1, SEQ ID NO: 1097, residues 164–457; rhg1, v.2, SEQ ID NO: 1098, residues 141–434), a transmembrane domain (rhg1, v.1, SEQ ID NO: 1097, residues 508–530; rhg1, v.2, SEQ ID NO: 1098, residues 33–51 and 485–507), and an STK domain (rhg1, v.1, SEQ ID NO: 1097, residues 578–869; rhg1, v.2, SEQ ID NO: 1098, residues 555–846). Examples of illustrative nucleic acid molecules include SEQ ID NOs: 5, 6, 8–23, and 28–43.
B) Rhg4
The present invention includes nucleic acid molecules that code for an Rhg4 protein or fragment thereof. Examples of such nucleic acid molecules include those that code for the proteins set forth in SEQ ID NOs: 1099 and 1116–1119. Examples of illustrative fragment molecules include, without limitation, an extracellular LRR domain (SEQ ID NO: 1099, residues 34–44), a transmembrane domain (SEQ ID NO: 1099, residues 449–471), and an STK domain (SEQ ID NO: 1099, residues 531–830). Examples of illustrative nucleic acid molecules include SEQ ID NOs: 7, 44–47, and 50–53.
C) Rhg1 and Rhg4
In another further aspect of the present invention, nucleic acid molecules of the present invention can comprise sequences which differ from those encoding a protein or fragment thereof in SEQ ID NO: 1097 through SEQ ID NO: 1119 due to fact that the different nucleic acid sequence encodes a protein having one or more conservative amino acid changes. It is understood that codons capable of coding for such conservative amino acid substitutions are known in the art.
It is well known in the art that one or more amino acids in a native sequence can be substituted with another amino acid(s), the charge and polarity of which are similar to that of the native amino acid, i.e., a conservative amino acid substitution. Conserved substitutions for an amino acid within the native polypeptide sequence can be selected from other members of the class to which the naturally occurring amino acid belongs. Amino acids can be divided into the following four groups: (1) acidic amino acids, (2) basic amino acids, (3) neutral polar amino acids, and (4) neutral nonpolar amino acids. Representative amino acids within these various groups include, but are not limited to: (1) acidic (negatively charged) amino acids such as aspartic acid and glutamic acid; (2) basic (positively charged) amino acids such as arginine, histidine, and lysine; (3) neutral polar amino acids such as glycine, serine, threonine, cysteine, cystine, tyrosine, asparagine, and glutamine; and (4) neutral nonpolar (hydrophobic) amino acids such as alanine, leucine, isoleucine, valine, proline, phenylalanine, tryptophan, and methionine.
Conservative amino acid changes within the native polypeptides sequence can be made by substituting one amino acid within one of these groups with another amino acid within the same group. Biologically functional equivalents of the proteins or fragments thereof of the present invention can have ten or fewer conservative amino acid changes, more preferably seven or fewer conservative amino acid changes, and most preferably five or fewer conservative amino acid changes. The encoding nucleotide sequence will thus have corresponding base substitutions, permitting it to encode biologically functional equivalent forms of the proteins or fragments of the present invention.
It is understood that certain amino acids may be substituted for other amino acids in a protein structure without appreciable loss of interactive binding capacity with structures such as, for example, antigen-binding regions of antibodies or binding sites on substrate molecules. Because it is the interactive capacity and nature of a protein that defines that protein's biological functional activity, certain amino acid sequence substitutions can be made in a protein sequence and, of course, its underlying DNA coding sequence and, nevertheless, obtain a protein with like properties. It is thus contemplated by the inventors that various changes may be made in the peptide sequences of the proteins or fragments of the present invention, or corresponding DNA sequences that encode said peptides, without appreciable loss of their biological utility or activity. It is understood that codons capable of coding for such amino acid changes are known in the art.
In making such changes, the hydropathic index of amino acids may be considered. The importance of the hydropathic amino acid index in conferring interactive biological function on a protein is generally understood in the art (Kyte and Doolittle, J. Mol. Biol. 157, 105–132 (1982). It is accepted that the relative hydropathic character of the amino acid contributes to the secondary structure of the resultant protein, which in turn defines the interaction of the protein with other molecules, for example, enzymes, substrates, receptors, DNA, antibodies, antigens, and the like. In making such changes, the substitution of amino acids whose hydropathic indices are within ±2 is preferred, those which are within ±1 are particularly preferred, and those within ±0.5 are even more particularly preferred.
It is also understood in the art that the substitution of like amino acids can be made effectively on the basis of hydrophilicity. U.S. Pat. No. 4,554,101, states that the greatest local average hydrophilicity of a protein, as govern by the hydrophilicity of its adjacent amino acids, correlates with a biological property of the protein. In a further aspect of the present invention, one or more of the nucleic acid molecules of the present invention differ in nucleic acid sequence from those encoding a peptide set forth in SEQ ID NO: 1097 through SEQ ID NO: 1119 or fragment thereof due to the fact that one or more codons encoding an amino acid has been substituted for a codon that encodes a nonessential substitution of the amino acid originally encoded.
Agents of the invention include nucleic acid molecules that encode at least about a contiguous 10 amino acid region of a protein of the present invention, more preferably at least D about a contiguous 11 to 14 or larger amino acid region of a protein of the present invention. It is understood that the present invention includes nucleic acid molecules that specifically hybridize or exhibit a particular identity to the nucleic acid molecules described in (i). See (a) above.
(ii) Nucleic Acid Molecule Markers and Collections of Such Molecules
One aspect of the present invention concerns nucleic acid molecules of the present invention that can act as markers. As used herein, a “marker” is an indicator for the presence of at least one phenotype or polymorphism, such as single nucleotide polymorphisms (SNPs), cleaveable amplified polymorphic sequences (CAPS), amplified fragment length polymorphisms (AFLPs), restriction fragment length polymorphisms (RFLPs), simple sequence repeats (SSRs), or random amplified polymorphic DNA (RAPDs). A “nucleic acid marker” as used herein means a nucleic acid molecule that is capable of being a marker for detecting a polymorphism or phenotype.
In one embodiment of the present invention, the nucleic acid marker specifically hybridizes to a nucleic acid molecule having a nucleic acid sequence selected from the group SEQ NOs: 1–1096 and complements thereof. In a preferred embodiment, the nucleic acid marker is capable of detecting an rhg1 SNP or INDEL set forth in table 2. In a preferred embodiment, the nucleic acid marker is capable of detecting an Rgh4 SNP or INDEL set forth in table 4. In another preferred embodiment the nucleic acid marker is a nucleic acid molecule capable of acting as a PCR primer to amplify an rhg1 or Rhg4 coding region. Examples of such primers include, without limitation, nucleic acid molecules having a nucleic acid sequence set forth in SEQ ID NO: 401–1096 and complements thereof. Such primers can be used in pairs to amplify a region (amplicons, e.g., without limitation, SEQ ID NOs: 54–400) that can be further investigated using techniques known in the art such as nucleic acid sequencing. Preferred pairs are those with identical “Seq ID” (see Description of the Sequence Listing) except for the fact that one “Seq ID” recites forward primer and one recites reverse primer.
In another embodiment of the present invention, the nucleic acid marker specifically hybridizes to a nucleic acid molecule having a sequence that is present on linkage group G within 500 kb or 100 kb, more preferably within 50 kb, even more preferably within 25 kb of an rhg1 allele, where the Rgh4 allele is preferably a sensitive allele, and more preferably a sensitive allele from A3244. In a preferred embodiment the nucleic acid marker specifically hybridizes to M5 a nucleic acid molecule having a sequence that is present on linkage group A2 within 500 kb or 100 kb, more preferably within 50 kb, even more preferably within 25 kb of an Rhg4 allele, where the Rgh4 allele is preferably a sensitive allele, and more preferably a sensitive allele from A3244.
As used herein, a “collection of nucleic acid molecules” is a population of nucleic acid molecules where at least two, preferably all, of the nucleic acid molecules differ, at least in part, in their nucleic acid sequence. It is understood, that as used herein, an individual species within a collection of nucleic acid molecules may be physically separate or alternatively not physically separate from one or more other species within the collection of nucleic acid molecules. An example of a situation where individual species may be physically separate but considered a collection of nucleic acid molecules is where more than two species are present in a single location such as an array.
As used herein, where a collection of nucleic acid molecules is a marker for a particular attribute, the level, pattern, occurrence and/or absence of the nucleic acid molecules associated with the attribute are not required to be the same between species of the collection. For example, the increase in the level of a species when in combination with the decrease in a second species could be diagnostic for a particular attribute. In a preferred embodiment of the present invention, the level, pattern, occurrence and/or absence of a nucleic acid molecule and/or collection of nucleic acid molecules of the present invention is a marker for SCN resistance.
In one embodiment, the marker is any nucleic acid molecule that specifically hybridizes to any nucleic acid sequence set forth herein. In another embodiment, the marker is a marker capable of distinguishing among the haplotypes of either rhg1 or Rhg4. In yet another embodiment, more than one marker is used to simultaneously distinguish more than one haplotype. In a preferred embodiment, two, three, four, six, eight, twenty five or fifty or more nucleic acid markers are used simultaneously. In another embodiment, one or more markers that are capable of distinguishing among the haplotypes of rhg1 and one or more markers that are capable of distinguishing among the haplotypes of Rhg4 are used together.
(iii) Nucleic Acid Molecules Having Promoter Sequences and Other Regulatory Sequences
The present invention includes nucleic acid molecules that are an rhg1 or Rhg4 promoter or fragment thereof. Examples of such nucleic acid molecules include those set forth in SEQ ID NO: 2, upstream of coordinate 45163 and SEQ ID NO: 3, upstream of coordinate 46798. As used herein a promoter is a nucleic acid sequence that when joined with a coding region is capable of expressing the protein or fragment thereof so encoded. In a preferred embodiment the promoter sequence corresponds to between 500 nucleotides and 5,000 nucleotides or between 300 nucleotides and 700 nucleotides of the nucleic acid sequence set forth in SEQ ID NO: 2 between coordinates 45163 and 40163, or SEQ ID NO:3 between coordinates 46798 and 41798, or the nucleic acid sequence set forth in SEQ ID NO: 4 between coordinates 111805 and 106805 Preferred partial promoter regions include the TATA box region, e.g. at coordinates 44234 through 44246 of SEQ ID NO: 2 and at coordinates 107826 through 107835 of SEQ ID NO: 4, and CAAT box region, e.g. at coordinates 106243 through 106259 of SEQ ID NO: 4.
Other regulatory sequences include introns or 3′ untranslated regions (3′UTRs) associated with rhg1 and Rhg4. In a preferred embodiment, an intron is selected from a nucleic acid comprising a sequence selected from SEQ ID NO: 2 (rhg1 v.1 at coordinates 45315–45449, 45510–46940, and 48764–48974), SEQ ID NO: 3 (rhg1 v.2 at coordinates 48764–48974) and SEQ ID NO: 4 (Rhg4 at coordinates 113969–114683). In another preferred embodiment, a 3′UTR is located within 5,000 nucleotides, more preferable within 1000 nucleotides in the 3′ direction of the last coding nucleotide of either rhg1 or Rhg4 (SEQ ID NO: 2, rhg1 v.1, coordinate 49573, SEQ ID NO: 3, rhg1, v.2, coordinate 49573, SEQ ID NO: 4, Rhg4, coordinate 115204).
It is understood that the present invention includes nucleic acid molecules that specifically hybridize or exhibit a particular identity to the nucleic acid molecules described in (iii). See (a) above.
(b) Protein and Peptide Molecules
A class of agents comprises one or more of the protein or peptide molecules encoded by SEQ ID NO: 1097 through SEQ ID NO: 1119 or one or more of the protein or fragment thereof or peptide molecules encoded by other nucleic acid agents of the present invention. As used herein, the term “protein molecule” and “peptide molecule” mean any protein or protein fragment or peptide or polypeptide molecule that comprises ten or more amino acids, preferably at least 11 or 12 or more, more preferably at least 13 or 14 amino acids. It is well know in the art that proteins may undergo modification, including post-translational modifications, such as, but not limited to, disulfide bond formation, glycosylation, phosphorylation, or oligomerization. Thus, as used herein, the terms “protein molecule” and “peptide molecule” include molecules that are modified by any biological or non-biological process. The terms “amino acid” and “amino acids” refer to all naturally occurring L-amino acids. This definition is meant to include norleucine, omithine, homocysteine, and homoserine.
One or more of the protein or peptide molecules may be produced via chemical synthesis, or more preferably, by expression in a suitable bacterial or eukaryotic host. Suitable methods for expression are described by Sambrook, et al., (In: Molecular Cloning, A Laboratory Manual, 2nd Edition, Cold Spring Harbor Press, Cold Spring Harbor, N.Y. (1989), or similar texts.
Another class of agents comprise protein or peptide molecules encoded by SEQ ID NO: 1097 through SEQ ID NO: 1119 or complements thereof or, fragments or fusions thereof in which non-essential, or not relevant, amino acid residues have been added, replaced, or deleted. An example of such a homolog is a protein homolog of each soybean species, including but not limited to alfalfa, barley, Brassica, broccoli, cabbage, citrus, garlic, oat, oilseed rape, onion, canola, flax, pea, peanut, pepper, potato, rye, soybean, strawberry, sugarcane, sugarbeet, soybean, maize, rice, cotton, sorghum, Arabidopsis, wheat, pine, fir, eucalyptus, apple, lettuce, peas, lentils, grape, banana, tea, turf grasses, etc. Particularly preferred non- soybean plants to utilize for the isolation of homologs would include alfalfa, barley, oat, oilseed rape, canola, ornamentals, sugarcane, sugarbeet, soybean, maize, rice, cotton, sorghum, Arabidopsis, wheat, potato, and turf grasses. Such a homolog can be obtained by any of a variety of methods. Most preferably, as indicated above, one or more of the disclosed sequences (SEQ ID NO: 1 through SEQ ID NO: 1096 or complements thereof) will be used to define a pair of primers that may be used to isolate the protein homolog-encoding nucleic acid molecules from any desired species. Such molecules can be expressed to yield protein homologs by recombinant means.
(c) Plant Constructs and Plant Transformants
One or more of the nucleic acid molecules of the invention may be used in plant transformation or transfection. Exogenous genetic material may be transferred into a plant cell and the plant cell regenerated into a whole, fertile or sterile plant. Exogenous genetic material is any genetic material, whether naturally occurring or otherwise, from any source that is capable of being inserted into any organism. In a preferred embodiment the exogenous genetic material includes a nucleic acid molecule of the present invention, preferably a nucleic acid molecule having at least 20 nucleotides of a sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 1096 and complements thereof. In a preferred embodiment, the nucleic acid molecule codes for a protein or fragment thereof described in Section (i). In another preferred embodiment, the nucleic acid molecule is a promoter or fragment thereof described in Section (iii).
Such genetic material may be transferred into either monocotyledons and dicotyledons including, but not limited to tomato, eggplant, maize, soybean, Arabidopsis, phaseolus, peanut, alfalfa, wheat, rice, oat, sorghum, rye, tritordeum, millet, fescue, perennial ryegrass, sugarcane, cranberry, papaya, banana, banana, muskmelon, apple, cucumber, dendrobium, gladiolus, chrysanthemum, liliacea, cotton, eucalyptus, sunflower, canola, turfgrass, sugarbeet, coffee and dioscorea (Christou, In: Particle Bombardment for Genetic Engineering of Plants, Biotechnology Intelligence Unit. Academic Press, San Diego, Calif. (1996).
In a preferred embodiment, the genetic material is transferred to a soybean. Preferred soybeans to transfer an rhg1 SCN resistance allele are selected from the group consisting of PI548402 (Peking), PI200499, A2869, Jack, A2069, PI209332 (No:4), PI404166 (Krasnoaarmejkaja), PI404198 (Sun huan do), PI437654 (Er-hej-jan), PI438489 (Chiquita), PI507354 (Tokei 421), PI548655 (Forrest), PI548988 (Pickett), PI84751, PI437654, PI40792, Pyramid, Nathan, AG2201, A3469, AG3901, A3904, AG4301, AG4401, AG4501, AG4601, PION9492, PI88788, Dyer, Custer, Manokin, and Doles.
Preferred soybeans to transfer an Rhg4 SCN resistance allele are selected from the group consisting of PI548402 (Peking), PI437654 (Er-hej-jan), PI438489 (Chiquita), PI507354 (Tokei 421), PI548655 (Forrest), PI548988 (Pickett), PI88788, PI404198 (Sun Huan Do), PI404166 (Krasnoaarmejkaja), Hartwig, Manokin, Doles, Dyer, and Custer.
Transfer of a nucleic acid that encodes for a protein can result in overexpression of that protein in a transformed cell or transgenic plant. One or more of the proteins or fragments thereof encoded by nucleic acid molecules of the invention may be overexpressed in a transformed cell or transformed plant. Such overexpression may be the result of transient or stable transfer of the exogenous genetic material. Such overexpression can also result in SCN resistance to one or more races of SCN.
Exogenous genetic material may be transferred into a host cell by the use of a DNA vector or construct designed for such a purpose. Design of such a vector is generally within the skill of the art (See, Plant Molecular Biology: A Laboratory Manual, Clark (ed.), Springier, N.Y. (1997).
A construct or vector may include a plant promoter to express the protein or protein fragment of choice. A number of promoters, which are active in plant cells, have been described in the literature. These include the nopaline synthase (NOS) promoter (Ebert et al., Proc. Natl. Acad. Sci.(U.S.A.) 84:5745–5749 (1987), the octopine synthase (OCS) promoter (which are carried on tumor-inducing plasmids of Agrobacterium tumefaciens), the caulimovirus promoters such as the cauliflower mosaic virus (CaMV) 19S promoter (Lawton et al., Plant Mol. Biol. 9:315–324 (1987), and the CaMV 35S promoter (Odell et al., Nature 313:810–812 (1985), the figwort mosaic virus 35S-promoter, the light-inducible promoter from the small subunit of ribulose-1,5-bis-phosphate carboxylase (ssRUBISCO), the Adh promoter (Walker et al., Proc. Natl. Acad. Sci.(U.S.A.) 84:6624–6628 (1987), the sucrose synthase promoter (Yang et al., Proc. Natl. Acad. Sci.(U.S.A.) 87:4144–4148 (1990), the R gene complex promoter (Chandler et al., The Plant Cell 1:1175–1183 (1989), and the chlorophyll a/b binding protein gene promoter, etc. These promoters have been used to create DNA constructs that have been expressed in plants; see, e.g., PCT publication WO 84/02913. The CaMV 35S promoters are preferred for use in plants. Promoters known or found to cause transcription of DNA in plant cells can be used in the invention.
For the purpose of expression in source tissues of the plant, such as the leaf, seed, root or stem, it is preferred that the promoters utilized have relatively high expression in these specific tissues. Tissue-specific expression of a protein of the present invention is a particularly preferred embodiment. For this purpose, one may choose from a number of promoters for genes with tissue- or cell-specific or -enhanced expression. Examples of such promoters reported in the literature include the chloroplast glutamine synthetase GS2 promoter from pea (Edwards et al., Proc. Natl. Acad. Sci.(U.S.A.) 87:3459–3463 (1990), the chloroplast fructose-1,6-biphosphatase (FBPase) promoter from wheat (Lloyd et al., Mol. Gen. Genet. 225:209–216 (1991), the nuclear photosynthetic ST-LS1 promoter from potato (Stockhaus et al., EMBO J. 8:2445–2451 (1989), the STK (PAL) promoter and the glucoamylase (CHS) promoter from Arabidopsis thaliana. Also reported to be active in photosynthetically active tissues are the ribulose-1,5-bisphosphate carboxylase (RbcS) promoter from eastern larch (Larix laricina), the promoter for the cab gene, cab6, from pine (Yamamoto et al., Plant Cell Physiol. 35:773–778 (1994), the promoter for the Cab-1 gene from wheat (Fejes et al., Plant Mol. Biol. 15:921–932 (1990), the promoter for the CAB-1 gene from spinach (Lubberstedt et al., Plant Physiol. 104:997–1006 (1994), the promoter for the cab1R gene from rice (Luan et al., Plant Cell. 4:971–981 (1992), the pyruvate, orthophosphate dikinase (PPDK) promoter from maize (Matsuoka et al., Proc. Natl. Acad. Sci. (U.S.A.) 90: 9586–9590 (1993), the promoter for the tobacco Lhcb1*2 gene (Cerdan et al., Plant Mol. Biol. 33:245–255 (1997), the Arabidopsis thaliana SUC2 sucrose-H+ symporter promoter (Truemit et al., Planta. 196:564–570 (1995), and the promoter for the thylakoid membrane proteins from spinach (psaD, psaF, psaE, PC, FNR, atpC, atpD, cab, rbcS). Other promoters for the chlorophyll a/b-binding proteins may also be utilized in the invention, such as the promoters for LhcB gene and PsbP gene from white mustard (Sinapis alba; Kretsch et al., Plant Mol. Biol. 28:219–229 (1995)).
For the purpose of expression in sink tissues of the plant, such as the tuber of the potato plant, the fruit of tomato, or the seed of maize, wheat, rice and barley, it is preferred that the promoters utilized in the invention have relatively high expression in these specific tissues. A number of promoters for genes with tuber-specific or -enhanced expression are known, including the class I patatin promoter (Bevan et al., EMBO J. 8:1899–1906 (1986); Jefferson et al., Plant Mol. Biol. 14:995–1006 (1990)), the promoter for the potato tuber ADPGPP genes, both the large and small subunits, the sucrose synthase promoter (Salanoubat and Belliard, Gene 60:47–56 (1987), Salanoubat and Belliard, Gene 84:181–185 (1989)), the promoter for the major tuber proteins including the 22 kd protein complexes and proteinase inhibitors (Hannapel, Plant Physiol. 101:703–704 (1993)), the promoter for the granule bound starch synthase gene (GBSS) (Visser et al., Plant Mol. Biol. 17:691–699 (1991)), and other class I and II patatins promoters (Koster-Topfer et al., Mol Gen Genet. 219:390–396 (1989); Mignery et al., Gene. 62:27–44 (1988)).
Other promoters can also be used to express a protein or fragment thereof in specific tissues, such as seeds or fruits. The promoter for β-conglycinin (Chen et al., Dev. Genet. 10: 112–122 (1989)) or other seed-specific promoters such as the napin and phaseolin promoters, can be used. The zeins are a group of storage proteins found in maize endosperm. Genomic clones for zein genes have been isolated (Pedersen et al., Cell 29:1015–1026 (1982)) and the promoters from these clones, including the 15 kD, 16 kD, 19 kD, 22 kD, 27 kD and genes, could also be used. Other promoters known to function, for example, in maize include the promoters for the following genes: waxy, Brittle, Shrunken 2, Branching enzymes I and II, starch synthases, debranching enzymes, oleosins, glutelins and sucrose synthases. A particularly preferred promoter for maize endosperm expression is the promoter for the glutelin gene from rice, more particularly the Osgt-1 promoter (Zheng et al., Mol. Cell Biol. 13:5829–5842 (1993)). Examples of promoters suitable for expression in wheat include those promoters for the ADPglucose pyrosynthase (ADPGPP) subunits, the granule bound and other starch synthase, the branching and debranching enzymes, the embryogenesis-abundant proteins, the gliadins and the glutenins. Examples of such promoters in rice include those promoters for the ADPGPP subunits, the granule bound and other starch synthase, the branching enzymes, the debranching enzymes, sucrose synthases and the glutelins. A particularly preferred promoter is the promoter for rice glutelin, Osgt-1. Examples of such promoters for barley include those for the ADPGPP subunits, the granule bound and other starch synthase, the branching enzymes, the debranching enzymes, sucrose synthases, the hordeins, the embryo globulins and the aleurone specific proteins.
Root specific promoters may also be used. An example of such a promoter is the promoter for the acid chitinase gene (Samac et al., Plant Mol. Biol. 25:587–596 (1994)). Expression in root tissue could also be accomplished by utilizing the root specific subdomains of the CaMV35S promoter that have been identified (Lam et al., Proc. Nati. Acad. Sci.(U.S.A.) 86:7890–7894 (1989)). Other root cell specific promoters include those reported by Conkling et al. (Conkling et al., Plant Physiol. 93:1203–1211 (1990)).
Additional promoters that may be utilized are described, for example, in U.S. Pat. Nos. 5,378,619; 5,391,725; 5,428,147; 5,447,858; 5,608,144; 5,608,144; 5,614,399; 5,633,441; 5,633,435; and 4,633,436. In addition, a tissue specific enhancer may be used (From et al., The Plant Cell 1:977–984 (1989)).
Preferred promoters are those set forth in Section (a)(iii) of Agents.
Constructs or vectors may also include, with the coding region of interest, a nucleic acid sequence that acts, in whole or in part, to terminate transcription of that region. A number of such sequences have been isolated, including the Tr7 3′ sequence and the NOS 3′ sequence (Ingelbrecht et al., The Plant Cell 1:671–680 (1989); Bevan et al., Nucleic Acids Res. 11:369–385 (1983)).
A vector or construct may also include regulatory elements. Examples of such include the Adh intron 1 (Callis et al., Genes and Develop. 1:1183–1200 (1987)), the sucrose synthase intron (Vasil et al., Plant Physiol. 91:1575–1579 (1989)) and the TMV omega element (Gallie et al., The Plant Cell 1:301–311 (1989)). These and other regulatory elements may be included when appropriate.
A vector or construct may also include a selectable marker. Selectable markers may also be used to select for plants or plant cells that contain the exogenous genetic material. Examples of such include, but are not limited to: a neomycin phosphotransferase gene (U.S. Pat. No. 5,034,322), which codes for kanamycin resistance and can be selected for using kanamycin, G418, etc.; a bar gene which codes for bialaphos resistance; genes which encode glyphosate resistance (U.S. Pat. Nos. 4,940,835; 5,188,642; 4,971,908; 5,627,061); a nitrilase gene which confers resistance to bromoxynil (Stalker et al., J. Biol. Chem. 263:6310–6314 (1988)); a mutant acetolactate synthase gene (ALS) which confers imidazolinone or sulphonylurea resistance (European Patent Application 154,204 (Sept. 11, 1985)); and a methotrexate resistant DHFR gene (Thillet et al., J. Biol. Chem. 263:12500–12508 (1988)).
A vector or construct may also include DNA sequence which encodes a transit peptide. Incorporation of a suitable chloroplast transit peptide may also be employed (European Patent Application Publication Number 0218571). Translational enhancers may also be incorporated as part of the vector DNA. DNA constructs could contain one or more 5′ non-translated leader sequences which may serve to enhance expression of the gene products from the resulting mRNA transcripts. Such sequences may be derived from the promoter selected to express the gene or can be specifically modified to increase translation of the mRNA. Such regions may also be obtained from viral RNAs, from suitable eukaryotic genes, or from a synthetic gene sequence. For a review of optimizing expression of transgenes, see Koziel et al., Plant Mol. Biol. 32:393–405 (1996).
A vector or construct may also include a screenable marker. Screenable markers may be used to monitor expression. Exemplary screenable markers include: a β-glucuronidase or uidA gene (GUS) which encodes an enzyme for which various chromogenic substrates are known (Jefferson, Plant Mol. Biol, Rep. 5:387–405 (1987); Jefferson et al., EMBO J. 6:3901–3907 (1987)); an R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues (Dellaporta et al., Stadler Symposium 11:263–282 (1988)); a β-lactamase gene (Sutcliffe et al., Proc. Natl. Acad. Sci.(U.S.A.) 75:3737–3741 (1978)), a gene which encodes an enzyme for which various chromogenic substrates are known (e.g., PADAC, a chromogenic cephalosporin); a luciferase gene (Ow et al., Science 234:856–859 (1986)); a xylE gene (Zukowsky et al., Proc. Natl. Acad. Sci.(U.S.A.) 80:1101–1105 (1983)) which encodes a catechol dioxygenase that can convert chromogenic catechols; an α-amylase gene (Ikatu et al., Bio/Technol. 8:241–242 (1990)); a tyrosinase gene (Katz et al., J. Gen. Microbiol. 129:2703–2714 (1983)) which encodes an enzyme capable of oxidizing tyrosine to DOPA and dopaquinone which in turn condenses to melanin; an α-galactosidase, which will turn a chromogenic α-galactose substrate.
Included within the terms “selectable or screenable marker genes” are also genes which encode a secretable marker whose secretion can be detected as a means of identifying or selecting for transformed cells. Examples include markers which encode a secretable antigen that can be identified by antibody interaction, or even secretable enzymes which can be detected catalytically. Secretable proteins fall into a number of classes, including small, diffusible proteins which are detectable, (e.g., by ELISA), small active enzymes which are detectable in extracellular solution (e.g., α-amylase, β-lactamase, phosphinothricin transferase), or proteins which are inserted or trapped in the cell wall (such as proteins which include a leader sequence such as that found in the expression unit of extension or tobacco PR-S). Other possible selectable and/or screenable marker genes will be apparent to those of skill in the art.
There are many methods for introducing transforming nucleic acid molecules into plant cells. Suitable methods are believed to include virtually any method by which nucleic acid molecules may be introduced into a cell, such as by Agrobacterium infection or direct delivery of nucleic acid molecules such as, for example, by PEG-mediated transformation, by electroporation or by acceleration of DNA coated particles, etc (Potrykus, Ann. Rev. Plant Physiol. Plant Mol. Biol. 42:205–225 (1991); Vasil, Plant Mol. Biol. 25:925–937 (1994)). For example, electroporation has been used to transform maize protoplasts (Fromm et al., Nature 312:791–793 (1986)).
Other vector systems suitable for introducing transforming DNA into a host plant cell include but are not limited to binary artificial chromosome (BIBAC) vectors (Hamilton et al., Gene 200:107–116 (1997)); and transfection with RNA viral vectors (Della-Cioppa et al., Ann. N.Y. Acad. Sci.(1996), 792 (Engineering Plants for Commercial Products and Applications), 57–61). Additional vector systems also include plant selectable YAC vectors such as those described in Mullen et al., Molecular Breeding 4:449–457 (1988)).
Technology for introduction of DNA into cells is well known to those of skill in the art. Four general methods for delivering a gene into cells have been described: (1) chemical methods (Graham and van der Eb, Virology 54:536–539 (1973)); (2) physical methods such as microinjection (Capecchi, Cell 22:479–488 (1980)), electroporation (Wong and Neumann, Biochem. Biophys. Res. Commnun. 107:584–587 (1982); Fromm et al., Proc. Natl. Acad. Sci. (U.S.A.) 82:5824–5828 (1985); U.S. Pat. No. 5,384,253); and the gene gun (Johnston and Tang, Methods Cell Biol. 43:353–365 (1994)); (3) viral vectors (Clapp, Clin. Perinatol. 20:155–168 (1993); Lu et al., J. Exp. Med 178:2089–2096 (1993); Eglitis and Anderson, Biotechniques 6:608–614 (1988)); and (4) receptor-mediated mechanisms (Curiel et al., Hum. Gen. Ther. 3:147–154 (1992), Wagner et al., Proc. Natl. Acad. Sci.(USA) 89:6099–6103 (1992)).
Acceleration methods that may be used include, for example, microprojectile bombardment and the like. One example of a method for delivering transforming nucleic acid molecules to plant cells is microprojectile bombardment. This method has been reviewed by Yang and Christou (eds.), Particle Bombardment Technology for Gene Transfer, Oxford Press, Oxford, England (1994)). Non-biological particles (microprojectiles) that may be coated with nucleic acids and delivered into cells by a propelling force. Exemplary particles include those comprised of tungsten, gold, platinum and the like.
A particular advantage of microprojectile bombardment, in addition to it being an effective means of reproducibly transforming monocots, is that neither the isolation of protoplasts (Cristou et al., Plant Physiol. 87:671–674 (1988)) nor the susceptibility of Agrobacterium infection are required. An illustrative embodiment of a method for delivering DNA into maize cells by acceleration is a biolistics α-particle delivery system, which can be used to propel particles coated with DNA through a screen, such as a stainless steel or Nytex screen, onto a filter surface covered with corn cells cultured in suspension. Gordon-Kamm et al., describes the basic procedure for coating tungsten particles with DNA (Gordon-Kamm et al., Plant Cell 2:603–618 (1990)). The screen disperses the tungsten nucleic acid particles so that they are not delivered to the recipient cells in large aggregates. A particle delivery system suitable for use with the invention is the helium acceleration PDS-1000/He gun is available from Bio-Rad Laboratories (Bio-Rad, Hercules, Calif.)(Sanford et al., Technique 3:3–16 (1991)).
For the bombardment, cells in suspension may be concentrated on filters. Filters containing the cells to be bombarded are positioned at an appropriate distance below the microprojectile stopping plate. If desired, one or more screens are also positioned between the gun and the cells to be bombarded.
Alternatively, immature embryos or other target cells may be arranged on solid culture medium. The cells to be bombarded are positioned at an appropriate distance below the microprojectile stopping plate. If desired, one or more screens are also positioned between the acceleration device and the cells to be bombarded. Through the use of techniques set forth herein one may obtain up to 1000 or more foci of cells transiently expressing a screenable or selectable marker gene. The number of cells in a focus which express the exogenous gene product 48 hours post-bombardment often range from one to ten and average one to three.
In bombardment transformation, one may optimize the pre-bombardment culturing conditions and the bombardment parameters to yield the maximum numbers of stable transformants. Both the physical and biological parameters for bombardment are important in this technology. Physical factors are those that involve manipulating the DNA/microprojectile precipitate or those that affect the flight and velocity of either the macro- or microprojectiles. Biological factors include all steps involved in manipulation of cells before and immediately after bombardment, the osmotic adjustment of target cells to help alleviate the trauma associated with bombardment and also the nature of the transforming DNA, such as linearized DNA or intact supercoiled plasmids. It is believed that pre-bombardment manipulations are especially important for successful transformation of immature embryos.
In another alternative embodiment, plastids can be stably transformed. Methods disclosed for plastid transformation in higher plants include the particle gun delivery of DNA containing a selectable marker and targeting of the DNA to the plastid genome through homologous recombination (Svab et al., Proc. Natl. Acad. Sci.(U.S.A.) 87:8526–8530 (1990); Svab and Maliga, Proc. Natl. Acad. Sci.(U.S.A.) 90:913–917 (1993); Staub and Maliga, EMBO J. 12:601–606 (1993); U.S. Pat. Nos. 5,451,513 and 5,545,818).
Accordingly, it is contemplated that one may wish to adjust various aspects of the bombardment parameters in small-scale studies to fully optimize the conditions. One may particularly wish to adjust physical parameters such as gap distance, flight distance, tissue distance and helium pressure. One may also minimize the trauma reduction factors by modifying conditions which influence the physiological state of the recipient cells and which may therefore influence transformation and integration efficiencies. For example, the osmotic state, tissue hydration and the subculture stage or cell cycle of the recipient cells may be adjusted for optimum transformation. The execution of other routine adjustments will be known to those of skill in the art in light of the present disclosure.
Agrobacterium-mediated transfer is a widely applicable system for introducing genes into plant cells because the DNA can be introduced into whole plant tissues, thereby bypassing the need for regeneration of an intact plant from a protoplast. The use of Agrobacterium-mediated plant integrating vectors to introduce DNA into plant cells is well known in the art. See, for example the methods described by Fraley et al., Bio/Technology 3:629–635 (1985) and Rogers et al., Methods Enzymol. 153:253–277 (1987). Further, the integration of the T-DNA is a relatively precise process resulting in few rearrangements. The region of DNA to be transferred is defined by the border sequences and intervening DNA is usually inserted into the plant genome as described (Spielmann et al., Mol. Gen. Genet. 205:34 (1986)).
Modem Agrobacterium transformation vectors are capable of replication in E. coli as well as Agrobacterium, allowing for convenient manipulations as described (Klee et al., In: Plant DNA Infectious Agents, Hohn and Schell (eds.), Springer-Verlag, New York, pp. 179–203 (1985)). Moreover, technological advances in vectors for Agrobacterium-mediated gene transfer have improved the arrangement of genes and restriction sites in the vectors to facilitate construction of vectors capable of expressing various polypeptide coding genes. The vectors described have convenient multi-linker regions flanked by a promoter and a polyadenylation site for direct expression of inserted polypeptide coding genes and are suitable for present purposes (Rogers et al., Methods Enzymol. 153:253–277 (1987)). In addition, Agrobacterium containing both armed and disarmed Ti genes can be used for the transformations. In those plant strains where Agrobacterium-mediated transformation is efficient, it is the method of choice because of the facile and defined nature of the gene transfer.
A transgenic plant formed using Agrobacterium transformation methods typically contains a single gene on one chromosome. Such transgenic plants can be referred to as being heterozygous for the added gene. More preferred is a transgenic plant that is homozygous for the added structural gene; i.e., a transgenic plant that contains two added genes, one gene at the same locus on each chromosome of a chromosome pair. A homozygous transgenic plant can be obtained by sexually mating (selfing) an independent segregant transgenic plant that contains a single added gene, germinating some of the seed produced and analyzing the resulting plants produced for the gene of interest.
It is also to be understood that two different transgenic plants can also be mated to produce offspring that contain two independently segregating, exogenous genes. Selfing of appropriate progeny can produce plants that are homozygous for both added, exogenous genes that encode a polypeptide of interest. Backcrossing to a parental plant and out-crossing with a non-transgenic plant are also contemplated, as is vegetative propagation.
Transformation of plant protoplasts can be achieved using methods based on calcium phosphate precipitation, polyethylene glycol treatment, electroporation and combinations of these treatments (See, for example, Potrykus et al., Mol. Gen. Genet. 205:193–200 (1986); Lorz et al., Mol. Gen. Genet. 199:178 (1985); Fromm et al., Nature 319:791 (1986); Uchimiya et al., Mol. Gen. Genet. 204:204 (1986); Marcotte et al., Nature 335:454–457 (1988)).
Application of these systems to different plant strains depends upon the ability to regenerate that particular plant strain from protoplasts. Illustrative methods for the regeneration of cereals from protoplasts are described (Fujimura et al., Plant Tissue Culture Letters 2:74 (1985); Toriyama et al., Theor Appl. Genet. 205:34 (1986); Yamada et al., Plant Cell Rep. 4:85 (1986); Abdullah et al., Biotechnology 4:1087 (1986)).
To transform plant strains that cannot be successfully regenerated from protoplasts, other ways to introduce DNA into intact cells or tissues can be utilized. For example, regeneration of cereals from immature embryos or explants can be effected as described (Vasil, Biotechnology 6:397 (1988)). In addition, “particle gun” or high-velocity microprojectile technology can be utilized (Vasil et al., Bio/Technology 10:667 (1992)).
Using the latter technology, DNA is carried through the cell wall and into the cytoplasm on the surface of small metal particles as described (Klein et al., Nature 328:70 (1987); Klein et al., Proc. Natl. Acad. Sci.(U.S.A.) 85:8502–8505 (1988); McCabe et al., Bio/Technology 6:923 (1988)). The metal particles penetrate through several layers of cells and thus allow the transformation of cells within tissue explants.
The regeneration, development and cultivation of plants from single plant protoplast transformants or from various transformed explants are well known in the art (Weissbach and Weissbach, In: Methods for Plant Molecular Biology, Academic Press, San Diego, Calif., (1988)). This regeneration and growth process typically includes the steps of selection of transformed cells, culturing those individualized cells through the usual stages of embryonic development through the rooted plantlet stage. Transgenic embryos and seeds are similarly regenerated. The resulting transgenic rooted shoots are thereafter planted in an appropriate plant growth medium such as soil.
The development or regeneration of plants containing the foreign, exogenous gene that encodes a protein of interest is well known in the art. Preferably, the regenerated plants are self-pollinated to provide homozygous transgenic plants. Otherwise, pollen obtained from the regenerated plants is crossed to seed-grown plants of agronomically important lines. Conversely, pollen from plants of these important lines is used to pollinate regenerated plants. A transgenic plant of the invention containing a desired polypeptide is cultivated using methods well known to one skilled in the art.
There are a variety of methods for the regeneration of plants from plant tissue. The particular method of regeneration will depend on the starting plant tissue and the particular plant species to be regenerated.
Methods for transforming dicots, primarily by use of Agrobacterium tumefaciens and obtaining transgenic plants have been published for cotton (U.S. Pat. No. 5,004,863; U.S. Pat. No. 5,159,135; U.S. Pat. No. 5,518,908); soybean (U.S. Pat. No. 5,569,834; U.S. Pat. No. 5,416,011; McCabe et al., Biotechnology 6–923 (1988); Christou et al., Plant Physiol. 87:671–674 (1988)); Brassica (U.S. Pat. No. 5,463,174); peanut (Cheng et al., Plant Cell Rep. 15:653–657 (1996), McKently et al., Plant Cell Rep. 14:699–703 (1995)); papaya; and pea (Grant et al., Plant Cell Rep. 15:254–258 (1995)).
Transformation of monocotyledons using electroporation, particle bombardment and Agrobacterium have also been reported. Transformation and plant regeneration have been achieved in asparagus (Bytebier et al., Proc. Natl. Acad. Sci.(USA) 84:5354 (1987)); barley (Wan and Lemaux, Plant Physiol 104:37 (1994)); maize (Rhodes et al., Science 240:204 (1988); Gordon-Kamm et al., Plant Cell 2:603–618 (1990); Fromm et al., Bio/Technology 8:833 (1990); Koziel et al., Bio/Technology 11:194 (1993); Armstrong et al., Crop Science 35:550–557 (1995)); oat (Somers et al., Bio/Technology 10:1589 (1992)); orchard grass (Horn et al., Plant Cell Rep. 7:469 (1988)); rice (Toriyama et al., Theor Appl. Genet. 205:34 (1986); Part et al., Plant Mol. Biol. 32:1135–1148 (1996); Abedinia et al., Aust. J. Plant Physiol. 24:133–141 (1997); Zhang and Wu, Theor. Appl. Genet. 76:835 (1988); Zhang et al., Plant Cell Rep. 7:379 (1988); Battraw and Hall, Plant Sci. 86:191–202 (1992); Christou et al., Bio/Technology 9:957 (1991)); rye (De la Pena et al., Nature 325:274 (1987)); sugarcane (Bower and Birch, Plant J. 2:409 (1992)); tall fescue (Wang et al., Bio/Technology 10:691 (1992)) and wheat (Vasil et al., Bio/Technology 10:667 (1992); U.S. Pat. No. 5,631,152).
Assays for gene expression based on the transient expression of cloned nucleic acid constructs have been developed by introducing the nucleic acid molecules into plant cells by polyethylene glycol treatment, electroporation, or particle bombardment (Marcotte et al., Nature 335:454–457 (1988); Marcotte et al., Plant Cell 1:523–532 (1989); McCarty et al., Cell 66:895–905 (1991); Hattori et al., Genes Dev. 6:609–618 (1992); Goff et al., EMBO J. 9:2517–2522 (1990)). Transient expression systems may be used to functionally dissect gene constructs (see generally, Mailga et al., Methods in Plant Molecular Biology, Cold Spring Harbor Press (1995)).
Any of the nucleic acid molecules of the invention may be introduced into a plant cell in a permanent or transient manner in combination with other genetic elements such as vectors, promoters, enhancers, etc. Further, any of the nucleic acid molecules of the invention may be introduced into a plant cell in a manner that allows for overexpression of the protein or fragment thereof encoded by the nucleic acid molecule.
Cosuppression is the reduction in expression levels, usually at the level of RNA, of a particular endogenous gene or gene family by the expression of a homologous sense construct Ig: that is capable of transcribing mRNA of the same strandedness as the transcript of the endogenous gene (Napoli et al., Plant Cell 2:279–289 (1990); van der Krol et al., Plant Cell 2:291–299 (1990)). Cosuppression may result from stable transformation with a single copy nucleic acid molecule that is homologous to a nucleic acid sequence found within the cell (Prolls and Meyer, Plant J. 2:465–475 (1992)) or with multiple copies of a nucleic acid molecule that is homologous to a nucleic acid sequence found within the cell (Mittlesten et al., Mol. Gen. Genet. 244:325–330 (1994)). Genes, even though different, linked to homologous promoters may result in the cosuppression of the linked genes (Vaucheret, C.R. Acad. Sci. III 316:1471–1483 (1993); Flavell, Proc. Natl. Acad. Sci.(U.S.A.) 91:3490–3496 (1994)); van Blokland et al., Plant J. 6:861–877 (1994); Jorgensen, Trends Biotechnol. 8:340–344 (1990); Meins and Kunz, In: Gene Inactivation and Homologous Recombination in Plants, Paszkowski (ed.), pp. 335–348, Kluwer Academic, Netherlands (1994)).
It is understood that one or more of the nucleic acids of the invention may be introduced into a plant cell and transcribed using an appropriate promoter with such transcription resulting in the cosuppression of an endogenous protein.
Antisense approaches are a way of preventing or reducing gene function by targeting the genetic material (U.S. Pat. Nos. 4,801,540 and 5,107,065 Mol et al., FEBS Lett. 268:427–430 (1990)). The objective of the antisense approach is to use a sequence complementary to the target gene to block its expression and create a mutant cell line or organism in which the level of a single chosen protein is selectively reduced or abolished. Antisense techniques have several advantages over other ‘reverse genetic’ approaches. The site of inactivation and its developmental effect can be manipulated by the choice of promoter for antisense genes or by the timing of external application or microinjection. Antisense can manipulate its specificity by selecting either unique regions of the target gene or regions where it shares homology to other related genes (Hiatt et al., In: Genetic Engineering, Setlow (ed.), Vol. 11, New York: Plenum 49–63 (1989)).
The principle of regulation by antisense RNA is that RNA that is complementary to the target mRNA is introduced into cells, resulting in specific RNA:RNA duplexes being formed by base pairing between the antisense substrate and the target mRNA (Green et al., Annu. Rev. Biochem. 55:569–597 (1986)). Under one embodiment, the process involves the introduction and expression of an antisense gene sequence. Such a sequence is one in which part or all of the normal gene sequences are placed under a promoter in inverted orientation so that the ‘wrong’ or complementary strand is transcribed into a noncoding antisense RNA that hybridizes with the target mRNA and interferes with its expression (Takayama and Inouye, Crit. Rev. Biochem. Mol. Biol. 25:155–184 (1990)). An antisense vector is constructed by standard procedures and introduced into cells by transformation, transfection, electroporation, microinjection, infection, etc. The type of transformation and choice of vector will determine whether expression is transient or stable. The promoter used for the antisense gene may influence the level, timing, tissue, specificity, or inducibility of the antisense inhibition.
It is understood that the activity of a protein in a plant cell may be reduced or depressed by growing a transformed plant cell containing a nucleic acid molecule whose non-transcribed strand encodes a protein or fragment thereof.
Post transcriptional gene silencing (PTGS) can result in virus immunity or gene silencing in plants. PTGS is induced by dsRNA and is mediated by an RNA-dependent RNA polymerase, present in the cytoplasm, that requires a dsRNA template. The dsRNA is formed by hybridization of complementary transgene mRNAs or complementary regions of the same transcript. Duplex formation can be accomplished by using transcripts from one sense gene and one antisense gene co-located in the plant genome, a single transcript that has self-complementarity, or sense and antisense transcripts from genes brought together by crossing. The dsRNA-dependent RNA polymerase makes a complementary strand from the transgene mRNA and RNAse molecules attach to this complementary strand (cRNA). These cRNA-RNAse molecules hybridize to the endogene mnRNA and cleave the single-stranded RNA adjacent to the hybrid. The cleaved single-stranded RNAs are further degraded by other host RNAses because one will lack a capped 5′ end and the other will lack a poly(A) tail (Waterhouse et al., PNAS 95: 13959–13964 (1998)).
It is understood that one or more of the nucleic acids of the invention may be introduced into a plant cell and transcribed using an appropriate promoter with such transcription resulting in the postranscriptional gene silencing of an endogenous transcript.
Antibodies have been expressed in plants (Hiatt et al., Nature 342:76–78 (1989); Conrad and Fielder, Plant Mol. Biol. 26:1023–1030 (1994)). Cytoplasmic expression of a scFv (single-chain Fv antibodies) has been reported to delay infection by artichoke mottled crinkle virus. Transgenic plants that express antibodies directed against endogenous proteins may exhibit a physiological effect (Philips et al., EMBO J. 16:4489–4496 (1997); Marion-Poll, Trends in Plant Science 2:447–448 (1997)). For example, expressed anti-abscissic antibodies have been reported to result in a general perturbation of seed development (Philips et al., EMBO J. 16: 4489–4496 (1997)).
Antibodies that are catalytic may also be expressed in plants (abzymes). The principle behind abzymes is that since antibodies may be raised against many molecules, this recognition ability can be directed toward generating antibodies that bind transition states to force a chemical reaction forward (Persidas, Nature Biotechnology 15:1313–1315 (1997); Baca et al., Ann. Rev. Biophys. Biomol. Struct. 26:461–493 (1997)). The catalytic abilities of abzymes may be enhanced by site directed mutagenesis. Examples of abzymes are, for example, set forth in U.S. Pat. Nos.: 5,658,753; 5,632,990; 5,631,137; 5,602,015; 5,559,538; 5,576,174; 5,500,358; 5,318,897; 5,298,409; 5,258,289 and 5,194,585.
It is understood that any of the antibodies of the invention may be expressed in plants and that such expression can result in a physiological effect. It is also understood that any of the expressed antibodies may be catalytic.
(d) Antibodies
One aspect of the present invention concerns antibodies, single-chain antigen binding molecules, or other proteins that specifically bind to one or more of the protein or peptide molecules of the present invention and their homologues, fusions or fragments. Such antibodies may be used to quantitatively or qualitatively detect the protein or peptide molecules of the present invention. As used herein, an antibody or peptide is said to “specifically bind” to a protein or peptide molecule of the present invention if such binding is not competitively inhibited by the presence of non-related molecules.
Nucleic acid molecules that encode all or part of the protein of the present invention can be expressed, via recombinant means, to yield protein or peptides that can in turn be used to elicit antibodies that are capable of binding the expressed protein or peptide. Such antibodies may be used in immunoassays for that protein. Such protein-encoding molecules, or their fragments may be a “fusion” molecule (i.e., a part of a larger nucleic acid molecule) such that, upon expression, a fusion protein is produced. It is understood that any of the nucleic acid molecules of the present invention may be expressed, via recombinant means, to yield proteins or peptides encoded by these nucleic acid molecules.
The antibodies that specifically bind proteins and protein fragments of the present invention may be polyclonal or monoclonal and may comprise intact immunoglobulins, or antigen binding portions of immunoglobulins fragments (such as (F(ab′), F(ab′)2), or single-chain immunoglobulins producible, for example, via recombinant means. It is understood that practitioners are familiar with the standard resource materials which describe specific conditions and procedures for the construction, manipulation and isolation of antibodies (see, for example, Harlow and Lane, In: Antibodies: A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor, N.Y. (1988)).
Murine monoclonal antibodies are particularly preferred. BALB/c mice are preferred for this purpose, however, equivalent strains may also be used. The animals are preferably immunized with approximately 25 μg of purified protein (or fragment thereof) that has been emulsified in a suitable adjuvant (such as TiterMax adjuvant (Vaxcel, Norcross, Ga.)). Immunization is preferably conducted at two intramuscular sites, one intraperitoneal site and one subcutaneous site at the base of the tail. An additional i.v. injection of approximately 25 μg of antigen is preferably given in normal saline three weeks later. After approximately 11 days following the second injection, the mice may be bled and the blood screened for the presence of anti-protein or peptide antibodies. Preferably, a direct binding Enzyme-Linked Immunoassay (ELISA) is employed for this purpose.
More preferably, the mouse having the highest antibody titer is given a third i.v. injection of approximately 25 μg of the same protein or fragment. The splenic leukocytes from this animal may be recovered 3 days later and then permitted to fuse, most preferably, using polyethylene glycol, with cells of a suitable myeloma cell line (such as, for example, the P3x63Ag8.653 myeloma cell line). Hybridoma cells are selected by culturing the cells under “HAT” (hypoxanthine-aminopterin-thyrnine) selection for about one week. The resulting clones may then be screened for their capacity to produce monoclonal antibodies (“mAbs”), preferably by direct ELISA.
In one embodiment, anti-protein or peptide monoclonal antibodies are isolated using a fusion of a protein or peptide of the present invention, or conjugate of a protein or peptide of the present invention, as immunogens. Thus, for example, a group of mice can be immunized using a fusion protein emulsified in Freund's complete adjuvant (e.g., approximately 50 μg of antigen per immunization). At three week intervals, an identical amount of antigen is emulsified in Freund's incomplete adjuvant and used to immunize the animals. Ten days following the third immunization, serum samples are taken and evaluated for the presence of antibody. If antibody titers are too low, a fourth booster can be employed. Polysera capable of binding the protein or peptide can also be obtained using this method.
In a preferred procedure for obtaining monoclonal antibodies, the spleens of the above-described immunized mice are removed, disrupted and immune splenocytes are isolated over a ficoll gradient. The isolated splenocytes are fused, using polyethylene glycol with BALB/c-derived HGPRT (hypoxanthine guanine phosphoribosyl transferase) deficient P3x63xAg8.653 plasmacytoma cells. The fused cells are plated into 96 well microtiter plates and screened for hybridoma fusion cells by their capacity to grow in culture medium supplemented with hypothanthine, aminopterin and thymidine for approximately 2–3 weeks.
Hybridoma cells that arise from such incubation are preferably screened for their capacity to produce an immunoglobulin that binds to a protein of interest. An indirect ELISA may be used for this purpose. In brief, the supernatants of hybridomas are incubated in microtiter wells that contain immobilized protein. After washing, the titer of bound immunoglobulin can be determined using, for example, a goat anti-mouse antibody conjugated to horseradish peroxidase. After additional washing, the amount of immobilized enzyme is determined (for example through the use of a chromogenic substrate). Such screening is performed as quickly as possible after the identification of the hybridoma in order to ensure that a desired clone is not overgrown by non-secreting neighbor cells. Desirably, the fusion plates are screened several times since the rates of hybridoma growth vary. In a preferred sub-embodiment, a different antigenic form may be used to screen the hybridoma. Thus, for example, the splenocytes may be immunized with one immunogen, but the resulting hybridomas can be screened using a different immunogen. It is understood that any of the protein or peptide molecules of the present invention may be used to raise antibodies.
Such antibody molecules or their fragments may be used for diagnostic purposes. Where the antibodies are intended for diagnostic purposes, it may be desirable to derivatize them, for example with a ligand group (such as biotin) or a detectable marker group (such as a fluorescent group, a radioisotope or an enzyme).
The ability to produce antibodies that bind the protein or peptide molecules of the present invention permits the identification of mimetic compounds of those molecules. A “mimetic compound” is a compound that is not that compound, or a fragment of that compound, but which nonetheless exhibits an ability to specifically bind to antibodies directed against that compound.
Having now generally described the invention, the same will be more readily understood through reference to the following examples which are provided by way of illustration, and are not intended to be limiting of the present invention, unless specified.
EXAMPLE 1
In this example, DNA is extracted from soybean plants, amplified, and mapped.
A single trifoliate leaf is collected from the newest growth of four week old soybean plants. Leaf tissue from the leaf is placed on ice and stored at −80° C. The frozen tissue is lyophilized, and approximately 0.01 grams of the tissue is used for DNA extraction. The 0.01 grams of leaf tissue is ground to powder in 1.4 ml tubes. 600 microliters (μl) of DNA extraction buffer consisting of 0.5M NaCl, 0.1M Tris-(hydroxymethyl) aminomethane pH 8.0, 0.05 M ethylenediaminetetra-acetic acid (EDTA), 10.0 g L−1 sodium dodecyl sulfate (SDS), and 2 g L−1 phenantroline (dissolved in 0.01 L ethanol) is heated to 65° C. (with 0.77 g L−1 dithiothreitol added immediately before use) is added to each tube, and each tube is mixed thoroughly. The samples are placed in a 65° C. water bath for 15 minutes and shaken by hand after 10 minutes. The samples are taken out of the water bath and cooled to room temperature, and then 200 μl of 5 M KOAc is added to each tube. The samples are inverted and placed at 4° C. for 20 minutes. Samples are then centrifuged for 12 minutes at 6200× g and the supernatant (about 600 μl) is transferred to new tubes. DNA is precipitated with 330 μl of cold isopropanol and placed at −20° C. for 1 hr. The DNA is pelleted by centrifuging at 6200× g for 10 minutes and washed with 70% EtOH. The DNA is pelleted by centrifugation at 6200× g for 10 minutes and dried using a Speed-Vac. The DNA is dissolved in 100 μl of TE0.1 (0.01 M Tris-HCl pH 8.0, 0.0001 M EDTA). The extraction will generally yield 500 ng DNA μl−1.
A polymerase chain reaction (PCR) is conducted with 5 to 10 ng genomic DNA in 10 μl volumes of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 0.001% gelatin, 1.5 mM MgCl2, 0.1 mM of each dNTP, 150 nM of each primer, 0.01 mM Cresol Red, 2% sucrose and 0.32 units of AmpliTaq DNA Polymerase (Perkin Elmer Instruments Inc., USA). For thermocycling, the Gene Amp PCR System 9700 (Perkin Elmer Instruments Inc., USA) is used with one step of 94° C. for 3 minutes, then 32 cycles of 94° C., 47° C., and 72° C. steps of 25 sec each and one final step of 72° C. for 3 minutes. The PCR products are run on a 6% polyacrylamide gel (30 cm×8 cm×1 mm) in 1× TAE (40 mM Tris-HCl, pH 8.3, 1 mM EDTA) at 180 v for 45 minutes. The gels are stained using SYBR Gold (Molecular Probes, Eugene, Oreg.) according to the manufacturer's instructions.
SSR primer screening for polymorphism is performed using PIC, HS-1, Will and PI507354 genotypes. SSRs that are polymorphic and easy to score (i.e., clear banding pattern and good separation between alleles) are mapped using the HS-1×PIC (F2) and/or Will x PI507354 (RIL) mapping populations. At least one SSR per BAC sequence is mapped. DNA markers that exhibited codominant banding patterns are scored as homozygous for one or the other parent or as heterozygous, exhibiting both parental alleles. Marker scores are checked for segregation distortion using the chi-squared test for goodness of fit to expected ratios. Linkage relationships are determined using Mapmaker Version 3.0b with a LOD of 3.0 (Whitehead Institute, Cambridge, Mass.).
EXAMPLE 2
DNA fragments containing candidates for genes rhg1 and Rhg4 from susceptible and resistant soybean lines are subcloned into a TA cloning plasmid (TOPO TA Cloning Kit, Version E, Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, Calif.).
Genomic DNA from 24 susceptible and 9 resistant lines is isolated using standard techniques. Approximately 500 nanograms (ng) of DNA is used for PCR amplification. Resistant BAC DNA is isolated by using AUTOGEN (AutoGen Corp., 35 Loring Drive Framingham, Mass.). PCR amplification is then performed using 0.1–0.2 ng of resistant BAC DNA. The primers that are used to amplify candidate rhg1 genes PCR are as follows:
Fragment I (2,892 bp) primer (SEQ ID NO: 25), GCA ATA CTT GAA GGA ATA TGT CCA C; primer (SEQ ID NO: 24), beginning at start codon, ATG GAT GGT AAA AAT TCA AAA CTA AAC; modified reverse primer 1 (SEQ ID NO: 1123), beginning 5 bp before start codon; GTT GTA TGG ATG GTA AAA ATT CAA AAC. Fragment II (1,746 bp) reverse primer 2 (SEQ ID NO: 27), ending at 13 bp after stop codon, GAC TGG CTG TGA CTG ATC TCT CT; primer 2 (SEQ ID NO: 26), CTC ACT TAC ACT GCT GAA TGC AGA.
The primers for Rgh4 PCR are as follows:
Forward primer (SEQ ID NO: 48), ATG TCT CTC CCC AAA ACC CTA CTT TCT CTC; reverse primer (SEQ ID NO: 49), ending at 2 bp after stop codon, GGT TAA CGG CAA TCC ATT GAA TCA AAG GAG.
PCR amplification is performed in an MJ Research PTC DNA Engine TM System, Model PTC-225 (MJ Research Inc, 590 Lincoln Street Waltham, Mass.). PCR is performed using the following components: 1μl DNA, 5 μl 10× buffer, 1μl primer 1 μl primer 2, 1 μl 10 mM dNTP, 1.5 μl 50 mM MgCl2, 0.2 μl Taq. (Platinum), 39.3μl H2O. The PCR program used is as follows: 95° C. for 10 minutes (step 1), 95° C. for 30 seconds (step 2), 70° C. for 30 seconds/−1° C. per cycle/72° C. for 3 minutes (step 3), repeat steps two through three 9 times (step 4), 95° C. for 30 seconds (step 5), 60° C. for 30 seconds (step 6), 72° C. for 3 minutes (step 7), repeat steps five through seven 34 times (step 8), 4° C. forever (step 9), end.
PCR products are separated on 1% agarose gel by electrophoresis. A single DNA band is excised from gel. Gel extraction is done using CLONTECH NucleoSpin Extraction Kit (Clonetech Laboratories Inc., 1020 East Meadow Circle, Palo Alto, Calif.). 2 μl of purified DNA is loaded on 1% agarose gel to check concentration. 40–100 ng of DNA is used for subcloning.
A TOPO cloning reaction is done according to the following: 4 μl of fresh PCR product, 1 μl Clontech Salt Solution, and 1 μl TOPO vector. The solution is mixed gently, incubated for 10 minutes at room temperature, and then placed on ice.
A one shot chemical transformation is performed as follows. 2 μl of the TOPO Cloning reaction is added to a vial of TOP 10 One Shot Chemically Competent E. coli and mixed gently. The mixture is then Incubated on ice for 30 minutes. The cells are then heat-shocked for 30 seconds at 42° C., and immediately transferred to ice. 250 μl of SOC medium is then added, and the mixture is incubated at 37° C. for 1 hour. 80 μl is then spread onto a selective plate, and 170 μl is spread onto another plate. The plates are incubated at 37° C. for 18–20 hours. The selective plates are LB agar plates with 100 μg/ml ampicillin, 40 μg/ml IPTG, and 40 μg/ml X-GAL.
After incubation, 8–10 white or light blue colonies are selected. The positive colonies are inoculated into LB medium containing 50 μg/ml ampicillin and incubated at 37° C. overnight. Sterilized glycerol is added to make 15% glycerol stock, which can be stored at −80° C.
Sanger sequencing reactions are performed on subclones using BigDye Terminators (Applied Biosystems, 850 Lincoln Centre Drive, Foster City, Calif.) and then analyzed on ABI 377/ABI 3700 automated sequencing machines (Applied Biosystems, 850 Lincoln Centre Drive, Foster City, Calif.). The sequences are evaluated for quality and error probability using the program, PBRED (Ewing and Green, Genome Res., 8:186–194 (1998), Ewing et al., Genome Res., 8:175–185, (1998)), assembled using the phrap assembler and viewed using consed (Gordon et al., Genome Res., 8:195–202). An rhg1 candidate gene is found in BAC 240017, and is about 4.5 kb in size. An Rhg4 candidate was found in BAC 318013, and is about 3.5 kb in size.
EXAMPLE 3
The physical mapping of a QTL (quantitative trait locus) is described in this example. Mapping is initiated with linkage analysis of SSR (simple sequence repeats) markers. Markers that are shown to be linked to the QTL of interest are used to PCR screen the soy BAC library and identify candidate BACs. Confirmed BACs are subcloned and sequenced, BAC-end sequenced, and fingerprinted. New markers are designed from good BAC-end sequences and used to screen the library, by either PCR or hybridization to high density grid filters, in order to extend the contigs. A BAC-end sequence and fingerprint database of soy BACs is used in conjunction with the above methods to help build and extend contigs. Sequenced BACs are aligned, and overlapping BACs are placed into contigs. These contigs, which contain unique sequences, are put into an ACEDB database, and predicted genes are annotated by hand using various programs. Candidates genes (for the gene of interest) are subdloned from genomic DNA of different lines by PCR using primers from outside the predicted coding regions. These subclones are sequenced and screened for SNPs (single nucleotide polymorphisms) and INDELs (insertions/deletions), and different haplotypes of the lines with and without the desired phenotype are examined for correlations between the haplotype and phenotype.
A single trifoliate leaf is collected from the newest growth of four week old soybean plants. The leaf tissue is placed on ice and stored at −80° C. The frozen tissue is lyophilized and approximately 0.01 grams of tissue is used for DNA extraction. The leaf tissue is ground to powder in 1.4 ml tubes and 600 μl of DNA extraction buffer [0.5M NaCl, 0.1M Tris-(hydroxymethyl) aminomethane pH 8.0, 0.05 M ethylenediaminetetra-acetic acid (EDTA), 10.0 g L−1 sodium dodecyl sulfate (SDS), 2 g L−1 phenantroline (dissolved in 0.01 L ethanol)] heated to 65° C. (with 0.77 g L−1 dithiothreitol added immediately before use) is added to each tube and mixed thoroughly. The samples are placed in a 65° C. water bath for 15 minutes and shaken by hand after 10 min. The samples are taken out of the water bath, cooled to room temperature, and 200 μl of 5 M KOAc is added to each tube. The samples are inverted and placed at 4° C. for 20 min. Samples are then centrifuged for 12 minutes at 6200× g and the supernatant (about 600 μl) is transferred to new tubes. DNA is precipitated with 330 μl of cold isopropanol and placed at −20° C. for 1 hr. The DNA is pelleted by centrifuging at 6200× g for 10 minutes and is washed with 70% EtOH. The DNA is pelleted by centrifugation at 6200× g for 10 minutes and dried using a Speed-Vac. The DNA is dissolved in 100 μl of TE0.1 (0.01 M Tris-HCl pH 8.0, 0.0001 M EDTA). The extraction yields 500 ng DNA μl−1.
The polymerase chain reaction (PCR) is conducted with 5 to 10 ng genomic DNA in 10 μl volumes of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 0.001% gelatin, 1.5 mM MgCl2, 0.1 mM of each dNTP, 150 nM of each primer, 0.01 mM Cresol Red, 2% sucrose and 0.32 units of AmpliTaq DNA Polymerase (Perkin Elmer Instruments Inc., USA, 761 Main Avenue, Norwalk, Conn.). For thermocycling, the Gene Amp PCR System 9700 (Perkin Elmer Instruments Inc., U.S.A., 761 Main Avenue, Norwalk, Conn.) is used with one step of 94° C. for 3 min, then 32 cycles of 94° C., 47° C. and 72° C. steps of 25 sec each and one final step of 72° C. for 3 min. The PCR products are run on a 6% polyacrylamide gel (30 cm×8 cm×1 mm) in 1× TAE (40 MM Tris-HCl, pH 8.3, 1 mM EDTA) at 180 v for 45 min. The gels are stained using SYBR Gold (Molecular Probes, Eugene, Oreg.) per manufacturers instructions.
SSR primer screening for polymorphisms is performed using PIC, HS-1, Will and PI507354 genotypes. SSRs that are polymorphic and easy to score (i.e., Clear banding pattern and good separation between alleles) are mapped using the HS-1 xPIC (F2) and/or Will x PI507354 (RIL) mapping populations. At least one SSR per BAC sequence is mapped. DNA markers that exhibited codominant banding patterns are scored as homozygous for one or the other parent or as heterozygous, exhibiting both parental alleles. Marker scores are checked for segregation distortion using the chi-squared test for goodness of fit to expected ratios. Linkage relationships were determined using Mapmaker Version 3.0b with a LOD of 3.0 (Whitehead Institute for Biomedical Research, Cambridge Mass.).
Thirty-two BAC DNA superpools (10 genomic equivalents) extracted from either 4608 clones (48 96-well microtiter plates) are used as templates for the first round of PCR screening. Following identification of the positive superpools, the second screening is performed against 4-D BAC DNA pools. Each clone of the superpool is addressed 4-dimentionally (7×7×12×8) and pooled in each dimension. Each set of 48 plates is divided into 6 sets of 7 plates and one set of 6 plates, and partitioned in two ways. The first partition is in numerical order, plates 1–7,8–14, . . . 43–48 representing 7 group or stack pools. The second partition is according to plate position within each of the respective stacks, plates [1, 8, 15, 22, 29, 36], [2, 9, 16, 23, 30, 37, 43] etc., representing 7 plate pools. Each well of the 96-well plates contains 12 columns and 8 rows. Clones from row 1 are pooled from all 48 plates to generate the row 1 pool. Clones of rows 2, 3, 4 . . . 8, and columns 1, 2, 3 . . . 12 are pooled to generate 8 row pools and 12 column pools respectively.
For each superpool, BAC DNA is extracted from a total of 34 subpools (7+7+8+12). Positive clones are identified by TaqMan/PCR screening of the 34 subpools if one positive clone is present. If more than one positive clone is present in a superpool, a third round of screening with N4 PCR reactions is performed.
Addresses of candidate BACs are identified, and the candidates are streaked out for single colony isolation and grown overnight at 37° C. A single, isolated colony is picked and streaked out and grown overnight at 37° C. PCR is repeated for the marker of interest (using the program designed for the relevant marker) using a smear of cells from the plate streaked from a single colony. The PCR product is run on a 2% agarose gel and purified using the Clonetech NucleoSpin Gel Extraction Kit (according to the manufacturer's instructions, Clonetech Laboratories Inc., 1020 East Meadow Circle, Palo Alto, Calif.) and 10–50 ng of the purified DNA are added to 10 pmol of each primer (forward and reverse), in a total volume of 6 μl of ddH2O and 2 μl of BigDye Terminators (Applied Biosystems, 850 Lincoln Centre Drive, Foster City, Calif.). The cycling conditions are: 96° C. for 1 minute (step 1), 96° C. for 10 seconds (step 2), 50° C. for 5 seconds (step 3), 60° C. for 4 minutes (step 4), steps 2–4 are repeated for 24 cycles (step 5), and hold at 4° C.
The generated sequence is compared to the consensus sequence using DNA comparison software. Confirmed clones are subcloned, sequenced, BAC-end sequenced, and Fingerprinted.
BAC-end sequencing is done using 3.2 pmol of SP6 and T7 primers (separately), approximately 600 ng-1 ug of BAC DNA (Autogen prepped, AutoGen Corp., 35 Loring Drive Framingham, Mass.) reaction, resuspended in 6 μl of ddH20, and 4 μl of BigDye Terminators (Applied Biosystems 850 Lincoln Centre Drive, Foster City, Calif.) to give a total reaction volume of 10 ul. The cycling conditions are: 96° C. for 2 minutes (step 1), 96° C. for 15 seconds (step 2), 50° C. for 15 seconds (step 3), 60° C. for 4 minutes (step 4), steps 2–4 are repeated for 50–60 cycles (step 5), 72° C. for 2 minutes (step 6), hold at 4° C. or 10° C. (step 7).
The reactions are ethanol precipitated and loaded on capillary sequencers. The newly generated BAC-end sequence is trimmed from the vector sequence, and entered into a database containing approximately 400,000 BAC-end sequences. Each BAC is blasted against the database to search for BAC-end matches extension of the contigs. New markers are designed from good BAC-end sequences, and these are then used to rescreen the library in order to build up contigs across the region of interest. Screening can be done in either of two ways: as above (PCR strategy), or by hybridization of high-density grid filters from Research Genetics (Research Genetics, 2130 Memorial Parkway, Huntsville, Ala.).
The probes used for hybridization are derived from clones or genomic DNA by PCR amplification using the vector or gene-specific primers, with the appropriate cycling conditions. PCR products are run on a 1% agarose gel containing ethidium bromide (0.2 ug/ml) in 1× TAE buffer at 100 volt for 1–2 hrs. Isolated DNA fragments are excised and gel-purified using the Clonetech NucleoSpin gel extraction kit (Clonetech Laboratories Inc., 1020 East Meadow Circle, Palo Alto, Calif.), before labeling. In order to check the size of the fragments and concentration, 2 μl of eluted DNA plus loading buffer are loaded on a 1% agarose gel along with DNA markers of known concentration and size. All the probes used to screen the library are tested individually for repetitiveness, with a smaller filter spotted with random clones from the library along with some positive control clones according to the protocol described below.
The A3244 soy library generated by a an EcoRI digest is spotted on 3 high density grid filters from Research Genetics (Research Genetics, 2130 Memorial Parkway, Huntsville, Ala.). Each filter has six fields, twelve 384 well plates are spotted in each field in duplicate, with a total of 27,648 clones spotted on each filter. The plates are spotted in a 5×5 grid (12 clones per 5×5 grid) pattern within each field. Each clone is spotted in duplicate with a specific orientation within the 5×5 grid, which, together with the field position, gives information about its address. In a first round hybridization procedure, multiple probes are labeled separately and then pooled together to hybridize to BAC filters. Positive BACs identified in this procedure are deconvoluted by rehybridization with the individual probes.
A hybridization oven is set at 65° C., and Church Buffer (0.5 M Sodium Phosphate, pH 7.0, 7% SDS, 1% bovine serum albumin, 1 mM EDTA, 100 μg/ml salmon sperm DNA) is prewarmed to 65° C. Membranes are washed in 500 ml of 0.1×SSC, 0.1% SDS in a large container at room temperature for 5 minutes with gentle shaking (50 rpm) on a rotary shaker. The membranes are rinsed with 500 ml of 0.1×SSC (no SDS) for 1 minute. The wash solution is poured off, and 500 ml of 6×SSC (no SDS) is added to equilibrate the membranes. Three filters are placed in a tube. The filters are separated from each other and the sides of the tube by a layer of mesh. Each tube is filled with 6×SSC and shaken gently with the tube vertical to help eliminate bubbles between the filters and tube wall. The 6×SSC solution is poured off, and 25 ml of pre-warmed Church buffer is added. The bottles are rotated in a hybridization oven at 60 rpm and 65° C. for 30 minutes or longer.
Probes are labeled using 1 μl of 40–50 uCi/μl [α32P dCTP], 50 ng of purified DNA in 49 μl of ddH2O, and Read-To-Go Labeling Beads from Amersham Pharmacia according to the manufacturers instructions (Amersham Pharmacia, Uppsala, Sweden). The probes are purified using the Bio-Spin Column P30 from BioRad according to manufacturers instructions (Bio-Rad Laboratories, 3316 Spring Garden Street, Philadelphia, Pa.). To 1 μl of the column-purified probe is added to a minipoly-Q vial (liquid scintillation vial) for each probe. 5 ml of scintillation liquid is added to each vial, and radiation activity for each vial is measured using a liquid scintillation counter.
After the probes are purified and counted for radioactivity, 10–20 probes and one control probe (from 50 μl reaction) are pooled with 107 cpm/probe each, into one 1.5 ml eppendorf tube. The pooled probes are denatured at 99° C. in a sand heating block for 10 minutes. The tubes are cooled on ice or ice water about 2 minutes, and then spun down at 14,000 rpm for 30 seconds in microcentrifuge. The tubes are pre-hybridized in 25 ml of Church buffer for at least 30 minutes, which is then poured off. 40 ml of fresh hybridization solution (pre-warmed Church buffer) is added. The pooled-probe solution is added to the hybridization tube. The tube is rotated in the hybridization oven at 60 rpm, 65° C. overnight.
The probe solution is poured off, 30 ml of pre-warmed (65° C.) 1×SSC, 0.1% SDS washing solution is added to the hybridization tube, the hybridization tube is rotated in the hybridization oven (at 65° C.) for 15 minutes, and the process is repeat two times. At the last wash, the tube is rotated 180° and at the same speed for 15 minutes at 65° C. The washing solution is poured off, and 2×SSC (no SDS) is added.
Excess liquid is removed from each filter by placing the filter on a piece of 3MM paper. The washed filter is placed on developed film with the DNA-side up (the side BACs were spotted on), covered with Saran wrap, and squeezed to force out liquid and bubbles. The Saran wrap is folded to the other side of the film, fixed it with tape, and then dried Kimwipes. The wrapped filters are placed into a film cassette with the DNA-side up (the side BACs were spotted on), which is placed on BioMax MS film (Biomax Technologies Inc., Vancouver, BC, Canada) in a darkroom, and exposed overnight at room temperature without an intensifying screen. Film is developed with a film developer in the dark room the next day, and each film is labeled with filter number, probe used for hybridization, exposure time, and date.
Starting from Field 3, a 384-well grid is put on the field with the A1 position of the grid on the upper right, and the grid is aligned to the image. The row and column position for each positive clone on the BAC recording spreadsheet is determined and recorded. The pattern of the hybridization signal is matched to known patterns. There are 6 plate reference numbers for each of twelve patterns, which are arranged in the same manner as the 6 fields. Based on the signal pattern and field number, a plate reference number is determined for each positive clone. The grid is moved to the next field and the process is repeated. The original plate number (P) is determined using the following formula: P=(N−1)×72+R, where N is the filter number on which the identified clone is present and R is the plate reference number previously determined. The complete address of the identified clone is given by the original plate number plus its position on the plate determined previously. BACs' addresses are identified and converted to “imp” files according to a Q-bot file format.
24 working plates are loaded into a Q-bot (Genetix, Queensway, New Milton, Hampshire, United Kingdom) 6-high hotel and media-filled 96-well plates are placed on the deck. The Q-bot is run following the standard manual using the program called “Rearraying98” with the settings given in Appendix III of the accompanying manual: BAC-Picking. Plates containing picked clones are placed in a shaker incubator and grown overnight at 37° C. at 200 rpm.
35 μl DNA solution are transferred from 96-well plates into a 384-well plate using a Platemate such that 4 96-well plates of DNA are combined into one 384-well plate. The 384-pin head (puck) is washed in 10% SDS solution for 5 minutes, ultrasonicated in a water bath for 3 minutes, washed with 70% ethanol for 1 min., and air dried for 3 minutes. The 384-well DNA source plates and membranes are arranged on the deck according to the instruction from the manual and the spotted grid design chosen for the membrane. Spotting pattern are designed so that there is one control probe at each of the 4 corners of the membrane. An asymmetric pattern is used to orient filters. The control probe concentration is about 5 ng/ul. Zeus is run according to instructions. If the DNA concentration is lower than 5 ng/ul, the Zeus is run a second time to double the amount of spotted DNA on the membrane. One of the empty spots is spot dyed, if available, using one 384-well dye plate. If an empty spot is not available, it is printed on one of the DNA spots. This spot marks the position for cutting filters into small membranes (9×12 cm). Membranes are interleaved between 3M papers and left to air-dry. Each corner of each membrane is marked with a permanent marker and numbered. Filters are denatured on the surface of 3M paper soaked with denaturalization solution for 4 minutes, and then neutralized on the surface of 3 M paper soaked with neutralization solution for 5 minutes. The filters are washed with 2×SSC for 5 minutes and then air dried. The filters are then baked at 80° C. for 1 hr. and cut into individual small membranes (9×12 cm) according to the marked corner.
To confirm and deconvolute, hybridizations are done as before, but with newly generated filters, and each probe is done separately with a single filter using the smaller tube. 15 ml of Church buffer is used for the hybridization.
Fingerprints are generated by digesting the BAC DNA with Hind III for 3 hours at 37° C. and running the reaction on a 0.8% gel at 200V for 19 hours. The gels are stained with SybrGreen, while shaking at room temperature for 45 minutes, and scanned with a FlourImager. The bands are sized using Frag software and the fingerprints are assembled into contigs within FPC. Every time new clones are added the contigs are rebuilt using a tolerance of 10 and a cutoff of 10−9.
Subclones are generated and Sanger sequencing reactions were performed on randomly chosen subclones using BigDye Terminators (Applied Biosystems, 850 Lincoln Centre Drive, Foster City, Calif.) then analyzed on ABI 377/ABI 3700 automated sequencing machines (Applied Biosystems, 850 Lincoln Centre Drive, Foster City, Calif.). 7–8 fold sequence coverage is thereby generated across the BAC. The sequences are evaluated for quality and error probability using the program, phred, assembled using the phrap assembler, and viewed using consed, as in example 2. For Bermuda standard BACs, all contigs are ordered and oriented and all gaps are closed using a directed primer walking strategy. A final quality value of phred40 (1 base error in 10,000 bases) with no gap regions, double coverage or two chemistries across single stranded areas is achieved.
The sequence contigs are put into an ACEDB database along with soy EST and plant EST matches, along with Blastx, Tblastx, and Plant Blastn hits. Genemark.hmm is used to predict possible genes, and GeneFinder is used to predict splicing sites, ORFs, potential coding regions, as well as start and stop codons. The contigs are then annotated by hand and predicted genes accepted, edited, and modified based on the characteristics present in the sequence and matches to protein, nucleotide, and EST databases.
The high-density BAC library membranes used for hybridization are made by Research Genetics (Research Genetics, 2130 Memorial Parkway, Huntsville, Ala.), using a modified Q-bot (Genetix, Queensway, New Milton, Hampshire, United Kingdom), 384-well plates containing BACs are spotted onto 22 cm×22 cm Hybond N+membranes (Amersham Pharmacia, Uppsala, Sweden). Bacteria from 72 plates are spotted twice onto one membrane, giving 55,296 colonies in total, or 27,648 unique clones per membrane. The plates are spotted into six “fields” per membrane, with each field having 12 plates spotted in duplicate. This spotting format results in six fields with 384 grids in each field. Each grid is a 5×5 matrix containing 12 unique clones in duplicate, with the center position left empty. The two positions occupied by each clone in duplicate are designed to give a unique pattern that indicates the plate location of each clone. After spotting, the bacteria on the membrane are incubated for 8 hours on LB-agar plates containing 12.5 ug/ml chloramphenicol. The membranes are then denatured, neutralized, washed in a standard procedure, UV-light crosslinked, and air-dried. The membranes can be stored and shipped at room temperature.
Every reference, patent, or other published work cited above is herein incorporated by reference in its entirety.

## Claims

1. A method of introgressing an allele into a soybean plant comprising
(A) crossing at least one SCN resistant soybean plant having an rhg1 SCN resistant allele with at least one SCN sensitive soybean plant having an rhg1 SCN sensitive allele in order to form a segregating population,
(B) screening said segregating population with one or more nucleic acid markers to determine if one or more soybean plants from said segregating population contains a deletion of 19 nucleotides corresponding to SEQ ID NO: 2 and encompassing position 48881, and
(C) selecting, if present, one or more soybean plants of said segregating population containing said deletion.

2. The method according to claim 1, wherein said one or more soybean plants of said segregating population have a yellow soybean seed.

3. A method of introgressing an allele from a first soybean plant comprising a polymorphism relative to a second soybean plant into a selected soybean plant comprising screening with one or more nucleic acid markers a population of soybean plants formed by a cross of said first and said second soybean plant and selecting a soybean plant, wherein said allele is an allele having one or more polymorphisms in a protein coding region corresponding to nucleotides 45163 to 45314, 45450 to 45509, 46941 to 48763 or 48975 to 49573 of SEQ ID NO: 2
thereby introgressing said allele from said first soybean plant comprising a polymorphism into said selected soybean plant.

4. The method according to claim 3, wherein said polymorphisms selected from the group consisting of 45173, 45309, 47057, 47140, 47208, 47571, 47617, 47796, 47856, 47937, 48012, 48060, 48073, 48135, 48279, 48413, 48681, 49012, and 49316 of SEQ ID NO: 2.

5. The method according to claim 3, wherein said introgressing said allele into said selected soybean plant results in a yellow soybean seed.

6. A method of introgressing an allele comprising a polymorphism into a soybean plant lacking said polymorphism comprising screening a population of soybean plants with one or more nucleic acid markers and selecting a soybean plant, wherein said one or more nucleic acid markers are capable of detecting one or more polymorphisms located at a position in SEQ ID NO: 2 selected from the group consisting of 45173, 45309, 47057, 47140, 47208, 47571, 47617, 47796, 47856, 47937, 48012, 48060, 48073, 48135, 48279, 48413, 48681, 49012, and 49316,
thereby selecting a soybean plant comprising said polymorphism.

7. The method according to claim 6, wherein said introgressing said allele comprising a polymorphism into said soybean plant results in one or more soybean plant having a yellow soybean seed and said polymorphism.

8. A method of introgressing an rhg1 SCN resistant allele into a non-resistant soybean plant comprising
(A) crossing at least one SCN resistant soybean plant having said rhg1 SCN resistant allele corresponding to an rhg1 SCN resistant allele present in Peking with at least one SCN sensitive soybean plant having an rhg1 SCN sensitive allele in order to form a segregating population,
(B) screening said segregating population with one or more nucleic acid markers to identify said rhg1 SCN resistant allele, wherein said one or more nucleic acid markers are capable of detecting a polymorphism located at a position in SEQ ID NO: 2 corresponding to nucleotides between 45163 and 49573, and
(C) selecting one or more members of said segregating population having said rhg1 SCN resistant allele.

9. The method according to claim 8, wherein said one or more members of said segregating population have a yellow soybean seed.

10. The method according to claim 8, wherein said one or more nucleic acid markers are capable of detecting a single nucleotide polymorphism or INDEL mutation.

11. The method according to claim 8, wherein said one or more nucleic acid markers are capable of detecting one or more polymorphisms located at a position in SEQ ID NO: 2 selected from the group consisting of 45173, 45309, 47057, 47140, 47208, 47571, 47617, 47796, 47856, 47937, 48012, 48060, 48073, 48135, 48279, 48413, 48681, 49012, 49316, and 46703.

12. The method according to claim 8, wherein said one or more nucleic acid markers are capable of detecting single nucleotide polymorphisms.

13. The method according to claim 12, wherein said single nucleotide polymorphisms are located at a position in SEQ ID NO: 2 selected from the group consisting of 45173, 45309, 47057, 47140, 47208, 47571, 47617, 47796, 47856, 47937, 48012, 48060, 48073, 48135, 48279, 48413, 48681, 49012, and 49316.

14. The method according to claim 8, wherein said one or more nucleic acid markers are capable of detecting INDEL mutations.